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1 Introduction 
Many cellular processes such as cell migration, adhesion, mitosis, morphogenesis and 
endocytosis critically depend on a dynamic filament system. In mammalian cells this 
filament system is composed of three different kinds of cytoskeletal filaments - 
microtubules, intermediate filaments and actin filaments. 
Microtubules consist of αβ-tubulin heterodimers and represent essential components of 
flagella and the mitotic spindle. In vivo microtubules are nucleated within the 
microtubule organising centre (MTOC) to which they remain attached with their minus 
ends while their plus ends grow into the cytoplasm. They form a distinct network that 
provides tracks for motor proteins that are engaged in intracellular transport, the 
organisation of organelles and cell division (Wade and Hyman, 1997).  
Intermediate filaments are stable, rope-like filaments that most likely provide 
mechanical stability to cells or cell sheets. Data from animal models suggest that they 
have additional functions in a whole range of metabolic signalling and regulatory 
processes unrelated to their mechanical function (Pallari and Eriksson, 2006).  
Over the last decades many studies have focused on unravelling the precise 
mechanisms of actin assembly and its regulation. It is evident today that actin 
polymerisation and depolymerisation is crucial for the formation of protrusive structures 
such as lamellipodia and filopodia, but the proteins and signalling pathways 
contributing to lamellipodia and filopodia formation are still under investigation. 
Lamellipodia formation critically depends on the actin nucleation activity of the Arp2/3-
complex, but in terms of filopodia formation much less is known about the specific 
mechanism of initiation and nucleation. 
Recently new classes of actin nucleators were found, one of them being the so called 
formin family. These proteins have been implicated in many actin-based processes 
such as cytokinesis, establishment and maintenance of cell polarity, stress fibre 
formation and cell migration. This protein family consists of 15 members, among them 
the well studied Diaphanous related formin 3 (mDia2/Drf3) and the yet insufficiently 
characterised formin FMNL2. In spite of significant efforts to unravel the precise cellular 
function of different formins, it is still highly controversial how exactly specific formins 
contribute to the formation of lamellipodia and filopodia. 
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1.1 Actin polymerization 
The actin cytoskeleton is involved in many highly dynamic processes such as cell 
migration, abrupt or continuous changes and maintenance of cell morphology and 
tumor metastasis. To ensure that cells are able to respond to a large variety of signals 
leading to actin rearrangement, actin polymerization has to be fast and tightly 
regulated. Biochemically however, spontaneous actin polymerisation requires a slow 
nucleation process. Self assembly of monomeric globular actin (G-Actin) to an actin 
dimer or trimer is thermodynamically unfavoured, which is why actin nucleators are 
required to overcome these kinetic barriers (see 1.3.1). 
Once a nucleation seed is formed, e.g. triggered by an actin nucleator, it becomes 
more favourable to add another monomer than to return to a dimer. ATP-Actin is 
incorporated at both sides of the growing actin filament in a process termed 
polymerisation to form helical filaments called F-actin (filamentous actin). Electron 
microscopy experiments of these actin filaments decorated with HMM (heavy mero 
myosin) revealed that actin filaments are polarized with a fast growing barbed and a 
slow growing pointed end (Huxley, 1963). As the monomers are shifted within the 
filament towards the pointed end, ATP-actin is slowly hydrolysed to ADP-actin. ADP-
actin has a lower affinity for the growing filament than ATP-actin resulting in 
dissociation from the filament, a process called depolymerisation. Since ATP hydrolysis 
lowers the affinity of ADP-bound actin within an actin filament as compared to ATP-
bound actin (Korn et al., 1987), it generates a difference in the critical concentration 
(Cc) between the barbed and the pointed end. Net polymerisation at either end occurs 
when the G-actin concentration is higher than the critical concentration, and net 
depolymerisation occurs when the G-actin concentration is lower than Cc. When 
equilibrium is established (steady state) pointed ends undergo constant disassembly 
which is exactly compensated by actin association to the barbed end, a process termed 
treadmilling (Figure 1). In this case actin filaments move forward while keeping a 
constant length (Pollard, 1986). ADP-actin disassembly from the pointed end 
constitutes the rate limiting step and determines the concentration of monomeric actin 
and thereby the rate of barbed end growth (Kirschner, 1980; Wegner, 1976; Wegner, 
1977). Continuous incorporation of actin monomers at the barbed end generates a 
force sufficient to push the membrane forward to form structures such as lamellipodia 
and filopodia. To couple membrane protrusion and retraction to extracellular signals, 
actin polymerisation and depolymerisation are tightly regulated by a huge variety of 
actin binding proteins such as formins and signalling proteins such as Rho-GTPases. 
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1.2 Cellular organisation of the actin cytoskeleton 
Cell motility is a prerequisite for many cellular processes such as embryonal 
development, proper immune response and the abnormal behaviour of metastasizing 
cancer cells. As a first step in migrating towards certain extracellular stimuli, cells 
exhibit a characteristic polarized morphology. At the cell front, actin assembly drives 
the formation of a flat membrane protrusion called lamellipodium and finger like 
projections termed filopodia (Figure 2). Focal adhesions are formed at the leading edge 
to anchor the protrusion to the extracellular matrix. Finally, to move forward, the cell 
retracts its trailing edge by combining actomyosin contractility and disassembly of 
adhesions at the rear. Dynamic actin structures like lamellipodia, filopodia and stress 
fibres (Figure 2) are crucial for fundamental processes such as cell migration. 
 
 
 
 
 
 
Figure 1: Actin treadmilling at steady state 
Actin monomers are incorporated in the barbed end and dissociate at 
the pointed end. Maturation of the filament leads to the hydrolysis of 
ATP-actin to ADP-actin and the release of Pi. Subsequently ADP-actin 
is exchanged to ATP-actin which can reincorporate into the barbed 
end (from Carlier and Pantaloni, 1997). 
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1.2.1 Lamellipodia/membrane ruffles 
Ingram and Abercrombie were among the first to systematically investigate the leading 
edge of motile cells (Ingram 1969; Abercrombie 1970). When this structure was moving 
parallel to the substrate it was referred to as lamellipodium when it turned upward it 
was designated as membrane ruffle. Subsequent analyses revealed that the 
lamellipodium consists of a dense array of actin filaments and demonstrated that 
protrusion was based on actin polymerisation. By injecting fluorescently labelled actin 
molecules into the cell body, the lamellipodium was discovered to be the primary site of 
actin incorporation (Glacy, 1983). The fast growing barbed end of the actin filament is 
orientated towards the plasma membrane (Small et al., 1978) pushing the membrane 
 
Figure 2: Migrating fibroblast showing different types of membrane protrusions 
Main protrusive structures frequently found in migrating cells are lamellipodia, filopodia, 
peripheral and dorsal ruffles. Microspikes, which remain embedded in the lamellipodium, 
and filopodia, which protrude beyond the cell periphery, consist of parallel bundles of actin 
filaments. Lamellipodia are characterised by their crisscross arrangement of actin 
filaments. By folding up- and backwards in a process termed ruffling lamellipodia generate 
peripheral or circular dorsal ruffles (bottom), the latter of which are implicated into 
macropinocytosis. Concentration of dynamic actin filaments (F-actin) at the cell periphery is 
indicated by the gradient of red intensity (from Ladwein and Rottner, 2008). 
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forward by incorporation of actin at the barbed end and depolymerisation at the pointed 
end in a treadmilling fashion.  
By applying critical-point-drying-replica technique Svitkina and colleagues observed 
multiple branches in the lamellipodium, giving rise to the dendritic nucleation model 
(Svitkina and Borisy, 1999; Mullins et al., 1998). In this model the Arp2/3-complex 
nucleates new actin filaments, caps their pointed ends and anchors them in a 70° angle 
to the sides of pre-existing filaments. This is supported by in vitro data showing that the 
Arp2/3-complex nucleates branched actin filaments with a characteristic angle of 70° 
(Blanchoin et al,. 2000; Pantaloni et al., 2001). However, recent data suggest that the 
critical point drying technique introduces distortions into actin networks, such that 
crossing filaments may appear branched (Small and Auinger, 2008). Actual negative 
staining and preliminary cryo electron tomography studies showed no indication for 
actin filament branching in the lamellipodium, showing that the lamellipodium is a 
distinct protrusive entity composed of a network of primarily unbranched actin filaments 
(Koestler et al., 2008; Small and Auinger, 2008). To fully understand the ultrastructure 
of the lamellipodium, additional electron tomography studies are required. 
1.2.2 Filopodia/microspikes 
Another type of cellular protrusion is termed filopodium. Filopodia are highly dynamic 
structures that can be found in many different cell types and were most intensely 
studied in motile cells such as fibroblasts and the neuronal growth cone. Filopodia are 
finger-like membrane projections filled with tight bundles of parallel actin filaments. 
They serve as pioneers during protrusion by sensing the environment e.g. for directed 
cell migration. Filopodia contain receptors for diverse signalling molecules and 
extracellular matrix molecules (Galbraith et al., 2007; Vasioukhin et al., 2000). In 
addition, they play a role in cell-cell adhesion in epithelial cells, wound closure in 
Drosophila (Wood et al., 2002) and in guiding axons and dendrites towards their proper 
targets in the neuronal growth cone (Gallo and Letourneau, 2004). Similar to 
lamellipodia, the fast growing ends of actin bundles within the filopodium are oriented 
towards the plasma membrane and push the membrane forward by continuous 
elongation. 
Lamellipodia frequently contain tight parallel bundles of actin filaments called 
microspikes, which remain embedded within the lamellipodium upon continuous 
protrusion. By protruding beyond the leading edge microspikes can develop into 
filopodia, however microspikes are no essential precursors for filopodia formation.  
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It is still highly controversial how filopodia are nucleated and so far two alternative 
models of filopodia formation have been presented. As filopodia are often associated 
with lamellipodia Svitkina and colleagues proposed that filopodia initiation and 
maintenance critically depends on Arp2/3-complex nucleated lamellipodial actin 
filaments (Svitkina et al., 2003). In this so called convergent elongation model the 
elongation of some barbed ends in the network is terminated by capping, whereas 
other filament barbed ends are bound by a tip-complex that allows continuous 
elongation and clustering of several barbed ends. This privileged barbed ends continue 
to elongate together and are subsequently crosslinked by the actin bundling protein 
fascin to generate the typical filopodial architecture of actin filaments (Gupton and 
Gertler, 2007). 
However, several independent studies failed to establish the requirement of 
lamellipodial filaments in filopodia formation (Nicholson-Dykstra and Higgs, 2008; 
Steffen et al, 2006). These observations led to an alternative model of filopodia 
formation by de novo nucleation. Here, actin filaments in filopodia do not derive from 
the underlying lamellipodial network, but are nucleated at filopodial tips by actin 
nucleators such as formins independent of the Arp2/3-complex (Faix and Rottner, 
2006). In this case, lamellipodia and filopodia are initiated and maintained by separable 
core machineries regulated by distinct signalling pathways (Faix et al., 2009). This 
hypothesis has been supported by recent findings in Dictyostelium showing that the 
formin dDia2 is essential for initiation and maintenance of filopodia in this cell type 
(Schirenbeck et al., 2005). In mammalian cells, increasing evidence suggests that 
filopodia formation is accomplished by formins such as mDia2 (Yang et al., 2007; Beli 
et al., 2008; see 1.3.1.2.2). 
1.2.3 Stress fibres 
Stress fibres were initially identified as thick actin filaments (Lewis and Lewis, 1924; 
Byers et al., 1984). Nowadays, it is well established that they are thick bundles of actin 
filaments containing contractile α-actinin-myosin structures, which allows them to 
produce contractile forces important to maintain tension and cell shape. Stress fibres 
often terminate at least with one end in focal contacts, which represent regions of very 
close contact between the ventral cell surface and the substratum (Izzard and Lochner, 
1976). A second type of adhesion structure termed focal complexes are defined as 
smaller adhesion sites residing at the base of lamellipodia, which can mature into focal 
contacts (Rottner et al., 1999b; Zaidel-Bar et al., 2003). 
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1.3 Regulation of actin assembly 
In vitro, actin polymerisation is too slow to account for the rapid morphological changes 
and fast protrusion in response to extracellular signals. To accelerate actin assembly in 
vivo, polymerisation is highly regulated by many different actin binding proteins. As 
mentioned earlier, nucleation, which represents the first step of de novo filament 
formation, is energetically unfavourable for which reason actin nucleators are 
necessary to catalyse formation of the actin seed. In addition, several other proteins 
are required to control polymerisation and depolymerisation, terminate filament growth 
by capping and for stabilisation, bundling and severing of the growing filaments (dos 
Remedios et al., 2003). A subset of these actin binding proteins has emerged to be 
essential for actin-based motility in vitro by reconstitution of actin-mediated motility on 
either bacteria or functionalised beads (Loisel et al., 1999; Wiesner et al., 2003). Actin-
based motility could be initiated and maintained in minimal motility medium containing 
an actin nucleator (Arp2/3-complex), an Arp2/3-complex activator (nucleating 
promoting factor e.g. N-WASP), an actin depolymerisation factor (ADF/cofilin) and a 
capping protein (Wiesner et al., 2003). Similar experiments in a more recent study 
revealed an Arp2/3-independent process, where actin-based motility is mediated by 
actin, profilin and the FH1-FH2-domain of a formin (Romero et al., 2004). 
1.3.1 Actin nucleators 
A bona fide actin nucleator can be defined as a factor that stimulates formation of a 
filament that grows rapidly at its barbed end. Additionally it is able to efficiently seed 
polymerization from a pool of profilin-bound actin monomers (profilin–actin), since this 
may be the dominant species of available ATP-actin monomers in eukaryotic cells 
(Chesarone and Goode, 2009). Over the last years an increasing number of actin 
nucleators have been identified and characterized. The first identified and very well 
characterised actin nucleator was the Arp2/3-complex. Other prominent actin 
nucleators are members of the formin family and WH2-domain-containing actin 
nucleators including Leiomodin (Lmod), Cordon bleu (Cobl) and Spire proteins. All of 
these proteins are proposed to nucleate actin filament networks with distinct properties. 
1.3.1.1 Arp2/3-complex 
1994 Machesky and colleagues initially purified the Arp2/3-complex from 
Acanthamoeba castellanii using its affinity for the actin-binding-protein profilin 
(Machevsky et al., 1994). Subsequently, the complex could be isolated from several 
other organisms including humans (Welch et al., 1997). The complex consists of seven 
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polypeptides including two actin-related-proteins Arp2 and Arp3, giving the complex its 
name. The remaining five subunits are referred to as ArpC1, ArpC2, ArpC3, ArpC4 and 
ArpC5 (Machesky et al., 1994; Higgs and Pollard, 1999). Sequence alignments 
(Kelleher et al., 1995) and the crystal structure of the bovine complex (Robinson et al., 
2001; Nolen et al., 2004) revealed that the subunits Arp2 and Arp3 possess strong 
structural similarity to actin and function as an actin-like heterodimer to template the 
nucleation of a daughter filament. Thus, the Arp2/3-complex bypasses the critical step 
of actin dimer formation and allows further addition of actin monomers to form a 
filament. Within the Arp2/3-complex, Arp2 and Arp3 constitute the core of the complex 
with the other subunits organised around them. 
The purified Arp2/3-complex possesses little activity on its own. In the crystal structure 
Arp2 and Arp3 are too far apart to form a pseudo actin dimer that nucleates actin 
filaments (Robinson et al., 2001). To enable actin nucleation the Arp2/3-complex needs 
to be activated which is achieved by so called nucleation promoting factors (NPFs) 
such as WASP/WAVE family proteins. Electron microscopy analyses of the Arp2/3-
complex bound to WASP indicate that a major conformational change takes place upon 
activation bringing Arp2 and Arp3 in close contact to enable filament nucleation (Rodal 
et al., 2005). Recent data revealed that phosphorylation is crucial for binding of the 
Arp2/3-complex to the pointed end of actin filaments and nucleating actin filaments, 
although it is dispensable for binding of NPFs or the sides of actin filaments (LeClaire 
et al., 2008).  
Once activated, the Arp2/3-complex initiates the formation of a new daughter filament 
that emerges from an existing (mother) filament in a y-branch configuration with a 
regular 70° branch angle in vitro (Mullins et al., 1998; Amann and Pollard, 2001). 
However recent data failed to detect branched actin filaments within the lamellipodium 
(Koestler et al., 2008; see 1.2.1), suggesting that additional yet unknown factors 
regulate the structural organisation of Arp2/3-complex-nucleated actin filaments in vivo. 
1.3.1.2 Formins 
The first identified member of the formin family was Formin1, named on the basis of the 
hypothesis that this gene was disrupted in mice with limb deformity defects (Woychik et 
al., 1990). Although a later study showed that the limb defects arose from disruption of 
an adjacent gene (Zuniga et al., 2004), the name formin has persisted. Formins can be 
found in a wide range of species including slime molds, plants, yeast, animals and 
humans (Higgs and Peterson, 2005; Rivero et al., 2005). Bioinformatic studies showed 
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that eukaryotic species have multiple formin genes, e.g. 15 formin genes were found in 
mammals. 
All formins share the typical formin homology 2 (FH2) domain, which is the most 
conserved part of these proteins. Crystallographic studies have now yielded structures 
of the FH2-domains of yeast Bni1 in complex with and without actin (Xu et al., 2004; 
Otomo et al., 2005b), mouse mDia1 (Shimada et al., 2004) and DAAM1 (Yamashita et 
al., 2007). All structures indicate that the FH2-domain is capable of dimerisation and is 
arranged in a donut-like structure, in which the two FH2 polypeptides associate such 
that the head of each subunit contacts the tail of the other subunit (Figure 4). 
In addition to the FH2-domain most formins contain a formin homology 1 (FH1) 
domain, which is typically located N-terminally to the FH2-domain and comprised of 
discrete tracks of contiguous proline residues (Higgs and Peterson, 2005; Rivero et al., 
2005). The number of polyproline tracks within the FH1-domain is highly variable - 
Fus1p from S. pombe contains a single polyproline track, while mouse mDia1 contains 
14 such tracks. Polyproline residues in the FH1-domain are well established to bind the 
actin-binding protein profilin (see 1.3.1.2.1) (Paul and Pollard, 2008; Neidt et al., 2009). 
The predominant class of formins in fungi and mammalian cells are diaphanous related 
formins (Drfs). Additionally to the FH1 and FH2-domain they are characterised by well-
defined intramolecular interactions between the N- and the C-terminus to maintain Drfs 
in an autoinhibited state. The Drfs include Dia (1, 2 and 3), DAAM (1 and 2), 
FMNL/FRL (1, 2 and 3), and FHOD (1 and 3) in mammalian cells and Bni1, Bnr1 and 
sepA in yeast. The N-terminal half of a Drf contains the GTPase-binding domain 
(GBD), the Diaphanous inhibitory domain (DID), the dimerisation domain (DD) and the 
coiled-coil domain (CC) (Figure 3A). C-terminally to the FH2-domain Drfs bear a 
Diaphanous autoinhibitory domain (DAD), which binds to the DID domain to keep the 
protein in an inactive conformation (Alberts et al., 2001; Watanabe et al., 1999) (Figure 
3). Drfs act as effectors of Rho-GTPases, which bind to the GBD and release 
autoinhibition (Alberts, 2001; Li and Higgs, 2003; Watanabe et al., 1999) (Figure 3B). 
Crystal structures of either the DAD- or Rho-bound N-terminus of mDia1 indicate that 
binding of Rho and DAD to the N-terminus is mutually exclusive, although the binding 
sites are only partially overlapping (Rose et al., 2005b; Lammers et al., 2005; Nezami 
et al., 2006). Remarkably, binding of RhoA to the N-terminus of mDia1 and binding of 
Cdc42 to the N-terminus of FRLα, respectively, is not sufficient to fully activate the 
respective formin (Li and Higgs, 2005; Seth et al., 2006). Therefore it is assumed that 
additional yet unknown factors are required to fully activate Drfs. 
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Little is known about how formins are inactivated. It has been assumed that formins 
can cycle between activated, partially active and inactivate states due to GTP 
hydrolysis upon Rho binding to GTPase-activating proteins (GAPs, see 1.3.7) (Martin 
and Chang, 2006; Kovar, 2006). In S. cerevisiae, the formin Bnr1 is replaced from the 
pointed end by a protein called Bud14 in vitro, but it remains unclear whether the Bnr1-
Bud14 interaction is subsequently disrupted to recycle Bnr1 for new actin assembly 
(Chesarone et al., 2009). Recent data reported another mechanism of inactivation for 
mammalian mDia2 during cytokinesis, which is mediated by a posttranslational 
modification. Activity of mDia2 is regulated by ubiquitin-mediated proteolysis, which is a 
well-characterised mechanism to degrade proteins via the proteasome. Subsequently, 
this is thought to contribute to the disassembly of the cytokinetic ring, especially 
considering that mDia2 is essential for proper ring assembly (DeWard and Alberts, 
 
Figure 3: Domain organisation and molecular regulation of diaphanous related 
formins  
(A) Schematic representation of the domain organization of a representative DRF 
such as mDia1. Abbreviations: GBD, GTPase binding domain; DID, Diaphanous-
inhibitory domain; DD, dimerisation domain; CC, coiled coil; FH1, formin homology 1 
domain; FH2, formin homology 2 domain; FH3 formin homology 3 domain; ARR, 
armadillo-repeat region. (B) The interaction of DAD with DID causes autoinhibition of 
DRFs. This is partly relieved by association of an active, GTP bound Rho-GTPase to 
GBD, resulting in dissociation of the DAD from the DID domain, leading to a partial 
activation of the DRF. An unknown additional signal(s) is required to fully activate 
the DRF (from Faix and Grosse; 2006). 
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2009). Whether a general mechanism of formin inactivation exists or if every formin has 
a specific way of becoming inactive will have to be investigated in the future. 
1.3.1.2.1 Formin activities on actin 
Formins are well characterised actin nucleators. Initial studies investigated the 
biochemical effects of isolated FH1-FH2 and FH2-domains of the yeast formin Bni1 on 
actin, which revealed that nanomolar concentrations directly nucleate actin assembly 
(Pruyne et al., 2002; Sagot et al., 2002a). Both studies found that actin filaments 
nucleated by Bni1 are linear (unbranched) and grow by polymerisation at their barbed 
ends. Additionally, it was reported that intact FH1-profilin interactions are required for 
Bni1-FH1-FH2 to efficiently assemble filaments from profilin-bound actin monomers.  
Up to date, many FH2 and FH1-FH2 fragments have been characterised including 
mDia (Li and Higgs, 2003; Harris et al. 2006a), FRL (Harris et al., 2004; 2006a), 
DAAM1 (Moseley et al., 2006), INF2 (Chhabra and Higgs, 2006) and many others. It is 
evident that FH2-domains almost universally nucleate actin polymerisation although 
they vary considerably in their actin assembly promoting potencies. Additionally these 
studies revealed that all formins nucleate unbranched actin filaments and remain 
associated with the barbed end as has been initially reported for Bni1. In contrast to the 
Arp2/3-complex formins lack structural similarity to actin. Kinetic modelling suggested 
that the FH2 dimer interacts directly with the polymerisation intermediate and stabilises 
it (Shimada et al., 2004; Xu et al., 2004). 
Most FH2-domains maintain a high affinity and persistent association with the barbed 
end of the filament. As they are processively moving with the growing filament and 
thereby preventing it from capping proteins (see 1.3.6) while allowing continuous 
elongation, they are often referred to as processive or leaky cappers (Zigmond et al., 
2003). To efficiently nucleate actin filaments, profilin-actin complexes must be inserted 
between the FH2-domain and the barbed end of the filament (Figure 4). Initially, it has 
been proposed that the formin is “stair stepping” on the elongating barbed ends, 
implying that the FH2 dimer equilibrates between alternating open and closed 
conformations to allow or prevent monomer addition (Xu et al., 2004). In the open state 
prior to subunit addition one FH2-domain partially dissociates from the actin filament, 
allowing subunit addition from the solution and thereby re-establishing the attached 
formin in the closed state. This model has been revised recently leading to a so called 
“stepping second” mechanism in which actin subunit addition onto the barbed end 
precedes translocation and dissociation of the formin dimer, meaning that dissociation 
depends on elongation (Paul and Pollard, 2008; 2009). 
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In most eukaryotic cells, profilin-actin is the predominant form of monomeric actin 
available for polymerisation (Pollard et al., 2000; Kaiser et al., 1999). The FH2-domain 
only poorly assembles filaments from profilin-actin. In contrast, FH1-FH2 is much more 
efficient in assembling actin filaments from either actin or profilin-actin. The polyproline 
stretches in the FH1-domain are capable of interacting with profilin-actin and 
concentrating profilin-actin near the filament barbed ends. In the current model, the 
FH1-domain forms a flexible rope-like structure (Figure 4) that allows rapid collisions 
between profilin-actin and the FH2-bound actin filament. After incorporation of the actin 
monomer into the filament the FH1-domain dissociates from the actin subunit and 
completes the elongation cycle (Vavylonis et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Although nucleation, elongation and capping appear to be activities conserved in most 
formins, these proteins can have additional, more specialised effects on actin filaments 
including bundling, severing and depolymerisation. Actin bundling activity has been 
described for the formins INF2 (Chhabra and Higgs, 2006), FRL1 and mDia1 (Esue et 
al., 2008). FRL1 and INF2 have additionally been implicated in filament severing and 
 
Figure 4: Schematic of a formin in action 
The FH2-domain and the dimerisation-domain mediate formin 
dimerisation. The FH1-domain recruits profilin-actin complexes and 
delivers them to the FH2-domain for incorporation into the growing 
filament. The growing actin filament sits inside the dimeric FH2-
domains which dynamically move with the growing filament. Grey 
lines emphasize the dynamic motion of the formin on the barbed end 
(modified from Chesarone et al., 2009). 
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depolymerisation (Harris et al., 2004; Chhabra and Higgs, 2006), but the physiological 
consequences of these activities remain elusive at this stage. 
 
1.3.1.2.2 Formin functions in cell migration 
Formin function has been linked to a wide variety of cellular processes in different cell 
types and tissues. They are considered to be involved in cytokinesis, endocytosis, cell 
polarity, morphogenesis, transcription and the stabilisation of microtubules. 
Furthermore, mammalian formins have been shown to be critically involved in cell 
adhesion and motility. In regard to this issue, mDia1 is the most thoroughly studied 
formin. It functions downstream of Rho in assembling stress fibres (Watanabe et 
al.,1999; Peng et al., 2003; Hotulainen and Lappalainen, 2006), which modulate cell 
adhesion to the substratum, and are essential for retraction of the trailing edge during 
cell migration. Several studies utilising active mDia1 variants reported the induction of 
massive thin actin fibres reminiscent of Rho-induced stress fibres (Higashida et al., 
2004; Copeland and Treisman, 2002; Satoh and Tominga, 2001; Tominaga et al., 
2000; Watanabe et al., 1999). The fact that depletion of mDia1 does not result in a loss 
of stress fibres might indicate that other formins can at least partially rescue the effect 
of mDia1 removal (Chhabra & Higgs, 2007; Peng et al., 2003). A possible candidate 
affecting stress fibre formation besides mDia1 may be the Drf FHOD1, since active 
variants have also been described to induce thick F-actin bundles (Gasteier et al., 
2003; Takeya et al., 2008; Koka et al., 2003).  
Besides its effects on stress fibre formation, active mDia1 elicited the formation of 
filopodia with the EGFP-tagged formin localising at their tips in several cell types 
(Sarmiento et al., 2008; Copeland et al., 2007; Higashida et al., 2004). Furthermore, 
RNA interference of mDia1 efficiently reduced fibroblast migration in scratch-wound 
assays (Goulimari et al., 2005). Additional data supporting the requirement of mDia1 in 
cell migration have been provided by Yamana and colleagues, who depleted mDia1 
expression in rat glioma cells (Yamana et al., 2006), and Eisenman et al., who 
analysed T-cells derived from Drf1-targeted mice (Eisenman et al., 2007). In both 
studies, the loss of mDia1 resulted in impaired cell migration. However, it is not clear if 
the effect of mDia1 on cell migration depends on its impact on actin polymerisation, 
microtubule stabilisation or is mediated by possible effects on cell polarity. Further 
studies will be needed to clarify this issue. 
                                                                                                           Introduction 
 
 14 
Ablation of mDia1 in murine fibroblast cells resulted in an elevated mDia2 (human 
homolog=Drf3) expression and an increased formation of lamellipodia and filopodia. 
Microinjection of anti-mDia2 antibody or the expression of a dominant-negative mDia2 
blocked Cdc42-induced actin reorganization, suggesting a potential role of mDia2 as 
an effector of Cdc42 (Peng et al., 2003). Another pathway leading to the formation of 
filopodia via mDia2 involves the Rho-GTPase Rif, indicating that filopodia formation via 
mDia2 can be induced by two distinct pathways (Pellegrin and Mellor, 2005). In 
multiple species, mDia2 localises to the tips of protruding filopodia and has been 
reported to be required for their formation, as shown for its Dictyostelium ortholog 
dDia2 (Yang et al., 2007; Peng et al., 2003; Pellegrin and Mellor, 2005; Schirenbeck et 
al., 2005). These findings suggest that the basic principle and mechanism of filopodia 
formation are conserved in many eukaryotes (Faix and Grosse, 2006). However, it is 
quite likely that other formins beside mDia2 are involved in filopodia formation, as 
NIH3T3 and Swiss3T3 cells are well known to form these protrusive structures but only 
express minute amounts of mDia2 (Block et al., 2008; Tominga et al., 2002). 
The haematopoietic FMNL1 (FRL1) has been described to interact with Rac in a 
nucleotide dependent manner. Over-expression of a truncated FMNL1 variant strongly 
inhibited cell adhesion and cell migration in macrophages, suggesting a role for FMNL1 
in reorganisation of the actin cytoskeleton (Yayoshi-Yamamoto et al., 2000). However, 
a more recent study observed release of the autoinhibited state only by active Cdc42 
but not by Rac (Seth at al., 2006). Other formins such as FMNL2 (Zhu et al., 2008) and 
FHOD1 (Koka et al., 2003; Westendorf, 2001) have been described to enhance cell 
motility, but how they influence the actin cytoskeleton needs to be investigated. 
1.3.1.3 WH2-domain-containing actin nucleators 
Recent studies revealed a third group of actin nucleators comprising Spire, Leiomodin 
(Lmod) and Cordon bleu (Cobl). They all contain the Wiskott-Aldrich syndrome protein 
homology 2 (WH2)-domain for actin nucleation, but seem to serve distinct cellular 
functions and mechanisms. WH2-domains can be found in many proteins involved in 
motility and they are capable of binding G-actin via their amphipathic N-terminal α-
helix.  
Spire contains four central WH2-domains, which are all required for maximal nucleation 
activity (Quinlan et al., 2005). The rate of actin filament nucleation mediated by spire is 
similar to formins, but much slower than observed for activated Arp2/3-complex. To 
nucleate new actin filaments, each WH2-domain binds an actin monomer thereby 
generating a prenucleation complex. The monomers are arranged in a way reminiscent 
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of a single short stranded actin filament to which actin monomers from the cytosolic 
pool can attach (Bosch et al., 2007; Quinlan et al., 2005). After nucleation, Spire 
proteins remain associated with the slow-growing pointed end of the new filament. 
Spire has been shown to work closely together with the fly formin cappuccino and the 
mammalian homolog FMN2 (Pechlivanis et al., 2009; Quinlan et al., 2007; Quinlan et 
al., 2005, Bosch et al., 2005). In the initial study, Spire did not affect the nucleation 
ability of Cappucino. However, more recent data suggest that the Spire/formin 
interaction blocks the FH2-driven actin nucleation, and leads to an increased actin 
nucleation by Spire (Quinlan et al., 2007). 
In contrast to Spire, which is widely expressed in higher eukaryotes, Cobl has been 
found in vertebrates only (Ahuja et al., 2007). It comprises three WH2 domains, which 
create a cross-filament trimer upon binding of three actin monomers. This trimer can 
then rapidly elongate and give rise to non-bundled, unbranched actin filaments. All 
three WH2 domains are crucial for actin nucleation in vitro. Cobl-mediated nucleation is 
very efficient, it reaches the performance of N-WASP-WA-Arp2/3-complex-mediated 
actin nucleation already at low nanomolar concentrations. In contrast to Arp2/3-
complex, Cobl does not shield the pointed end from depolymerisation. Cobl has been 
described to control neuronal morphology and development. 
The third member of WH2-containing actin nucleators is Leiomodin, which seems to be 
restricted to muscle tissue (Chereau et al., 2008) that apparently lacks Spire and Cobl 
(Schumacher et al., 2004; Ahuja et al., 2007). Leiomodin comprises just one WH2 
domain but is capable of recruiting 3 actin monomers via two additional actin binding 
sites, thereby enabling nucleation. As knockdown of leiomodin severely compromised 
sarcomere assembly in cultured muscle cells, a role for leiomodin in the nucleation of 
tropomyosin-decorated filaments in muscles has been suggested. 
1.3.2 Nucleation promoting factors 
As mentioned previously, the Arp2/3-complex needs to be activated by nucleation 
promoting factors. Most prominent members of this group are the Wiskott-Aldrich 
syndrome protein (WASP) (Winter et al. 1999; Yarar et al., 1999), N-WASP (Rohatgi et 
al., 1999) and the suppressor of cyclic AMP repressor Scar/WASP-family verprolin-
homologous (WAVE) proteins (Machesky et al., 1999). More recent studies have 
uncovered even further Arp2/3-complex activators, such as WASH (Linardopoulou et 
al., 2007), WHAMM (Campellone et al., 2008) and JMY (Zuchero et al., 2009). 
All NPFs share a conserved CA region capable of binding the Arp2/3-complex. Via this 
region, NPFs interact with four subunits within the Arp2/3-complex – Arp3, Arp2, 
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ARPC1 and ARPC4 (Zalevsky et al., 2001a, b). The CA region is necessary and 
sufficient to bind Arp2/3-complex, but it is not sufficient to activate Arp2/3-complex in 
vitro (Hüfner et al., 2001; Marchand et al., 2001; Weaver et al., 2001). To cause 
activation of the Arp2/3-complex, NPFs require an actin-binding site in addition to the 
CA-region. This actin-binding site can either bind G-actin in case of class I NPFs or F-
actin in case of class II NPFs. 
Class I NPFs, which include ActA, WASP, N-WASP, WASH, WHAMM, JMY and Scar, 
have one or two WH2-domains capable of G-actin binding. These WH2-domains are 
often referred to as V-domains (verprolin homology domain), which can normally be 
found N-terminal to the CA region, but can be positioned differently (Skoble et al., 
2000; Zalevsky et al., 2001a). Class I NPFs bind to the inactive Arp2/3-complex and G-
Actin, thus forming a NFP*ARP2/3*G-actin assembly. Within this assembly, the 
interaction between the Arp2/3-complex and the CA-region of the NPF may cause an 
activating conformational change in the complex (Robinson et al., 2001; Zalevsky et al., 
2001b). Simultaneous binding of the Arp2/3-complex and G-Actin by the NPF probably 
supports the generation of a nucleation core. According to the current model, this 
ternary assembly interacts with a pre-existing “mother filament” (Machesky et al., 1999) 
resulting in the complete activation of the Arp2/3-complex and nucleation of a new 
daughter filament. 
Class II NPFs include mammalian cortactin and yeast Abp1p. In contrast to class I 
NPFs, they are capable of binding actin filaments and Arp2/3-complex simultaneously, 
since they exhibit a F-actin binding FAB domain instead of the G-actin binding WH2-
domain in class I NPFs. This FAB domain is crucial for Arp2/3-complex activation 
(Goode et al., 2001; Uruno et al., 2001; Weaver et al., 2001). The precise mechanism 
of Arp2/3-complex activation mediated by class II NPFs is not well understood. The fact 
that they bind F-actin instead of G-actin might provide a functionally relevant 
distinction, as these NPFs were shown to be less potent than class I NPFs in vitro. 
Cortactin lacks a central region and fails to promote an activating conformational 
change in the Arp2/3-complex (Goley et al., 2004), perhaps explaining its weak NPF 
activity. Notably, cortactin and N-WASP can bind to the Arp2/3-complex 
simultaneously, but whereas N-WASP is released after actin filament branching, 
cortactin remains associated with the nucleator (Egile et al., 2005; Weaver et al., 
2002). Cortactin might therefore predominantly serve to stabilize the branch rather than 
initial induction of nucleation. Accordingly, its lamellipodial turnover was found to be 
largely uncoupled from that of the Arp2/3-complex and class I NPFs (Lai et al., 2008).  
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1.3.2.1 WASP and WAVE proteins 
Very well characterised Arp2/3-complex activators are WASP and WAVE (also Scar = 
suppressor of cyclic AMP repressor) proteins. This family comprise the haematopoietic-
specific WASP, ubiquitous N-WASP and three WAVE isoforms (1, 2 and 3) in 
mammals. 
WASP and N-WASP are predominantly found in an autoinhibited conformation caused 
by interaction between the C- and the N-terminus. In addition to the previously 
described VCA motif, WASP proteins exhibit a CRIB-motif (for Cdc- and Rac-
interactive binding), which binds to the Rho-GTPase Cdc42. Binding of Cdc42 to the 
CRIB-motif and the second messenger PIP2 to an adjacent basic region activates 
WASP proteins by releasing its autoinhibition (Prehoda et al., 2000; Kim et al., 2000; 
Stradal et al., 2004). Further, WASP interacting proteins such as WIP (WASP 
interacting protein) (Ramesh et al., 1997), Toca-1 (transducer of Cdc42-dependent 
actin assembly 1) (Ho et al., 2004) and WISH (Takenawa and Miki, 2001) have been 
reported to additionally regulate their activity. Recent data demonstrated an additional 
level of regulation via dimerisation, which increases the affinity of active WASP species 
for Arp2/3-complex and thereby enhancing actin assembly (Padrick et al., 2008). The 
function of WASP proteins has been linked to receptor mediated endocytosis, PIP2-
induced vesicle movement and actin tail or pedestal formation induced by Vaccinia 
virus, Shigella or pathogenic E. coli (Benesch et al., 2002; Linder et al., 2000; Lommel 
et al., 2001; Frischknecht et al., 1999; Snapper et al., 2001;  Lommel et al., 2004; Egile 
et al., 1999).  
Since N-WASP acts downstream of Cdc42, which is well established to induce 
filopodia although it is not required for their formation (Czuchra et al., 2005), it had 
appeared intuitive to assume that filopodia are nucleated by a complex of Cdc42-N-
WASP-Arp2/3 (Bu et al., 2008; Martinez-Quiles et al., 2001). However this assumption 
turned out to be wrong, as N-WASP could not be detected in filopodia by using either 
GFP-tagged fusion proteins or antibodies specific for endogenous protein (Faix and 
Rottner, 2006). Finally, deletion of the N-WASP gene in murine cells (Lommel et al., 
2001; Snapper et al., 2001) and knockdown of N-WASP in Drosophila cells (Biyasheva 
et al., 2004) did not abolish filopodia formation, indicating that N-WASP is dispensable 
for this process. 
In contrast to WASP-proteins, recombinant purified WAVE proteins are constitutively 
active (Lebensohn and Kirschner, 2009; Machesky et al., 1999). WAVE-proteins are 
naturally integrated in heteropentameric complexes with Sra-1 (Pir121), Nap 1, Abi-1, 
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and HSPC300 or their homologs (Eden et al., 2002; Gautreau et al., 2004). Individual 
depletion of single WAVE-complex components leads to downregulation of the other 
components as well, demonstrating stability and integrity of the complex as a whole 
(Innocenti et al., 2004; Kunda et al., 2003; Steffen et al., 2004). Over the last years, a 
matter of discussion has been whether the WAVE-complex is intrinsically active or 
inactive (Eden et al.,2002; Innocenti et al.,2004; Kim et al., 2006; Derivery et al., 2009). 
Reports showing that WAVE-complex is constitutively active have recently been 
challenged by Lebensohn and Kirschner claiming that previous data of constitutive 
activity are artefacts of in vitro manipulation and purified WAVE-complex is basally 
inactive (Lebensohn and Kirschner, 2009). This conclusion is in line with several other 
studies reporting basal inactivity of the WAVE-complex (Ismail et al., 2009; Derivery et 
al., 2009; Eden et al., 2002). It can be activated by the Rho-GTPase Rac and acidic 
phospholipids as well as by a specific state of phosphorylation (Lebensohn and 
Kirschner, 2009; Ismail et al., 2009). Whether activation of the WAVE-complex results 
in the dissociation of the subunits Sra-1 and Nap1 (Eden et al., 2002), recruitment of 
the active complex to sites of actin assembly (Steffen et al., 2004; Innocenti et al., 
2004), an allosteric change that exposes the VCA domain of WAVE (Lebensohn and 
Kirschner, 2009) or a combination of these models awaits further investigation. The 
WAVE-complex has been shown to be crucial for the formation of lamellipodia and 
membrane ruffles in mammals and Drosophila, since these structures are abolished 
upon removal of different subunits (Innocenti et al., 2004; Kunda et al., 2003; Steffen et 
al., 2004). 
 
1.3.3 ADF/cofilin 
The effects of ADF/cofilins are diverse and their regulation is complex. ADF/cofilins 
have been shown to enhance the turnover of actin filaments in vitro (Carlier et al., 
1997). They crucially contribute to actin dynamics since they are part of the minimal 
machinery that is required for actin-based propulsion of beads or Listeria (Loisel et al., 
1999, see 1.3). ADF/cofilins have a higher affinity for ADP-bound F-actin and promote 
dissociation of ADP-actin from the pointed end of an actin filament. These actin 
monomers can subsequently be recycled for new actin polymerisation. Besides 
increasing the depolymerisation rate ADF/cofilins are capable of severing pre-existing 
filaments. In one model, this is thought to generate new barbed ends capable of 
elongation and to promote actin-based motility (Bamburg and Wiggan, 2002). 
ADF/cofilins are regulated by multiple mechanisms, including inactivation by 
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phosphorylation and polyphosphoinositide interaction, the effects of pH and the 
synergistic or competitive interactions of ADF/cofilins with other actin binding proteins 
(Van troys et al., 2008) 
1.3.4 ENA/VASP 
Enabled/Vasodilator-stimulated phosphoproteins (Ena/VASP) play a crucial role in cell 
movement and shape changes in vertebrates. They localise to sites of active actin 
assembly including focal adhesions, stress fibres, lamellipodia and filopodia (Reinhard 
et al., 1992; Gertler et al., 1996; Rottner et al., 1999a; Svitkina et al., 2003). Three 
Ena/VASP proteins are expressed in vertebrates, namely Mena, Evl and VASP. All 
members of the Ena/VASP family share the N-terminal EVH1-domain required for 
subcellular localization, followed by a central proline-rich region (PRD), and finally a C-
terminal EVH2-domain mediating interactions with actin as well as the multimerisation 
of the molecule. In vitro, VASP binds G- and F-actin and nucleates and bundles actin 
filaments (Schirenbeck et al., 2006; Laurent et al., 1999). It is capable of binding profilin 
and profilin-actin through a central prolin rich domain (Ferron et al., 2007; Kursula et al, 
2008). Controversy arises concerning the capping activity of VASP, as some studies 
indicated that VASP can compete with capping proteins, whereas others reported the 
contrary (Trichet et al., 2008, Bear and Gertler, 2009). Meaningful data supporting the 
anti-capping activity of VASP was recently provided by Breitsprecher et al. 
(Breitsprecher et al., 2008). Using VASP immobilized on beads they showed that actin 
filaments elongated continuously even in the presence of high concentrations of 
capping protein. Additionally, they reported that VASP accelerated filament elongation 
independently of profilin. 
The Dictyostelium VASP is a binding partner of dDia2 and cooperates with the formin 
in filopodia formation in this cell type. Dictyostelium cells lacking either the single VASP 
member or dDia2 failed to form filopodia, suggesting a critical role of VASP and dDia2 
in filopodia formation (Schirenbeck et al., 2005). The crucial role of VASP in filopodia 
formation is suggested to be its bundling activity, which is restricted to the tip of 
nascent filopodia before other actin bundling proteins like fascin stabilise the filopodia 
shaft (Schirenbeck et al., 2006). Similar results were obtained in neurons, showing that 
Ena/VASP-deficient cortical neurons lack filopodia and failed to elaborate neuritis 
(Kwiatkovski et al., 2007). In contrast to Dictyostelium cells, which require both VASP 
and dDia2 for filopodia formation, ectopic expression of mDia2 in neurons is sufficient 
to restore the formation of filopodia independently of VASP (Dent el al., 2007). Whether 
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this indicates cell type-specific mechanisms for the initiation of filopodia requires further 
investigation. 
1.3.5 Profilin 
Profilin is a small abundant protein capable of binding and sequestering G-actin. It is 
best known for its ability to promote the exchange of ADP for ATP in actin monomers 
released from filaments and thereby replenishing the pool of ATP-actin in the cell 
(Mockrin et al., 1980; Goldschmidt et al., 1992). By binding to actin monomers, profilin 
decreases the concentration of free actin monomers available for filament elongation. 
Thus, it prevents spontaneous nucleation in the absence of F-actin barbed ends and 
facilitates controlled polymerisation. 
Profilin can bind simultaneously to G-actin and to prolin-rich region as e.g. in the FH1-
domain of formins. In case of formin-mediated actin nucleation, profilin-actin binds to 
the FH1-domain and is transferred to the FH2-domain for incorporation into a growing 
filament, thus increasing the elongation rate of filaments associated with the formin 
FH1FH2-domain (Kovar et al., 2006) At high profilin concentrations, free profilin 
competes with actin-bound profilin for binding the FH1 polyproline tracks and thereby 
inhibits profilin-actin transfer onto barbed ends (Kovar et al., 2006; Vavylonis et al., 
2006). A recent study suggests that formins preferentially select specific isoforms of 
profilin-actin, which may provide an important mechanism to specialise formins for 
specific cellular processes (Neidt et al., 2008). 
1.3.6 Capping protein 
The heterodimeric capping protein (CP) is an essential element of the actin 
cytoskeleton regulating the polymerisation of actin filaments. It can be found in every 
eukaryotic organism and every metazoan cell type (Cooper and Sept, 2008). The 
functional unit comprises an α/β-heterodimer and although the two subunits lack any 
sequence similarity their secondary structure is very similar (Yamashita et al., 2003). 
The two subunits bind very tightly to each other and both are required for actin binding 
activity in vitro and stability in vivo (Amatruda et al., 1992). 
Capping protein binds with high affinity to the barbed end of actin filaments, thereby 
preventing the addition and the loss of actin monomers and at the same time leaving 
the pointed end unaffected (Caldwell et al. 1989; Casella et al., 1989). Capping protein 
is essential to reconstitute Arp2/3-mediated motility in vitro (Loisel et al., 1999) (see 
1.3). Knockdown of capping protein abrogated lamellipodia formation (Iwasa and 
Mullins, 2007; Mejillano et al., 2004), and was accompanied by an increase in filopodia 
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formation (Mejillano et al., 2004; Hug et al., 1995). This supports the crucial role of 
capping protein for Arp2/3-mediated actin assembly in vivo.  
1.3.7 Rho-GTPases 
The actin cytoskeleton is highly regulated by a family of small proteins named Rho-
GTPases. They are found in all eukaryotic cells and in mammalian cells 20 genes 
encoding Rho-GTPases have been identified. Based on sequence similarity and 
functions these Rho-GTPases can be divided into five main subgroups, the Rho-like, 
Rac-like, Cdc42-like, Rnd and RhoBTB like (Figure 5). Among them the Rho-like, Rac-
like and Cdc42-like are the best studied Rho-GTPases so far. 
Rho GTPases act as key molecular switches regulating the formation of cellular 
protrusions. Their activity is tightly controlled by alternating between an active GTP-
bound and an inactive GDP-bound status (Figure 6). Guanine nucleotide exchange 
factors (GEFs) catalyse the exchange of GDP for GTP and thereby activate the Rho-
GTPase (Raftopoulou and Hall, 2004; Rossman et al., 2005). The active, GTP-loaded 
GTPase is capable of interacting with downstream effectors such as formins to mediate 
a specific response.  Guanine activating proteins (GAPs) stimulate the intrinsic GTPase 
 
Figure 5: The Rho- family of proteins 
Mammalian cells exhibit 20 Rho family members. These protein family is devided into 5 main 
subgroups, namely Rho-like, Rnd, Cdc42-like, Rac like and RhoBTB (from Burridge and 
Wennerberg, 2004). 
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activity which hydrolyses GTP to GDP thus inactivating the protein (Bernards, 2003). 
GDP dissociation inhibitors (GDIs) inhibit the dissociation of GDP from Rho-GTPases 
and block the intrinsic and GAP-catalysed GTPase activity to prevent spontaneous 
activation (DerMardirossian and Bokoch, 2005; Dovas and Couchman, 2005). 
Additionally, GDIs interact only with prenylated Rho-GTPases, extract them from 
membranes and sequester them in the cytoplasm away from their regulators and 
targets (Dovas and Couchman, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Membrane binding and thus proper targeting is achieved by posttranslational addition 
of a prenyl moiety (e.g. geranylgeranyl) to the C-terminus of Rho-GTPases. Finally, 
Rho-GTPases are regulated by phosphorylation and ubiquitination; however, the 
contribution of these modifications to the physiological behaviour is unclear. 
Our knowledge about the cellular functions of Rho-GTPases has been improved by 
over-expression studies in cell lines using either dominant negative or constitutively 
active Rho-GTPases, which inhibit or overstimulate Rho-GTPase signalling. Additional 
understanding has been provided by loss of function studies using transient 
 
Figure 6: The GTPase cycle 
Rho GTPases cycle between an active (GTP-bound) and an 
inactive (GDP-bound) state. In mammalian cells, a large family of 
85 Guanine exchange factors (GEFs) catalyse the exchange of 
GDP for GTP, thereby activating Rho-GTPases. Activated Rho-
GTPases interact with downstream effectors to elicit specific 
responses. GTPases activating factors (GAPs), comprised of 80 
members in mammals, stimulate GTP hydrolysis, thus 
inactivating the protein (from Jaffe and Hall, 2005). 
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approaches like RNA interference and conditional knockout mice and cell lines, 
respectively.  
The Rho-GTPase Cdc42 has a crucial role in the regulation of cell polarity, vesicle 
trafficking and early cell development in D. melanogaster and C. elegans. By activating 
the nucleation promoting factor N-WASP, Cdc42 promotes Arp2/3-mediated actin 
nucleation e.g. in endocytosis. In many cell types, constitutively active and dominant 
negative Cdc42 influence the formation of filopodia, but the molecular mechanism of 
Cdc42-induced filopodia formation is still controversial, since one of its direct effectors 
N-WASP is dispensable for the formation of these protrusive structures (see 1.3.2.1). 
Over the last years, Diaphanous related formins (e.g. mDia2), whose activity is 
controlled by Rho-GTPases such as Cdc42, emerged as key regulators of filopodia. 
However, Cdc42-deficient cell lines are still capable of forming these finger like 
projections (Czuchra et al., 2005). This indicates that other Rho-GTPases can 
contribute to the formation of filopodia, given that besides Cdc42 other Rho-GTPases 
such as Rif (Rho in filopodia), Wrch1 and RhoD can trigger the initiation of these 
structures (Aspenström et al., 2009; Burridge and Wennerberg, 2004; Ellis and Mellor, 
2000). 
The Rac protein family comprises Rac1, Rac2 and Rac3 and RhoG. Rac1 is 
ubiquitously expressed in human tissue, Rac2 is restricted to the haematopoietic 
system and Rac3 is most abundant in the brain. Data from knockout mice indicate that 
although the three Rac isoforms share a high sequence similarity, they have non-
redundant functions (Wheeler et al., 2006). Rac1 is a key regulator of lamellipodia and 
membrane ruffles in a variety of cell types including fibroblasts and epithelial cells 
(Ridley, 2001). Activation of the WAVE-complex by binding of Rac to the subunit Sra-1 
results in Arp2/3-complex mediated actin nucleation (see 1.3.2.1), stimulating the 
formation of lamellipodia and membrane ruffles. Local activation of a photoactivatable 
Rac is sufficient to induce cell motility and controls the direction of cell migration (Wu et 
al., 2009), supporting the critical role of Rac in protrusion.  
Stress fibre formation is regulated by the Rho-family comprising three isoforms RhoA, 
RhoB and RhoC. Rho activates Rho-associated-kinase (Rock), which inhibits myosin 
light chain phosphatase and phosphorylates myosin light chain thereby stimulating 
actomyosin II contractility in stress fibres (Chrzanowska-Wodnicka and Burridge, 1996; 
Kimura et al., 1996). Additionally, RhoA is well established to activate the formin 
mDia1, which may promote the formation of stress fibres (see 1.3.1.2.2) and to activate 
LIM kinase, which in turn inhibits the depolymerisation factor ADF/cofilin resulting in 
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more stable actin filaments e.g. in stress fibres (Amano et al., 2001; Maekawa et al., 
1999; Pritchard et al., 2004). 
Rho-GTPases are also capable of influencing the activity of each other. The crosstalk 
between them employes activation and suppression e.g. by interacting with specific 
GEFs and GAPs or interactions between their respective downstream signalling 
pathways (Burridge and Wennerberg, 2004). It is well established that Cdc42 can 
activate Rac (Nobes and Hall, 1995), resulting in the formation of lamellipodia and 
membrane ruffles. RhoG has been described to activate Rac via binding to ELMO1, 
which activates the unconventional Rac GEF Dock180 (Katoh and Negishi, 2003). 
Furthermore, downregulation of the Rac1 pathway promotes the enlargement of focal 
contacts, whereas inhibition of the RhoA pathway stimulates membrane ruffling, 
revealing an antagonism between Rac1 and RhoA (Rottner et al., 1999b). This 
antagonism is supported by data showing that Rock, which is a well established 
downstream effector of RhoA, phosporylates the Rac specific GAP, FilGAP, thereby 
inactivating Rac and suppressing cell spreading (Ohta et al., 2006). 
1.3.7.1 Rho-GTPases and Formins 
Diaphanous-related formins are well established effectors of Rho-GTPases. Binding of 
Rho-GTPase to the GTPase binding domain releases the autoinhibited state (see 
1.3.1.2) and thereby enables actin polymerisation mediated by formins. Each formin is 
activated by a distinct subset of Rho-GTPases, e.g. mDia1 by RhoA, RhoB and RhoC 
(Rose et al., 2005a; Watanabe et al., 1999), mDia2 by Cdc42 and Rif (Peng et al., 
2003; Pellegrin and Mellor, 2004) and DAAM1 by RhoA and Cdc42 (Aspenström et al., 
2006). For others like FMNL2 and -3 it is still unclear which Rho-GTPases are able to 
release the autoinhibiton in these formins. 
In addition to the Rho-GTPase-mediated activation of formins, increasing evidence 
suggests a possible positive feedback regulation. mDia1 activates RhoA via binding of 
the Rho GEF LARG, which in turn is controlled by RhoA-induced release of mDia1 
autoinhibition (Kitzing et al., 2007). The Drfs DAAM1 and mDia2 have been shown to 
activate RhoA probably also by interacting with a Rho-GEF (Habas et al., 2001), 
suggesting that at least some formins are capable of promoting Rho-activation. 
 
1.4 Aims of this thesis 
The work presented here aimed at shedding light on the influence of diaphanous 
related formins on cell migration especially on the formation of lamellipodia and 
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filopodia. In this context the Drfs Drf3 and FMNL2 where of main interest, as they are 
widely expressed and abundant in various tissue culture cell lines. To characterise Drf3 
and FMNL2, both proteins were cloned and the dynamic localisation of the EGFP-
tagged proteins analysed in motile cells. A constitutively active Drf3 construct was used 
as a tool to study the ultrastructure of formin-induced filopodia, and to determine the 
mechanism of filopodia formation. Additionally, the requirement of Drf3 for the 
formation of filopodia and lamellipodia was investigated. 
In the second part of this thesis, the diaphanous related formin FMNL2 was subject of 
functional characterisation, including biochemical interaction studies, cellular 
localisation analyses and –in collaboration- in vitro nucleation and TIRF experiments. 
Finally, I explored the contribution of FMNL2 to cell migration by employing RNA 
interference. 
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2 Material and Methods 
2.1 Chemicals, Media, Buffers 
If not stated otherwise, all chemicals were purchased from the following companies: 
Amersham, Bioscience, BioRad, Boehringer Mannheim, Fermentas, Fluka, GE 
Healthcare, Invitrogen, Life Technologies, Merck, Macherey-Nagel, Millipore, New 
England Biolabs, PAA, Promega, Qiagen, Riedel de Haen, Roche, Roth, Sigma-
Aldrich, Serva and TaKaRa. 
The quality standard was p.a. (per analysis). 
All buffers were prepared in deionised water, which has been purified by a milli-Q-
system (Millipore). 
2.2 Cell Culture Reagents and Plasticware 
Cell culture media and additives were from Gibco, Invitrogen, PAA or Sigma unless 
stated otherwise. Plasticware was obtained from Corning, Falcon and Nunc. 
2.3 Enzymes und Reagents for Molecular Biology 
Enzymes were from New England Biolabs, MBI Fermentas or Roche. T4-DNA Ligase 
and alkaline phosphatase were obtained from Roche. Phusion DNA Polymerase was 
purchased from Finnzymes. Oligonucleotides were from Biosprings or MWG-Biotech. 
DNA-standards were from Eurogentec and protein markers from MBI Fermentas. 
2.4 Vectors 
For generation of EGFP-fusion constructs, pEGFP-C1, -C2, -C3 and -N1, -N2, -N3 
vectors were used (Clontech). The pGEX-6P-1, -2 and -3 vectors for the production of 
GST (glutathione-S-transferase) fusion proteins were purchased from Amersham 
Biosciences.  
2.5 Bacteria culture: 
Escherichia coli TG2 (Stratagene) for amplification of plasmids: Genotype: supE hsd∆5 
thi ∆(lac-proAB) ∆(srl-recA)306::Tn10(tetr) F[traD36 proAB+ lacIq lacZ∆M15]. 
Escherichia coli JM110 (Stratagene) for amplification of plasmids:  Genotype: rpsL 
(Strr) thr leu thi-1 lacY galK galT ara tonA tsx dam dcm supE44 ∆(lac-proAB) [F´ 
traD36 proAB lacIqZ∆M15]. 
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Escherichia coli GM2163 (Fermentas) for amplification of plasmids: Genotype: F-ara-14 
leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm-6 hisG4 rfbD1 rpsL136 
dam13::Tn9 xylA5 mtl-1 thi-1 mcrB1 hsdR2. 
2.5.1 Media for bacterial culture: 
 
LB-medium (Luria Bertain broth): 
bacto-tryptone  10 g/l 
bacto-yeast extract  5 g/l 
NaCl    120 mM 
 
SOB-medium: 
bacto-tryptone  20 g/l 
bacto-yeast extract  5 g/l 
NaCl    0,6 g/l  
KCl    0,1 g/l  
 
 
SOC-medium:  
SOB – Medium   
+ MgCl2   10 mM 
             +  MgSO4   10 mM 
                        +  Glucose   20 mM 
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2.6 Molecular biological standard techniques: 
2.6.1 Plasmids 
Plasmid Origin Source 
EGFP-N2-DRF3 ∆N human Jan Faix, Hannover Medical School, 
Hannover, Germany 
EGFP-C1-Drf3∆N human Jan Faix, Hannover Medical School, 
Hannover, Germany 
EGFP-N2-Drf3 full length human this thesis 
EGFP-C1-Drf3 full length human Jan Hänisch, HZI, Braunschweig, Germany 
EGFP-C1-DRf3∆DAD human Jan Faix, Hannover Medical School, 
Hannover, Germany 
EGFP-C1-mDia 1∆DAD mouse Jan Faix, Hannover Medical School, 
Hannover, Germany 
EGFP-C1-mDia 1 full length mouse Jan Faix, Hannover medical school, 
Hannover, Germany 
EGFP-C1-DAAM1  human this thesis 
EGFP-C1-DAAM1∆C50  human this thesis 
EGFP-C3-FMNL2C full length human this thesis 
EGFP-N1-FMNL2C full length human this thesis 
EGFP-N1-FMNL2∆DAD human this thesis 
EGFP-N1-FMNL2∆DAD G2A human this thesis 
EGFP-C1-FMNL2∆DAD human this thesis 
EGFP-FMNL2-GBD human Christine Standfuß-Gabisch,  
Theresia Stradal, HZI, Braunschweig, 
Germany 
EGFP-FMNL2-Arr human this thesis 
EGFP-C3-FMNL2A human this thesis 
EGFP-C3-FMNL2B human this thesis 
EGFP-N1-FMNL2A human this thesis 
EGFP-N1-FMNL2B human this thesis 
EGFP-N1-FMNL2C-G2A human this thesis 
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EGFP-N1-FMNL2A-G2A human this thesis 
EGFP-N1-FMNL2B-G2A human this thesis 
EGFP-C3-FMNL3 mouse this thesis 
EGFP-C3-FMNL3-Arr mouse this thesis 
Prk5-myc cdc42L61 human Laura Machesky (Beatson Institute, 
Glasgow, UK) 
Prk5-myc-RacL61 human Laura Machesky (Beatson Institute, 
Glasgow, UK) 
GST-cdc42L61 human Alan Hall (University College, London, UK) 
GST-cdc42N17 human Alan Hall (University College, London, UK) 
GST-Rac1L61 human Alan Hall (University College, London, UK) 
GST-Rac1N17 human Alan Hall (University College, London, UK) 
GST-RhoAL63 human Petra Hagendorff, Theresia Stradal, HZI, 
Braunschweig, Germany 
MBP-RifL77 human Petra Hagendorff, Theresia Stradal, HZI, 
Braunschweig, Germany 
MBP-RhoGV12 human Petra Hagendorff, Theresia Stradal,  HZI, 
Braunschweig, Germany 
MBP-RhoDV26 human Petra Hagendorff, Theresia Stradal, HZI, 
Braunschweig, Germany 
Table 1: List of constructs used in this work. 
2.6.2 Oligonucleotide primers 
 Name Sequence 5´to 3´ Purpose 
1 DAAM1 
BamH1 fwd 
GAGAGGATCCATGGCCCCAAGAAAGAGAGGTG Cloning of 
DAAM1 
2 DAAM1 Sal1 
rev (mut) 
GAGAGTCGACTTAGAAATTAAGGTTTGTGATTG Cloning of 
DAAM1 
3 DAAM1 seq 
fwd 
AGTCTCAAGACTGCCATCA Sequencing 
4 DAAM1 seq rev TCTGAGCCAGAACGAATTG Sequencing 
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5 DAAM1 DAD 
Sal I rev 
GAGGTCGACACTTTTACGTTCCCTTTCAC Cloning of 
DAAM1 ∆DAD 
6 DAAM1 delta 
C50 Sal I rev 
GAGGTCGACTTCTTCACTATTCTCTTTAGC Cloning of 
DAAM1∆C50 
7 FMNL2 Sal I 
fwd 
GAGGTCGACATGGGCAACGCAGGGAGCA Cloning of 
FMNL2 
8 FMNL2 1316 
rev 
TCCCGAACGACATCCAGCTC Cloning of 
FMNL2 
9 FMNL2 1084 
fwd 
GACAAGCTTCAAGTCCAGATCC Cloning of 
FMNL2 
10 FMNL2 1492 
rev 
ATGGACAATGTGCCAGAAGC Cloning of 
FMNL2 
11 FMNL2 1903 
fwd 
AAGCCCAATCAGATCAATGG Cloning of 
FMNL2 
12 FMNL2 Sac II 
rev 
GAGACCGCGGTCACATTGTTATTTCGGCA Cloning of 
FMNL2 
13 FMNL2 seq fwd TTATGGTGGCTTCTATGCAG Sequencing 
14 FMNL2 seq rev TTGACTTTGTATCTAAGAGC Sequencing 
15 FMNL2 DAD 
SacII 
GAGCCGCGGTTGCTGCTGCCTCTTTGATTTATG Cloning of FMNL2 
∆DAD 
16 FMNL2-GBD 
Not1rev Stopp 
GAGCGGCCGCTTATCTGACAAGACAAACGGC Cloning of 
FMNL2-GBD 
17 FMNL2-ARRstop 
Sac2 rev 
GAGAGACCGCGGTTACATGAGTTGCTTTTCCAG Cloning of 
FMNL2-Arr 
18 FMNL2 A2 fwd TGCAGTCGACATGGCCAACGCAGGGAGCATGG Mutagenesis of 
FMNL2 
19 FMNL2 A2 rev CCATGCTCCCTGCGTTGGCCATGTCGACTGCA Mutagenesis of 
FMNL2 
20 mFMNL3 192 
fwd 
GGATCTGATCTGTGACCAGG Cloning of 
FMNL3 
21 mFMNL3 
BamH1 w/o 
stopp rev 
GAGAGGATCCACAGTTTGACTCGTC Cloning of 
FMNL3 
                                                                                                     Material and Methods 
 
 31 
22 mFMNL3 Xho 
fwd 
GAGACTCGAGATGGGCAACCTGGAGAGC  Cloning of 
FMNL3 
23 mFMNL3 rev TCTCCTCCGGAACTTCTTCC  Cloning of 
FMNL3 
24 FMNL3 seq fwd 
942 
CAGCAACATTGACTTCATGG  Sequencing 
25 FMNL3 seq rev 
2021 
GTTTGACTTACAGACACTACC           Sequencing 
26 FMNL3-Arr SalI 
rev 
GAGAGTCGACTAGCAGCTGCTTCTCCAG  Cloning of 
FMNL3-Arr 
Table 2: List of primers for amplifying, sequencing and site directed mutagenesis used in this 
thesis. 
 
Oligonucleotides used in this thesis were synthesised either by Biospring or MWG 
Eurofins. Oligonucleotides were designed with Primer 3 webinterface 
(http://frodo.wi.mit.edu/primer3) or Vector NTI Suite 8 and 10 (Invitrogen). 
 
2.6.3 Generation of constructs 
EGFP-fusion constructs were generated by polymerase chain reaction (PCR) 
introducing the respective cutting sites at the C- and N-terminus of the appropriate 
fragment. Phusion DNA Polymerase was used according to the manufacturer´s 
protocol. Annealing temperature and extension time were adapted according to the 
used primers (annealing temperature calculated with Vector NTI Suite 8) and the size 
of the expected product, respectively.  If suitable native cutting sites were used to fuse 
the fragment to the respective vectors, EGFP-vectors and fragments were cut with 
similar enzymes or enzymes producing compatible ends and subsequently ligated 
using T4-DNA-ligase. 
Human DAAM1 full length constructs were generated using the Image Clone 
IRATp970B1285D and IRAKP96141452Q (imaGenes, Germany) as template and the 
primers 1 and 2 in the PCR reaction. For the generation of the ∆C50 construct lacking 
the DAD-domain, primers 1 and 6 were used. Both PCR fragments were cut with 
BamH1 and Sal1 and ligated in an EGFP-C1 vector (Clontech) cut the same way. 
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The generation of the human FMNL2 full length construct was performed in several 
steps including a number of intermediates constructs, generation of which is shown in 
Table 3. 
 
Name  Fragments   Vector  Fragment source 
Intermediate 1  FMNL2 
 SalI/HindIII 
 (1 -1088bp; 
 Primers 7&8) 
 EGFP-C3 
 SalI/HindIII 
IMAGEClone       
IRALp962K1959Q2 
(imaGenes, Germany) 
Intermediate 2 FMNL2 
HindIII/EcoRV 
(1088-1471bp; 
Primers 9&10) 
 pBluescript SK II 
 HindIII/EcoRV 
 Hela S3 cDNA 
Intermediate 3 FMNL2 
EcoRV/EcoRI 
(1471-1953bp) 
 Intermediate 2 
 EcoRV/EcoRI 
fragment synthesised by   
GenScript (GenScript USA 
Inc., USA) 
Intermediate 4 Intermediate 3 
(1088-1953) 
HindIII/EcoRI 
Intermediate 1 
HindIII/EcoRI 
- 
EGFP-C3-
FMNL2  
FMNL2 
EcoRI/SacII 
(1953-3278bp; 
Primers 11&12) 
 Intermediate 4 
 EcoRI/SacII 
 
 Hela S3 cDNA 
Table 3: Generation of EGFP-FMNL2 fusion protein. 
 
For cloning of FMNL2 isoforms A and B, C-terminal sequences encompassing the 
isoform-specific sequences were synthesized by GenScript (GenScript USA Inc., USA) 
and exchanged with the C-terminus of FMNL2C using internal BamH1 and C-terminal 
SacII cutting sites. 
The FMNL3∆N construct was generated using the IMAGE Clone IRAKp961L0355Q 
(imaGenes, Germany) encoding the murine FMNL3 sequence (residues 63-1028). For 
generation of FMNL3 full length the N-terminus  (aa 1-103)  was amplified from mouse 
B16-F1 cDNA (see 2.6.13) and fused to the FMNL3∆N sequence by using an internal 
BspEI cutting site. 
All constructs were verified by restriction digest, sequencing and expression tests. 
2.6.4 Site directed mutagenesis: 
In this thesis, the Quick change site-directed mutagenesis kit (Stratagene) was used to 
switch the amino acid glycin2 of FMNL2 into alanine in order to obtain a FMNL2 mutant 
that cannot be myristoylated. The reaction was performed as described in the Quick 
change site directed mutagenesis manual. 
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2.6.5 DNA Sequencing 
For sequencing, DNA samples were sent to MWG Operon (Martinsried, Germany). ABI 
sequence files were edited and aligned with Vector NTI Suite 8 and 10. 
2.6.6 Restriction Digest and Dephosphorylation 
2-15 µg plasmid DNA were restriction digested in a total volume of 10-100 µl in the 
appropriate restriction buffer containing 10 U restriction enzyme for 1-2 hours at 37°C. 
To prevent cutted DNA vectors from religating they were dephosphorylated using 1 U 
alkaline phosphatase (Roche) for 5 minutes at 50°C.  Afterwards restricted fragments 
were analyzed by gel-electrophoresis. 
2.6.7 DNA Extraction from Agarose Gels 
DNA fragments for subcloning were extracted from agarose gels using the NucleoSpin 
Extract II Kit from Machery&Nagel (Macherey-Nagel, Düren, Germany) according to 
manufacturers´ instructions.  
2.6.8 Ligation 
T4-DNA ligase (Roche) was used to covalently link DNA fragments with required 
vectors as recommended by the manufacturer. 10 - 100ng of the vector was mixed with 
3x molar excess of the fragment and incubated either for 30min - 4h at room 
temperature or overnight at 4°C. Afterwards, the re action was transformed into 
competent TG2 E. coli. 
2.6.9 Generation of CaCl2-competent E. coli 
To generate competent E. coli that are highly efficient in taking up DNA, the protocol 
was as follows: an overnight culture of TG2 was diluted 1:100 into SOB medium and 
incubated under agitation at 37°C until OD 600 reac hed 0.5. The bacteria were 
harvested by centrifugation (5000 x g, 10 min, 4°C) . The pellet was resuspended in 1/5 
of the culture volume of ice-cold 0.1 M CaCl2 and incubated for 20 minutes on ice. After 
centrifugation (5000 x g, 10 min, 4°C), bacteria we re resuspended in 1/100 to 1/200 of 
the culture volume of ice-cold 0.1 M CaCl2 and incubated for 3 hours on ice. The 
bacteria were supplemented with glycerine to a final concentration of 10% (v/v), snap-
frozen in liquid nitrogen and stored at –80°C. 
2.6.10 Transformation of E. Coli 
For transformation, 50 - 100µl aliquots of competent E. coli were thawn on ice, mixed 
gently with 100 ng Plasmid-DNA or 10 - 15µl of a ligation reaction and incubated on ice 
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for 30 min. Bacteria were then heat shocked at 42°C  for 1min, left on ice for 1min and 
resuspended in 250µl of SOC-Medium.  Bacteria were gently shaken at 37°C for 1 hour 
and plated on agarplates containing the appropriate antibiotic and incubated for 12 - 
16h at 37°C. 
2.6.11 Preparation of plasmids from E. Coli 
Plasmid midi and maxi preparations were performed using the Nucleo Bond plasmid 
purification kit 100 and 500 from Macherey&Nagel, respectively. 
For plasmid mini preparations, 1-1.5 ml LB-medium containing the appropriate 
antibiotic were inoculated with single colonies and incubated at 37°C o/n. Bacteria were 
harvested by centrifugation and resuspended in 100 µl buffer 1 with RNAse A. After 
adding 200µl of buffer 2 and 150 µl of ice-cold buffer 3, the bacterial suspension was 
incubated 3-5 minutes on ice. The bacterial lysate was harvested after centrifugation of 
the suspension at 12000 g for 5 minutes and mixed with 400 µl isopropanol to 
precipitate the eluted plasmid DNA. This mixture was incubated at room temperature 
for 2 minutes and centrifuged at 12000 g for 5 minutes. The DNA pellet was washed 
with 70% Ethanol several times and dried at 37°C fo r approximately 30 minutes. The 
DNA pellet was redissolved in 50 µl Baker H2O. 
2.6.12 RNA Purification 
For the purification of total RNA from tissue culture cells all solutions were prepared in 
DEPC treated water. RNA free plastic ware was purchased from Roth (Karlsruhe, 
Germany). 
To prepare total RNA from tissue culture cells a confluent 10cm dish was washed once 
with PBS and then lysed in 1ml peqGOLD TriFast™ reagent. Probes were then 
incubated for 10 min at room temperature. 100µl of 1-Bromo-3-chloropropane was 
added for each ml of tissue culture lysate, and mixed for 15sec. The mixture was 
incubated at room temperature for 10-15min and subsequently centrifuged for 15min at 
12000g at 4°C. The upper aqueous phase was transfer red into a new Eppendorf tube, 
and an equal amount of isopropanol was added and mixed gently. After 15min of 
incubation at room temperature, the sample was centrifuged at 14000g for 15min at 
4°C. The supernatant was transferred into a new Epp endorf tube and washed with 1ml 
75% EtOH and centrifuged at 7500g for 8min at 4°C. The RNA pellet was dried at 37°C 
and solved in an appropriate amount of DEPC-treated water under agitation at 56°C for 
10min. 
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2.6.13 cDNA Synthesis 
cDNA synthesis has been carried out using the Omniscript reverse transcriptase kit 
(Qiagen) according to the manufacturer´s instruction. 
For the reverse transcriptase reaction, the following primers were used: 
 
 Fragment Used primer sequence 5´to 3´ cDNA source 
FMNL2  TTTTTTTTTTTTTTTTTTTTT Hela S3 
FMNL2 TTTTTTTTTTTTTTTTTTTTT Hela S3 
FMNL3 TCTCCTCCGGAACTTCTTCC B16-F1 
Table 4: Primers used for cDNA synthesis 
2.6.14 Quantification of DNA and RNA 
The photometric absorption of DNA and RNA in solution has a maximum at a 
wavelength of λ = 260 nm. To determine the concentration of nucleic acid, an aliquot of 
the solution was diluted to an extinction of the optical density (OD) OD260 = 0.1- 1.0, 
which corresponds to a concentration range, in which the absorption in still linear. The 
concentration of the DNA and RNA can be calculated by including the molar extinction 
coefficient (ε) of RNA or DNA (40 or 50 µg/µl, respectively) as follows: OD260• dilution 
factor • ε µg/µl = cDNA µg/µl 
 
2.7 Protein Biochemistry 
2.7.1 Sodiumdodecylsulphate-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
Sodiumdodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed essentially according to Laemmli (Laemmli, 1970). SDS-PAGE gels were 
run in Minigel apparatures (Biometra) with 1 mm spacers. 
2.7.2 Coomassie Blue Staining 
After transfer onto PVDF-membranes, proteins were stained with a 0.1%  Coomassie 
R-250 solution in 10% acetic acid and 25% isopropanol for 30-60 minutes. This was 
followed by destaining of the membrane in 10% acetic acid and 40% methanol. 
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2.7.3 Protein extracts from cultured cells  
Extracts from adherent tissue culture cells were obtained as follows: first, the cells were 
washed with 1x PBS. For standard extracts, 4x reducing SDS-sample buffer was 
added directly to the cells (500 µl on a 10 cm-diameter dish), then scraped off the dish 
using a cell scraper, boiled at 95°C for 5 minutes and stored at –20°C. For measuring 
the protein concentration in cell lysates, cells were lysed in ice cold IP-buffer (15mM 
KCl, 50mM NaCl, 8mM Tris base, 12mM Hepes, 5 mM MgCl2, 1% Triton X -100 + 1 
aliquot Roche complete Protease inhibitor per 10ml). 
2.7.4 Pull-down Assays 
To determine interactions between respective Rho-GTPases and FMNL2, B16-F1 cells 
growing in 10cm dishes were transfected with EGFP fusion constructs containing the 
GTPase-binding domain and the Armadillo repeats of FMNL2 (FMNL2-Arr) or a 
constitutively active FMNL2 construct lacking the DAD-domain (FMNL2∆DAD). Cells 
were lysed with 500µl of ice cold IP-buffer (15mM KCl, 50mM NaCl, 8mM Tris base, 
12mM Hepes, 5 mM MgCl2, 1% Triton X - 100 + 1 aliquot Roche complete Protease 
inhibitor per 10ml). After centrifugation for 15 minutes at 15000 x g at 4°C, FMNL2-Arr 
and FMNL2∆DAD, respectively, were precipitated from the cell lysate using 30µl 
gluthathione-sepharose beads coupled with dominant negative or constitutively active 
GST- or MBP-tagged recombinant Rho-GTPases for 1 hour at 4°C on a rotary wheel. 
Beads were then washed three times with cold IP-buffer. Precipitates were resolved by 
SDS-PAGE and analysed by immunoblotting with the antibodies listed in Table 5 and 
Table 6.  
 
2.7.5 Determination of protein concentration 
Protein concentration was determined using the Precision Red Advance protein assay 
(Cytoskeleton) according to the manufacturer´s manual. 
 
2.7.6 Pyrene assays and total-internal-reflection-microscopy (TIRFM) 
Actin polymerization assays and TIRF microscopy assays were performed by Dennis 
Breitsprecher and Dr. Jan Faix (Hannover Medical School) as described in 
Schirenbeck et al. (2005), Breitsprecher et al. (2008) and Breitsprecher et al. (2009). 
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2.8 Immunobiological Methods 
2.8.1 Primary Antibodies 
Primary antibodies used in this study are listed in Table 5. 
 
Description Protein Mc/Pc Application Provided by 
101G4B2 GFP Mc WB Barbara Behrendt, HZI, 
Braunschweig, Germany 
270F3 GFP Mc IP, WB, IF Synaptic Systems, Göttingen, 
Germany 
Drf3 Drf3 Pc WB Jan Faix, MH Hannover, Germany  
FMNL2 FMNL2 Mc WB, IF Abcam, Germany 
323H3 ArpC5 Mc IF Millard et al., 2002 
W8.3 Abi Mc IF Innocenti et al., 2004 
5500 VASP Pc IF Andrea Jenzora, HZI, Braunschweig, 
Germany 
55K2 Fascin Mc IF Santa Cruz Biotechnology Inc, Santa 
Cruz,CA, USA 
289H10 Cortactin Mc IF Synaptic Systems, Göttingen, 
Germany 
T4026 ß-Tubulin ascites WB Sigma Aldrich, Germany 
Table 5: Primary antibodies 
 
2.8.2 Secondary Reagents 
Secondary Reagents used in this study are listed in Table 6. 
Description Species 
Antibody 
Species 
Antigen 
Coupled to Provided by 
A4a Goat mouse PO coupled Dianova 
B4C Goat rabbit PO coupled Dianova 
B12C Goat Rabbit Alexa Fluor 488 Invitrogen (molecular probes) 
B13C Goat Rabbit Alexa Fluor 594 Invitrogen (molecular probes) 
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A 12C Goat Mouse Alexa Fluor 488 Invitrogen (molecular probes) 
A13C Goat Mouse Alexa Fluor 594 Invitrogen (molecular probes) 
A16C Goat Mouse Alexa Fluor 350 Invitrogen (molecular probes) 
Ph12 
Phalloidin 
  Alexa Fluor 488 Invitrogen (molecular probes) 
Ph13 
Phalloidin 
  Alexa Fluor 594 Invitrogen (molecular probes) 
Ph16 
Phalloidin 
  Alexa Fluor 350 Invitrogen (molecular probes) 
Table 6: Secondary reagents 
 
2.8.3 Western Blots 
Western blots were performed as follows: after separation on SDS-PAGE gels, proteins 
were transferred onto PVDF-membrane (Immobilon P, Millipore) using a semidry 
blotting system (Pegasus, Phase, Germany) and a glycine methanol SDS blotting 
buffer  [50mM Tris, 39 mM glycine, 0.037 (w/v) SDS, 20% (v/v) methanol] at a constant 
current of 2 mA per cm2 of gel area for 60 minutes (for proteins of interest up to 60 
kDa) up to 120 minutes (for proteins of interest up to 150 kDa). Transfer efficiency was 
monitored by staining of the membranes with Ponceau S solution [0.5% PonceauS 
(Sigma), 40% methanol, 15% acetic acid]. Membranes were blocked for 30 minutes at 
room temperature or at 4°C overnight in blocking bu ffer [10% dry-milk in TBS-T buffer 
(20mM Tris-HCl pH 7.6; 137 mM NaCl; 0.1% Tween20)]. Afterwards, membranes were 
incubated overnight at room temperature or at 4°C i n 1% dry-milk in TBS-T buffer 
containing the primary antibody usually at a concentration of 1µg/ml. Membranes were 
washed three times in TBS-T buffer for 10 minutes and then incubated for 1 hour at 
room temperature with 1% dry-milk in TBS-T buffer containing the secondary antibody. 
Membranes were again washed three times with TBS-T buffer and then incubated for 
up to 4 minutes with the chemiluminescence substrate Lumilight (Roche) in the case of 
peroxidise-coupled secondary antibodies and exposed to Hyperfilm ECL (Amersham 
Biosciences). 
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2.9 Tissue culture, transfection and treatments 
2.9.1 Media and solvents 
Growth medium 1 :  
DMEM (Dulbecco´s Modified Eagle Medium, Gibco) 
4,5g/l glucose  
   FCS PAA EU (PAA)     10% 
    L-glutamine (Gibco)     2mM 
 
Growth medium 2: 
 DMEM (Dulbecco´s Modified Eagle Medium, Gibco),  
4.5 g/l glucose 
FCS Lot: 047K3395 (Sigma)    10% 
L-glutamine (Gibco)      2 mM 
Non-essential amino acids (Gibco)    1 x 
Sodium-pyruvate (Gibco)     1 mM 
 
Growth medium 3:   
DMEM (Dulbecco´s Modified Eagle Medium, Gibco) 
4,5 g/l glucose 
   FCS PAA Clone (PAA)    10%  
   L-glutamine (Gibco)     2mM 
   Puromycin      1µg/ml 
 
Microscopy Medium 1: 
  F12-HAM Medium Hepes Modification (Sigma) 
   FCS PAA EU (PAA)     10% 
   L-glutamine (Gibco)     2mM 
   Penicillium (Gibco)     25000U 
Streptomycin (Gibco)     25000µg 
                                                                                                     Material and Methods 
 
 40 
2.9.2 Used cell lines 
 
Name Organism Type Growth 
medium 
Source 
B16-F1 Mus 
musculus 
Melanoma, skin 1 ATTC 
(CRL-6323) 
3-9 Mus 
musculus 
Cdc42 fl/- fibroblast 
 
2 Cord Brakebusch, 
University of 
Copenhagen 
3-9-7 Mus 
musculus 
Cdc42 -/- fibroblast 2 Cord Brakebusch, 
University of 
Copenhagen 
VA13 
NS14-4 
Homo 
sapiens 
Pulmonary fibroblasts stably 
transfected with Nap1 RNAi 
(pSuper.retro.puro-Nap1 
RNAi) 
3 Annika Steffen, HZI 
VA13 C33 Homo 
sapiens 
Pulmonary fibroblasts stably 
transfected with mock RNAi 
(pSuper.retro.puro) 
3 Annika Steffen, HZI 
Hela S3 Homo 
sapiens 
adenocarcinoma 
cerevix epithelial 
cells 
2 ATTC 
(CCL-2.2) 
Table 7: Cell lines employed in this work. 
All cell lines were cultivated at 37°C and 7.6% (v/v) CO2. 
 
2.9.3 Culture of cells prior to microscopic analyses 
For Live-cell imaging, cells transiently transfected with respective constructs were 
seeded subconfluently on 15mm acid–washed glass coverslips (15mm) coated with 
25µg/ml Laminin (Roche) or 25µg/ml Fibronectin (Roche). Cells seeded on Laminin 
were allowed to spread for at least 3 hours, cells seeded on Fibronectin were allowed 
to spread for at least 3 hours or overnight. 
Coverslips had been pretreated as follows: glass coverslips were incubated in a 
mixture of 60% ethanol and 40% concentrated HCl for 1 to 3 hours under agitation. 
Coverslips were then extensively washed in water that was repeatedly exchanged. 
Coverslips were allowed to dry separately on Whatman filterpaper overnight and 
autoclaved. 
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2.9.4 Transfections 
Transfections were carried out using SuperFect (Qiagen, Germany, for B16-F1), 
FuGene HD (Roche, Germany, for HeLa S3) or with FuGene 6 [Roche, Germany, for 
Cdc42 (fl/-), Cdc42 (-/-) and B16-F1 cells used for FMNL2 knockdown experiments], 
according to manufacturer´s protocols.  
In brief, 50 µl Optimem were mixed with 3 µl FuGene (6 or HD) and 1 µg DNA and 
incubated for 20 minutes at room temperature. The mixture was added to cells in a 3 
cm diameter dish containing freshly replaced medium and incubated for 24 hours. 
For B16-F1 transfections, 1 µg DNA was mixed with 300 µl DMEM high glucose and 6 
µl SuperFect and incubated for 40 min at RT. 2 ml pre-warmed growth medium were 
added to the reaction mix and the complete solution was added to the cells (in a 3-cm 
diameter dish) after aspiring the old medium. Cells were cultivated with the  
transfection medium for 16 h. For transfections of cells in larger dishes, the mixture 
was scaled up accordingly. 
 
2.9.5 Treatment of B16-F1 cell with Aluminium Fluoride 
To induce lamellipodia in B16-F1 cells, cells were treated with aluminium fluoride  
(ALF4-). As a phosphate analogue, aluminium fluoride binds with high affinity, but 
reversibly, to sites in proteins occupied by phosphate as e.g. in Rho-GTPases (Hahne 
et al, 2001). B16-F1 cells express high amounts of the Rho-GTPase Rac1, which is 
activated by aluminium treatment, resulting in the formation of lamellipodia. 
50µM aluminium chloride and 30mM sodium fluoride were mixed in B16-F1 medium, 
added to the cells and incubated for 15-20 min immediately before fixation. 
2.9.6 Knockdown of gene expression by transient RNA interference 
Drf3 knockdown vectors were provided by Theresia Stradal and Petra Hagendorff (HZI, 
Braunschweig) and FMNL2 and FMNL3 knockdown vectors were purchased from 
Invivogen.  
The time course of the run-down of Drf3, FMNL2 and FMNL3 was assessed by 
immunoblotting as a function of time after transfection of the knockdown plasmid. 
For this purpose, cells were transfected with Drf3 knockdown or control vector (Table 
8). 16-20 hours after transfection FACS-sorting was performed. For FMNL2 and 
FMNL2/3 knockdown, cells were co-transfected with the respective knockdown vector 
and the pPur vector mediating puromycin resistance. 16-20h after transfection, the 
growth medium was replaced by medium containing 2 µg/ml puromycin. Knockdown 
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cell populations from day 2 through day 6 after transfection were subjected to western 
blot analysis. 
 
Target gene Sequence 5´ to 3´ Specifity Vector 
Drf3 Hum 341 AAGCCACTGTCAGAGAATG human pSiren-ZsGreen 
mDia2 Mus 
1358 
AACGGACCCTGACTTCACA mouse pSiren-ZsGreen 
scrambled 
control 
NNNNNNNNNNNNNN  psiRNA-h7SK 
GFP:Zeo control 
FMNL2-1 GGAAGTCTGCGGATGAGATAT mouse psiRNA-h7SK 
GFP:Zeo 
FMNL2-2 GGAATTAAGAAGGCGACAAGT mouse psiRNA-h7SK 
GFP:Zeo 
FMNL3 GAAACCTATCAAGACCAAGTT mouse&human psiRNA-h7SK 
GFP:Zeo 
FMNL3 GGTGCAGATTCAAGCGTACCT mouse psiRNA-h7SK 
GFP:Zeo 
Table 8: Knockdown vectors employed in this work 
 
2.10 Immunofluorescence Microscopy and Live-Cell Imaging 
2.10.1 Labelling of the Actin Cytoskeleton 
Phalloidin, a component derived from the mushroom Amanita phalloides, specifically 
binds to actin filaments and stabilizes them against depolymerization (Cooper, 1987). 
Fluorescent derivatives Alexa FluorTM 488 -coupled phalloidin and Alexa FluorTM 594 - 
coupled phalloidin (Molecular Probes), 3 U/ml was dissolved in 1% BSA in PBS and 
used to stain actin filaments in permeabilized cells. 
 
2.10.2 Fixation procedures, stainings and analysis 
For phalloidin stainings, cells were fixed with 4% formaldehyde (PFA) in PBS for 20 
minutes and extracted with a mixture of 0.1% Triton X-100 in PFA (4%) for 1 minute. 
For fascin stainings, cells were fixed in -20°C met hanol for 10 minutes. Afterwards, 
cells were washed three times with PBS and blocked with 5% horse serum in 1%BSA 
for 1h at room temperature.   
To stain for filamentous actin, fluorescently coupled phalloidin was added and the 
coverslips with cells were incubated on parafilm in a humid chamber at room 
temperature. For staining of other cytoskeletal proteins like Abi and Arp2/3-complex 
antibodies were diluted in 1% BSA and incubated for 1h at room temperature. After 
washing the coverslips extensively with PBS, the samples were incubated for 1h at 
room temperature with the appropriate secondary antibody that was either coupled with 
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Alexa FluorTM350, Alexa FluorTM 488 or Alexa FluorTM 594. The samples were mounted 
in 5 µl Mowiol 4-88 (Calbiochem) supplemented with n-propylgallate (2.5 µg/ml), dried 
and stored in the dark at 4°C until analysis.  
Preparations were analyzed on an inverted microscope (Axiovert 100TV, Zeiss, Jena, 
Germany) using a 63x/1.4 NA or a 100x/1.4 NA plan apochromatic objective. For triple 
stainings analysis was performed using a 63x/1.25 NA or a 100X/1.3 NA Plan-Neofluar 
objective. The microscope was equipped for epifluorescence with electronic shutters 
(i.e. Uniblitz Electronic 35mm shutter including driver Model VMMD-1, BFI Optilas) to 
allow for computer-controlled opening of the light paths, filterwheel (e.g. LUDL 
Electronic Products LTD, SN: 102691 and driver SN: 1029595) to enable two-colour 
epi-fluorescence in combination with appropriate dichroic beamsplitters and emission 
filters (Chroma Technology Corp., Rockingham, USA), tungsten lamp (Osram, 
HLX64625, FCR 12V, 100W) for phase contrast optics and mercury lamp (HBO 
100W/2, Osram) for epifluorescence and immersion oil (refraction index of 1.518, 
Zeiss).  Images were acquired with a back-illuminated, cooled charge-coupled-device 
(CCD) camera (TE-CCD 800PB, CoolSnap K4 or CoolSnap HQ2, Princeton Scientific 
Instruments, Princeton, USA) driven by IPLab software (Scanalytics Inc., Fairfax, USA) 
or MetaMorph software (Molecular Devices, Sunnydale, USA). Data and images were 
processed using ImageJ and Adobe Photoshop 7.0 software. 
2.10.3 Electron microscopy 
Electron microscopy images were performed by Vic Small, Stefan Köstler and Edith 
Urban at the Austrian Academy of Science, Austria. For negative stain electron 
microscopy cells were grown on formvar films and processed essentially as described 
by Auinger & Small (2008).  
2.10.4 Life cell Imaging and data analysis 
Cells were observed in an open chamber (Warner Instruments, reading, UK) with a 
heater controller (model TC-324B, SN:1176) at 37°C.  Ham’s F12 HEPES buffered  
medium (Sigma) including complete supplements of the regular growth medium (see 
2.9.1) was used for imaging B16-F1 cells. For Hela cells and Cdc42 fl/- and -/- 
fibroblast cells growth medium 2 + 25mM HEPES was used for live cell imaging. During 
these experiments, the imaging medium was exchanged roughly every 30 minutes. 
Rates of filopodia initiation were assessed from randomly chosen cell peripheries with 
30 µm in width and over a time period of 20 min. Twenty independent cells were 
analyzed for each experimental condition, i.e. control and Drf3 knockdown cells. Newly 
formed filopodia were marked manually at the time point of initiation and counted 
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subsequently. In total, 393  and 489 filopodia were marked and counted for control and 
Drf3 knockdown cells, respectively. Statistical analyses were carried out using 
SigmaPlot, version 11.0 (SPSS, Chicago, IL) and Microsoft Excel, 2003 (Redmond, 
WA). 
Random cell migration assays (Pankov et al., 2005; Kopecki et al., 2007) were 
performed by using an AxioCam MRm camera (Carl Zeiss) on an Axiovert 200 
automatic microscope equipped with closed heating and CO2 perfusion devices. For 
random migration assays, cells were plated subconfluently in a 6 well petridish and 
recorded over 24h with a time intervall of 15min between frames. Migration analyses 
were carried out using the track objects function of Metamorph (Molecular Devices 
Corp.). Data were logged into Excel files and processed using Exel 2003 and Sigma 
Plot 10.0. 
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3 Results  
Prominent protrusive structures generated by the polymerisation of actin filaments 
include filopodia and lamellipodia. The mechanism underlying the formation of these 
fundamental structures has been the subject of many studies over the last years. 
Meaningful data obtained from functional interference studies established that the 
formation of lamellipodia depends on the nucleating activity of the Arp2/3-complex 
(Nicholson-Dykstra and Higgs, 2008; Steffen et al., 2006; Innocenti et al., 2004). On the 
contrary, the way filopodia are nucleated still remains controversial. It has been 
proposed that filopodia are effectively and continuously initiated by the elongation of 
pre-existing lamellipodial filaments (Svitkina et al., 2003; Korobova and Svitkina, 2008) 
but several studies failed to establish the requirement of lamellipodial filaments in 
filopodia formation (Gomez et al., 2007; Steffen et al., 2006). Therefore, another model 
has been put forward implicating distinct signalling pathways and separable core 
machineries driving the formation of filopodia and lamellipodia (reviewed in Faix et al., 
2009). This implies de novo nucleation of filopodia by a yet unknown actin nucleator. 
Diaphanous related formins (Drfs) appeared as promising targets to be analysed 
concerning this issue given that they nucleate linear, unbranched actin filaments as can 
be found e.g. in filopodia. This protein family has already been described to regulate a 
large variety of cellular and morphogenetic functions (reviewed in Faix and Grosse, 
2006). More specifically they have already been implicated in the formation of stress 
fibres or actin cables in yeast (Watanabe et al., 1997; Evangelista et al., 2002), but if 
and how they contribute to filopodia and lamellipodia formation is still under discussion. 
3.1 Subcellular localisation of Diaphanous related formin 3 (Drf3) 
In Dictyostelium cells, the Drf dDia2 was shown to be critical for filopodia formation 
suggesting that nucleation and/or elongation of filopodial actin filaments by a formin  
regulate the assembly of these structures (Schirenbeck et al., 2005). To obtain further 
insight into the functions of the mammalian homolog mDia2/Drf3, localisation studies 
were performed utilising genetically encodable fluorescent tags like e.g. EGFP. This 
allows to visualize precisely where in a given cell a protein accumulates and provides 
the opportunity to study the dynamic behaviour of a protein of interest in real time. 
Taking advantage of this tool, full length Drf3 was fused to EGFP and expressed in 
B16-F1 mouse melanoma cells. Western Blot analysis showed that the fusion protein 
could be detected in cell extracts running at the expected molecular weight (Figure 19). 
Similar to previous observations (Yang et al., 2007), full length Drf3 was entirely 
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cytosolic and did not interfere with the motility of B16-F1 cells (Figure 7A, 
Supplementary movie 1). This was presumably due to autoinhibition of the full length 
formin as has been shown for instance for the Diaphanous related formins mDia1 and 
FRLα (Seth et al., 2006). To obtain a Drf3 variant incapable of autoinhibition, and thus 
rendered active, a small C-terminal part of the protein encoding the DAD-domain 
(Figure 7B) was removed. Expression of this construct, called Drf3∆DAD, in B16-F1 
cells strongly induced the formation of filopodia, with the active formin localising to the 
tip of each filopodium (Figure 7C and Supplementary movie 2). The appearance of 
these filopodia correlated with the expression level of Drf3∆DAD. B16-F1 cells 
expressing high levels of Drf3∆DAD formed big, club-shaped filopodia, whereas 
filopodia in low expressing cells had a tapered shape, similar in morphology to 
constitutively formed filopodia (Figure 7D and E). In most cells, filopodia formation 
occurred at the expense of lamellipodia, suggesting a mutual antagonism between 
lamellipodia and filopodia formation in this cell type. 
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3.2 Cdc42 and Rif induce filopodia via Drf3 
One important feature of Diaphanous related formins is their ability to become activated 
upon interaction with Rho-GTPases in a nucleotide-dependent manner (Alberts, 2001; 
Watanabe et al., 1997). Relieving the intramolecular interaction between the DID and 
the DAD-domain by binding of an activated Rho-GTPase is prerequisite for actin 
assembly and proper localisation within the cell (Seth et al., 2006; Martin et al., 2007). 
In vitro data showed that Drf3 binds Cdc42 in a nucleotide-dependent manner (Alberts 
et al., 1998). Subsequently, FRET experiments indicated that active Cdc42 is able to 
interact with Drf3 at sites of actin remodeling (Peng et al., 2003), but more striking 
results were observed upon co-transfection of Drf3 with constitutively active Rif, which 
induced filopodia tipped by the formin (Pellegrin and Mellor, 2005).  
 
Figure 7: Expression of active Drf3∆DAD induces the formation of filopodia 
(A) EGFP-tagged full-length Drf3 is entirely cytoplasmic. (B) Schematic illustration of the used 
Drf3∆DAD constructs lacking amino acid residues 1056–1110. GBD, GTPase-binding domain; DID, 
Diaphanous-inhibitory domain; DD, Dimerisation domain; CC, Coiled coil; FH, Formin-homology 
domain; DAD, Diaphanous-auto-inhibitory domain. (C) Drf3∆DAD expressing cell displaying 
numerous filopodia. (D) and (E) Filopodial protrusions formed in high and low Drf3∆DAD 
expressors, respectively. Scale bar in (C) is 10 µm and valid for (A) and (C). Scale bars in (D) and 
(E) are 5 µm. 
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Assuming that co-expression of Cdc42 or Rif would release the autoinhibiton of Drf3 
and subsequently cause proper subcellular localisation, B16-F1 cells transfected with 
EGFP-Drf3 full length were co-transfected with constitutively active Cdc42 (L61) or 
constitutively active Rif (L77). Surprisingly, co-expression of active Cdc42 was not 
sufficient to induce filopodia with Drf3 localising at the tips, but instead caused 
translocation of Drf3 to the whole plasma membrane (Figure 8A). This could be 
explained, at least in part, by strong activation of Rac via Cdc42, which would result in 
the formation of lamellipodia rather than filopodia (DerMardirossian et al. 2004; Nobes 
and Hall, 1995). This is supported by the fact that B16-F1 cells transfected with active 
 
Figure 8: Cdc42-induced targeting of Drf3 to the plasma membrane and the 
tips of filopodia upon Rac inhibition. 
A) Co-expression of full length Drf3 and active Cdc42 (L61) translocated Drf3 to the 
plasma membrane in  B16-F1 cells. B) After suppression of Rac signalling by dominant 
negative approach, filopodia formation through active Cdc42 could be induced (arrows 
in B right panel), and Drf3 localised at tips of these filopodia (arrows in B left panel). 
Bars equal 10 µm 
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Cdc42 exhibit a pancake-like shape (Figure 8A), which can also be observed upon 
expression of active Rac GTPases. To overcome this, I exploited dominant negative 
mutants, which are a popular tool to suppress the activity of specific Rho-GTPases, 
because they can act as “dead ends” of specific signalling pathways (Feig, 1999). 
Thus, the activity of Rac has been suppressed via triple transfection of Drf3 full length, 
active Cdc42 (L61) and dominant negative Rac (N17). As expected, this induced the 
formation of filopodia without or with much less concomitant membrane ruffling, and 
Drf3 could be observed at the tips of filopodia (Figure 8B), although this phenotype was 
not as distinct as that caused by over-expression of Drf3∆DAD alone. 
 
On the contrary, co-transfection of Drf3 with constitutively active Rif (L77) resulted in 
formation of dozens of Drf3 marked filopodia comparable to the phenotype observed 
upon transfection of B16-F1 cells with Drf3∆DAD (Figure 9). This clearly demonstrates 
that Drf3 targeting to filopodia tips can be potently effected by Rif expression and may 
or may not involve Cdc42 signalling. In addition, this remarkable change in subcellular 
Drf3 localisation upon co-expression of active Rif proved the functionality of the Drf3 full 
length fusion protein.  
 
Figure 9: Co-transfection of Drf3 full length with constitutively active Rif induces filopodia. 
Co-expression of constitutively active Rif (L77) induced the formation of filopodia (A) comparable 
to the phenotype observed with EGFP-Drf3∆DAD and strongly targeted Drf3 to tips of filopodia 
(B). Bar equals 10 µm. 
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3.3 Drf3-induced filopodia are initiated by de novo nucleation 
To determine if filopodia are formed by convergent elongation of pre-existing 
lamellipodial filaments or if they are nucleated independently of lamellipodial filaments, 
the Drf3∆DAD-induced filopodia were examined more closely. Following filopodia 
dynamics over time by live-microscopy revealed that frequently a thickening of filopodia 
after protruding beyond the lamellipodia edge could be observed (Figure 10).  
Sometimes this thickening was 
accompanied by an increase in fluorescent 
intensitiy of EGFP-Drf3∆DAD (data not 
shown). Additionally, fluorescent intensities 
of active Drf3 directly correlated with the 
intensitiy of phalloidin staining marking 
filamentous F-Actin (Figure 11), indicating 
that an increase in active Drf3 at filopodia 
tips results in an increase of actin 
filaments. 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Spontaneous 
thickening of Drf3∆DAD-
induced filopodia. 
Panels of time-lapse sequences 
of parts of Drf3∆DAD-over-
expressers showing filopodia after 
having separated from the cell 
periphery. Note thickening of 
filopodia tips and concomitant 
increase in intensity (A) or 
widening of the fluorescence 
signal (arrows in (B–D)). Bar in 
(D) is valid for all images and 
corresponds to 2 µm. 
 
                                                                                                     Results 
 
 51 
 
 
To obtain more evidence in favour of or against the de novo nucleation of filopodia, the 
ultra-structure of actin filaments within the club-shaped filopodia was examined in more 
detail. Therefore, electron microscopy of whole mount specimen was performed in 
collaboration with Prof. J. Victor Small (IMBA, Vienna, Austria). An average filopodium 
has a uniform diameter of 0.1-0.2 µm and is composed of many densely packed 
filaments (Vignjevic et al., 2006, Svitkina et al., 2003), as shown in Figure 12A. The 
shafts of the Drf3-induced club-shaped filopodia consisted of a moderate number of 
long, parallel actin filaments. The tips however had a diameter up to 0.7 µm, with a 
higher number of filaments in the tips compared to the shafts of these structures 
(Figure 12B and C). Frequently, it could be observed that a newly formed filopodium is 
emanating from a pre-existing filopodium (Figure 12D), which can not be explained by 
convergent elongation of lamellipodial filaments. 
 
Figure 11: B16-F1 cell over-expressing EGFP-tagged Drf3∆DAD and 
counterstained for phalloidin. 
Line-scans show fluorescence intensities as measured for F-actin and 
Drf3∆DAD in the tip regions of three distinct filopodia of variable prominence. 
Colour codes used in the curves at the bottom (curves A, B, C) highlight the 
different measurements as indicated in the images at the top. A robust 
correlation between Drf3∆DAD and F-actin amounts is observed in these 
filopodia. Bar equals 3 µm. 
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Figure 12: Filopodia ultra-structure in control and 
Drf3∆DAD over-expressing cells. 
Transmission electron micrographs of negatively-stained 
whole mount cytoskeletons of B16-F1 control cell (A) or 
Drf3∆DAD over-expressors (B–D). (a) Typical control 
filopodium formed in non-transfected B16-F1 cell, not 
displaying filopodial thickening in the tips, frequently observed 
with Drf3∆DAD-induced filopodia (B–D). Note prominent actin 
filament accumulation in filopodia clubs, and a low number of 
long, linear filaments along the shafts (B, C). (D) shows 
representative example of filopodial club, branching off 
another. Scale bars are 500 nm. 
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Counting of individual filaments in the tip and the shaft of Drf3-induced filopodia as 
indicated in Figure 13A revealed a linear correlation between filopodia width and 
filament number (Figure 13B), thus a constant packing density of actin filament within 
these structures (Figure 13C).  All these data strongly indicate that it is very unlikely 
that filopodia are exclusively formed by convergent elongation as proposed by Svitkina 
et al., but support de novo nucleation of Drf3-induced filopodia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Analysis of filament numbers in Drf3∆DAD-
induced filopodia  
B16-F1cells over-expressing EGFP-tagged Drf3∆DAD were 
subjected to manual counting of filaments. Crossing white 
lines drawn across tip or shaft regions as indicated (A). Scale 
bar equals 500 nm. (B) Filament numbers as assessed from 
tips of filopodial clubs plotted versus tip widths (N =22). (C) 
Comparison of filament numbers in tips and shafts of 
Drf3∆DAD-induced filopodia as indicated, which 
corresponded on average to 10.68 ± 1.19 and 10.42 ± 1.13 
filaments per 100 nm, respectively. 
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3.4 Drf3-induced filopodia formation in the absence of functional 
WAVE-complex 
Lamellipodia formation critically depends on WAVE-complex-mediated Arp2/3-complex 
activation leading to the nucleation of new lamellipodial filaments. Assuming that 
filopodia are exclusively formed by convergent elongation of lamellipodial filaments, 
cells expressing reduced levels of all WAVE-complex components by RNAi should be 
unable to form filopodia. Additionally, it was previously published that the WAVE-
complex subunit Abi-1 interacts with Drf3 and is required for efficient induction of 
filopodia and targeting of the formin to the membrane (Beli et al., 2008).  
To test whether active Drf3∆DAD required lamellipodial filaments for induction of 
filopodia and Abi for targeting to the membrane, I exploited stable Nap1 knockdown 
VA-13 fibroblast cells, previously established to lack lamellipodia and to display a 
strongly reduced level of all WAVE-complex components including Abi-1 (Steffen et al., 
2006). Stable control and Nap1 knockdown fibroblasts were transfected with EGFP-
Drf3∆DAD. As seen in Figure 14, active Drf3 was sufficient to induce filopodia in mock-
treated fibroblasts tipped by the active formin as expected, although the response was 
not as pronounced as in B16-F1 cells (Supplementary movie 3). Remarkably, also 
Nap1 knockdown cells that lack lamellipodia were able to form numerous filopodia 
upon transfection with Drf3∆DAD (Figure 15). Although these cells express reduced 
levels of Abi-1, which has been implicated for targeting Drf3 to the membrane, Drf3 still 
localized to the tips of filopodia to extents comparable to mock-treated cells (Figure 15 
and Supplementary movie 4), strongly indicating that Abi is not required for Drf3 
targeting to filopodial tips. 
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Figure 14: Control siRNA-treated (Control RNAi) VA-13 fibroblast cell (Steffen et al., 
2006) transiently transfected with Drf3∆DAD.  
Arrows mark filopodia tipped by the EGFP-tagged formin. Bar equals 10 µm. 
 
 
Figure 15: Nap1 knockdown VA-13 fibroblast (Nap1 RNAi) transiently expressing 
Drf3∆DAD.  
Note prominent formation of filopodia tipped by EGFP-tagged DRf3∆DAD (arrows) in spite 
of WAVE-complex loss of function and coincident lack of lamellipodia (Steffen et al., 2004) 
Bar equals 10 µm. 
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3.5 Drf3∆DAD-induced filament networks contain lamellipodial 
marker proteins and fascin 
As mentioned previously, filopodia formation in Drf3∆DAD-expressing cells occurred at 
the expense of lamellipodia. However, in some cases Drf3∆DAD could also be 
observed at the tips of protrusive sheet-like structures as seen in Figure 16 and Figure 
17. Following the dynamics of Drf3∆DAD in these lamellipodia-like-structures by live 
video microscopy, it became obvious that Drf3∆DAD showed a lateral movement 
different from other components typically found in lamellipodia-like WAVE-complex 
components (Stradal et al., 2001; Steffen et al., 2004) and VASP (Rottner et al., 1999) 
(see Supplementary movie 5). On top of that, the enrichment of Drf3∆DAD was more 
variable than observed with other lamellipodia components. To further investigate the 
nature of these protrusive structures, immunofluorescence stainings were performed. 
Drf3∆DAD expressing cells were stained with phalloidin (Figure 16A). Additionally, 
Drf3-enriched filament networks reminiscent of lamellipodia were counterstained for 
Arp2/3-complex and prominent nucleating promoting factors like the WAVE complex 
member Abi-1 and Cortactin. As seen in Figure 16B and Figure 17A and B, these 
 
Figure 16: Drf3∆DAD can target to the tip of a lamellipodium like 
structure.  
EGFP-tagged Drf3∆DAD accumulation at the tips of lamellipodial actin 
filament networks, as stained by phalloidin (A) and harbouring Arp2/3-
complex (B) as indicated. Bars equal 10µm. 
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structures were prominently labelled by Arp2/3-complex, Abi-1 and Cortactin, indicating 
their structural relationship to lamellipodia. However, the same structures were also 
prominently enriched for the actin crosslinking protein fascin (Figure 17C, arrow). This 
protein is typically found in microspikes, as shown in Fig. 11C of a neighbouring 
untransfected cell (Figure 17C, asterisk), but also in filopodia (Nemethova et al., 2008) 
and is well established to be required for microspike/filopodia formation (Vignjevic et al., 
2006). This unusual enrichment of fascin at Drf3∆DAD-labelled lamellipodia-like-
structures indicates that these protrusive structures do not represent canonical 
lamellipodia, but instead a hybride of lamellipodia and filopodia. 
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3.6 Loss of Drf3 does not alter filopodia initiation in Hela S3 cells 
Over the last years conflicting results on the influence of Drf3 on filopodia and 
lamellipodia formation have been published. In Dicytostelium discoideum, dDia2 is 
essential for the formation and maintenance of filopodia (Schirenbeck et al., 2005). In 
the mammalian system, knockdown of mDia2 has been described to abrogate 
lamellipodia and filopodia formation on one hand (Yang et al. 2007), or to induce the 
formation of lamellipodia at the expense of filopodia on the other hand (Beli et al., 
 
Figure 17: Drf3∆DAD induced lamellipodia-like- 
structures contain Arp2/3 complex and fascin.  
B16-F1cells expressing EGFP-tagged Drf3∆DAD were 
counterstained for the WAVE-complex component Abi, 
cortactin and fascin as indicated. Note prominent co-
accumulation of Drf3∆DAD with the respective component. 
Asterisk in fascin image highlights typical label on micro-
spikes (Vignjevic et al., 2006) embedded into the 
lamellipodium of a neighbouring, non-transfected cell. 
Scale bar equals 10 µm. 
                                                                                                     Results 
 
 59 
2008). The latter results were obtained in Hela and the former in B16-F1 cells, although 
it is presently unclear if the observed differences are due to use of different cell types. 
In any case an important prerequisite to study the influence of Drfs on cell migration is 
the information about their relative expression in different cell lines. Thus expression 
profiles of Drf1- 3 in different murine and human cells lines were acquired using 
Genechip technology (cooperation with Drs. Robert Geffers and Theresia Stradal, HZI, 
Braunschweig) (Figure 18).  
It turned out that Drf1 (mDia1) was expressed in all tested cell lines, whereas Drf2 
(mDia3) and Drf3 (mDia2) were much less abundant. Specifically, Drf3 was of low 
abundance in the murine cell lines tested here, including B16-F1 cells, that have been 
used by Yang et al., as well as in NIH 3T3 cells as reported previously (Tominaga et 
al., 2000; Peng et al., 2003). In contrast high expression of Drf3 could be detected in 
 
Figure 18: Microarray analyses of cell lines as indicated. 
(A) Expression levels of Drf1-3 normalized to ß-actin. Note most prominent 
Drf3 expression in Hela S3, VA-13 and THP-1. (B) Arp3, (C) N-
WASP/WASP and (D) WAVE isoform expression as normalized to β-actin. 
Black solid and dashed lines in (A), (C) and (D) indicate average background 
levels ± standard deviation from all Gene Chips. 
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VA-13 fibroblasts and the epithelial cell lines Hela S3 and CaCo2. These results were 
confirmed by western blot analyses of murine and human cell lines commonly used in 
our lab using a polyclonal anti-Drf3 antibody (Figure 19), originally raised against an N-
terminal fragments (residues 1-565) of human Drf3.  
 
In line with the microarray data, no expression of Drf3 could be detected in B16-F1, 
NIH 3T3 and Swiss 3T3 cells, whereas most prominent Drf3 expression was observed 
in Hela S3 and CaCo2 cells. We conclude this was not due to a lack of reactivity of the 
antibody with murine mDia2/Drf3, since the murine N-terminus tagged with EGFP was 
readily detected (data not shown). 
As mentioned above, the function of Drf3 in lamellipodia and filopodia formation is still 
controversial. To reconcile these differences and in order to get more insight into the 
mechanism of filopodia formation, loss of function studies using Hela S3, which 
express a high amount of Drf3, have been performed. To do this expression of Drf3 in 
Hela S3 cells was transiently knocked-down by RNAi. These cells have been subjected 
to video microscopy to study their ability to form filopodia and to analyse their dynamics 
in the absence of Drf3 (Figure 20A). Surprisingly, counting the number of newly formed 
filopodia in a 30µm-wide cell periphery over a period of 20min showed that interference 
with Drf3 protein levels in Hela S3 cells did not impair filopodia formation, which is in 
contrast to previously published results (Figure 20B). In fact, the average rate of 
filopodia initiation was increased rather then decreased in Drf3 knockdown compared 
 
Figure 19: Expression of Drf3 in different murine and human cell lines 
Different murine and human cell lysates subjected to western blot analysis using a polyclonal 
α-Drf3 antibody. Please note expression of Drf3 in Hela S3, A431 and CaCo2 cells  and the 
correct molecular weight (150 kDa) of N- and C-terminal EGFP-Drf3 fusion proteins. Antibody 
against actin was used as loading control. Asterisk marks non-specific crossreaction in CaCo2 
cells. 
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to mock-treated cells, although the reasons for this remained unclear. These data do 
not support the idea of Drf3 being the main nucleator of actin filaments in filopodia 
formed by Hela cells. 
As mentioned above, Drf3∆DAD was occasionally observed to accumulate at the tips of 
lamellipodia-like structures that were interpreted to constitute canonical lamellipodia 
previously (Yang et al., 2007). To test if Drf3 might indeed have a role in lamellipodia 
formation, mock-treated and Drf3 knockdown Hela S3 cells were co-transfected with 
myc-tagged constitutively active Rac (L61), which is well known to elicit the formation of 
lamellipodia (Ridley et al., 1992). Expression of active Rac was confirmed by α-myc 
staining. Control cells and Hela cells with reduced Drf3 levels exhibited a pancake-like 
shape, which is typical for expression of active Rac (Figure 21). Both cell populations 
where capable of lamellipodia formation as shown in Figure 21A, D and G. Together 
these data indicate that Drf3 is dispensable for the formation of both filopodia and 
lamellipodia, at least in Hela S3 cells. 
 
Figure 20: Filopodia formation does not require Drf3 in Hela cells. 
(A) Hela S3 cells transiently knocked down for Drf3 were still able to form filopodia. Bar equals 
10µm. (B) Quantification of newly formed filopodia in mock and Drf3 knockdown cells derived 
from four independent experiment. Hela S3 cells expressing reduced levels of Drf3 can initiate 
filopodia. Mock treated cells formed 19,65 ± 1,4 and Drf3 knockdown cells 24,45± 1,7 filopodia 
per 30µm cell periphery and a time period of 20min. Data represent filopodia analysed from 20 
cells for each condition, in total 393 filopodia for control and 489 filopodia for Drf3 knockdown 
cells were counted. Efficient knockdown of Drf3 was confirmed by Western Blotting (right 
panel). Actin was used as a loading control. 
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Figure 21: Drf3 is not required for Rac-induced lamellipodia formation. 
Mock (A-C) and Drf3 knockdown (D-F) Hela S3 cells expressing the pSiren-ZsGreen Drf3 
silencing vector, visible by a green fluorescence (ZsGreen). (B and E) Cells have been co-
transfected with myc-tagged-constitutively active Rac (L61) stained by α-myc antibody, to 
induce the formation of lamellipodia. (A and D) Phalloidin staining revealed that Mock and Drf3 
knockdown cells are able to form lamellipodia upon expression of active Rac. Bar in G is valid 
for all images and equals 10µm. 
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3.7 Formin expression profiles 
Filopodia are an evolutionary conserved structure found in many different cell types. 
Although they can clearly occur downstream of multiple signalling pathways it is 
conceivable that a core machinery of filopodial actin assembly and a common 
molecular mechanism exists in all cell types able to form these protrusive structures 
(Ladwein and Rottner, 2008; Faix et al., 2009). In contrast to published results the data 
accumulated so far indicate that Drf3 is not required for filopodia formation in Hela S3 
cells. This conclusion is supported by the fact that cell lines like Swiss or NIH 3T3 and 
B16-F1 cells are able to form filopodia in a robust fashion, although they express 
 
Figure 22: Expression profile of formins in different murine and human cell lines. 
Microarray analyses showed abundant expression of Drf1, DAAM1 and FMNL2 in all tested cell 
lines (marked yellow), some formins like FMNL3 where only expressed in significant amounts in 
murine cell lines, others like Drf3 only in human cell lines. ++++ represents values >500; +++ 
>250; ++ >150; +(+) >100; + =app. 100; (+) >50; - <50; only values above 100 are considered 
significant. 
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minute amounts of Drf3, pointing towards significant redundancy in the system, 
mediated perhaps by other formins.  
To narrow down further candidates of mammalian formins potentially capable of 
effecting filopodia formation in addition to mDia2/Drf3, the expression of thirteen 
members of the formin family in various tissue culture cell lines was analysed by array 
analysis (collaboration with Drs. Robert Geffers and Theresia Stradal, HZI, 
Braunschweig). Given that filopodia formation can occur in multiple cell types such as 
fibroblasts, epithelial or neuronal cells, widely expressed formins were considered most 
interesting for further analysis. As shown in Figure 22, Drf1, DAAM1 (Dishevelled-
associated activator of morphogenesis-1) and FMNL2 (Formin related gene in 
leukocytes 2) are the only formins that are expressed in high levels in all tested cell 
lines.  
Since mDia1 binds to Rho rather than Cdc42 (Faix and Grosse, 2006), and its genetic 
removal in fibroblasts enhances filopodia formation rather than compromising it (Peng 
et al., 2003), mDia1 was unlikely to be crucial for filopodia formation and was therefore 
not studied in more detail. 
Work in Xenopus leavis oocytes implicated a role for DAAM1 to relay signalling from 
the Wnt:Frizzled ligand receptor system, via dishevelled, to regulate cell polarity during 
gastrulation (Habas et al., 2001). A recent publication concerning dDAAM1 in 
Drosophila reported a critical role for this formin in filopodia formation of axonal growth 
cones (Matusek et al., 2008). In addition, DAAM1 has been described as downstream 
effector of RhoA and Cdc42 (Aspenström et al., 2006), making it an interesting 
candidate to study its function in Cdc42-induced filopodia formation. I therefore 
explored the subcellular localisation of the diaphanous related formin DAAM1. DAAM1 
cDNA was amplified from a RZPD Clone (see 2.6.3) and fused to the enhanced green 
fluorescent protein (EGFP), expressed in B16-F1 cells and subjected to live-cell 
microscopy. However, neither full length DAAM1 nor an active variant lacking the DAD-
domain associated to any protrusive structures such as lamellipodia or filopodia in 
these cells (data not shown).  
I then turned to the next ubiquitously expressed formin FMNL2 (Figure 22). To date, 
FMNL2 is poorly characterized and not many data concerning its function in the 
mammalian system are available. It has been reported that FMNL2 is upregulated in 
colorectal cancer tumors and metastatic lymph nodes that harbour a high invasive 
ability (Zhu et al., 2008). Recently, different active variants of FMNL2 (and -3) or 
hybrids of them have been shown capable of targeting to the cell periphery (Vaillant et 
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al., 2008). Altogether these data pointed towards a potential role of FMNL2 in migration 
and in the protrusion of lamellipodia or filopodia.  
3.8 Generation of fluorescently-labelled FMNL2 
To have a closer look at the subcellular localisation of FMNL2 it was necessary to 
generate a fluorescently-labelled fusion protein. Amplification of FMNL2 cDNA by PCR 
and subsequent cloning was challenging, since FMNL2 contains approximately 300bp 
with a very high GC-content (above 80%) encoding the proline-rich region in the FH1-
domain. Therefore, EGFP-FMNL2 fusion protein was engineered by fusion of a cDNA 
clone harbouring a truncated sequence (RZPD Clone IRALp962K1959Q2) with PCR-
derived Hela S3 FMNL2 cDNA sequences and codon-optimised, synthesised 
fragments (GenScript) (see 2.6.3).  
The C-terminal part of FMNL2 amplified from Hela S3 cDNA contained a FMNL2 splice 
variant referred to below as FMNL2C, according to the NCBI reference sequence 
NM_001004422.1 that has been temporarily suppressed because of insufficient data 
supporting this transcript. In addition to the FMNL2C variant, two other well described 
splice variants FMNL2A and FMNL2B (Katoh and Katoh, 2003; Vaillant et al. 2009) 
with C-terminal divergence due to alternative splicing of exon 26 (Figure 23) were of 
major interest to the project. Thus, FMNL2A and FMNL2B C-terminal regions where 
synthesised by GenScript and exchanged with the C-terminal part of FMNL2C.  
FMNL2 belongs to the family of diaphanous related formins and possesses a 
conserved domain organisation with a GTPases binding domain (GBD), a FH1- and 
FH2-domain, a Diaphanous-inhibitory- (DID) and a diaphanous-autoinhibitory-domain 
(DAD) as shown in Figure 23. Based on my experience with other formins like Drf3 and 
DAAM1, I first designed a potentially active variant of FMNL2 lacking the DAD-domain. 
To do this the core DAD-domain containing the GAIEDIIT-motif (Higgs and Peterson, 
2005 and see Figure 23) was deleted, resulting in a construct lacking the C-terminal 56 
aminoacids; this construct was termed FMNL2∆DAD. 
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3.9 Subcellular localisation of FMNL2 splice variants 
Based on published data and the abundant expression of FMNL2 in all tested cell lines, 
FMNL2 appeared as promising target to be analysed concerning its potential function 
in protrusions such as filopodia and lamellipodia. Therefore, I explored the subcelluar 
localisation of three FMNL2 splice variants A, B and C by transiently transfecting B16-
F1 cells with the respective EGFP-tagged full length FMNL2 constructs. The 
transfected cells were subjected to video microscopy. As control for non-specific 
targeting to cytoskeletal structures, B16-F1 cells were transfected with a vector 
expressing EGFP alone (EGFP-C1, Clontech) and treated in the same way (Figure 
24A). 
In line with the conclusion that FMNL2 is an autoinhibited formin, full length EGFP-
FMNL2A and EGFP-FMNL2B did not accumulate in any specific way at protrusive 
structures like lamellipodia and filopodia. A strong signal of both splice variants could 
be observed in the perinuclear region simply due to high thickness in this area. The 
much thinner peripheral regions of the cells were almost entirely devoid of detectable 
fluorescence (Figure 24B and C, white arrows), although they contained an actively 
protruding lamellipodium (Figure 24B and C and Supplementary movie 6 and 7). On 
the contrary, EGFP-tagged full length FMNL2C weakly associated with the 
lamellipodium, but did not affect the motility or the morphology of B16-F1 cells (Figure 
24D and Supplementary movie 8). This accumulation in the leading edge was clearly 
more distinct than the unspecific localisation of EGFP alone (Figure 24A), and was 
therefore considered to be of potential functional relevance. 
 
Figure 23: Domain organisation of FMNL2 and splice variants  
Overview of domain organization of FMNL2, showing the longest isoform described so far 
(FMNL2B). Numbers correspond to amino acid residues. FMNL2 possesses an GTPase 
binding domain (GBD), a Diaphanous-inhibitory-domain (DID) and dimerisation-domain (DD), a 
formin homology 1 (FH1) and 2 (FH2) and a diaphanous-autoinhibitory-domain (DAD). The 
bottom provides a sequence comparison of isoforms derived from alternatively-spliced 
transcript variants. 
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The lack of localisation of full length FMNL2A and B was considered to be due to 
autoinhibition of the protein. To overcome this, the C-terminal diaphanous 
autoinhibitory domain (DAD) was removed leading to a presumably active FMNL2 
variant. Interestingly, FMNL2∆DAD strongly accumulated at the tips of protruding 
filopodia (Figure 25 and Supplementary movie 9), similar to what was previously 
observed with mDia2 (Block et al., 2008, Yang et al., 2007). In contrast to mDia2, 
FMNL2∆DAD did not interfere with lamellipodia formation as frequently observed for 
mDia2, and did localize to the tips of protruding lamellipodia as was observed above 
for full length FMNLC. This suggests that FMNL2C may not be fully autoinhibited, as 
has previously been described for the close relative FRL2 (FMNL3) (Vaillant & 
Copeland, 2008) and a splice variant of FMNL1 (Han et al., 2009). The authors of both 
studies proposed that the C-termini of this FRL/FMNL subfamiliy formins do not 
comprise functional DAD-domains. Our data would fit this hypothesis in case of the C-
variant of FMNL2 but not in case of FMNL2A and B. 
 
 
Figure 24: FMNL2A and FMNL2B are entirely cytosolic whereas FMNL2C localises to the 
leading edge of B16 mouse melanoma cells. 
As a control, B16-F1 mouse melanoma cells were transiently transfected with EGFP alone and 
subjected to video microscopy using fluorescence and phase contrast optics (A). Please note a 
weak accumulation of EGFP to the lamellipodium (arrows).  Expression of EGFP-FMNL2A  (B) 
and FMNL2B (C) in B16-F1 cells did not interfere with lamellipodia formation. Both splice variants 
lacked any accumulation at the leading edge of the cell (arrows in B and C). In contrast to 
FMNL2A and -B, full length EGFP-FMNL2C accumulated at the lamellipodium tip in B16-F1 cells 
(arrowheads in D). Scale bars equal 10µm. 
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The previously shown localisation of mDia2∆DAD to structures reminiscent of but not 
identical to lamellipodia (Figure 17) was accompanied by an unusual accumulation of 
the actin bundling protein fascin, normally found in microspikes. To ensure that the 
localisation of FMNL2 to lamellipodia tips was not an artefact derived from 
overactivation of the formin, cells were stained for lamellipodial marker proteins and 
fascin. Phalloidin staining of FMNL2∆DAD expressing B16-F1 cells confirmed the 
formation of lamellipodia, as expected (Figure 26A). Any other lamellipodia marker 
protein like Arp2/3-complex (Figure 26B), Abi-1 (Figure 26C), Cortactin (Figure 26D) 
and VASP (Figure 26E) nicely co-localised with FMNL2∆DAD lamellipodia. In addition, 
fascin displayed a normal subcellular positioning, strongly associating with microspikes 
within the lamellipodium, but absent form the very leading edge of the cell (Figure 26F). 
This was in marked contrast to the fascin localisation of mDia2∆DAD overexpressors, 
which appeared to force fascin to the leading edge (Figure 17). Thus, we conclude that 
FMNL2∆DAD-labelled structures at the cell periphery constitute bona fide lamellipodia. 
To prove that the localisation of FMNL2 to lamellipodia was of physiological relevance 
 
Figure 25: FMNL2∆DAD at the tips of protruding filopodia and lamellipodia. 
B16-F1cells were transiently transfected with EGFP-tagged FMNL2∆DAD, and 
subjected to video microscopy using phase contrast and widefield fluorescence 
imaging essentially as described previously (Block et al., 2008). (A) Examples of 
protruding filopodia; note the accumulation of the active formin at the tips of 
centrifugally growing filopodia (arrow). (B) Phase contrast and (C) fluorescence image 
of the same cell forming a prominent lamellipodium as characteristic for these cells 
moving on laminin (Rottner et al., 1999). Arrowheads in (C) highlight the specific 
accumulation of active FMNL2 at the tip of the protruding lamellipodium. Bar in (A) and 
(C) corresponds to 1µm and 10µm, respectively. 
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and no over-expression or overactivation artefact, B16-F1 cells were stained for 
endogenous FMNL2 using a commercially available monoclonal α-FMNL2 antibody. 
As shown in Figure 27, endogenous FMNL2 is enriched at the leading edge of B16-F1 
cells showing for the first time convincingly the endogenous localisation of a 
diaphanous-related-formin to the lamellipodium. Together, the enrichment of 
endogenous FMNL2 and EGFP-FMNL2∆DAD in these protrusive structures point 
towards a functional role for FMNL2 in lamellipodial protrusion and organisation. 
 
 
 
 
Figure 26: FMNL2∆DAD-stained lamellipodia contain Arp2/3-complex and Arp2/3-
complex activators but no fascin.  
B16-F1 cells were transiently transfected with EGFP-FMNL2∆DAD, fixed with paraformaldehyde 
and counterstained for Arp2/3-complex (B), the WAVE-complex subunit Abi-1(C), the Arp2/3-
complex activator Cortactin (D) and VASP (E). Note prominent co-accumulation of EGFP-
FMNL2∆DAD with the respective component. In (F), EGFP-FMNL2∆DAD transfected cells were 
counterstained for the actin bundling protein fascin. Note prominent accumulation of fascin at 
microspikes, as expected, but no targeting to the leading edge. Scale bar is valid for all images 
and equals 10µm.  
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3.10 FMNL2 interacts with Cdc42 and Rac1 in a nucleotide 
dependent manner 
 
Rho-GTPase are widely established to stimulate actin polymerisation by activating 
WASP/WAVE-family proteins and diaphanous-related formins. The latter exist in an 
autoinhibited state via intramolecular interaction of the DAD and the DID domain. Upon 
binding of a GTP-bound Rho-GTPase to the GTPase-binding domain (GBD) of the 
formin, this autoinhibition is released (Nezami et al., 2006; Wallar et al., 2006), which is 
thought to be a prerequisite for proper subcellular localisation of the activated formin. In 
general, each Drf is activated by a distinct subset of Rho-GTPase (Ridely, 2006).The 
formation of the active, GTP-bound state of the GTPase is accompanied by a 
conformational change in two regions (known as switch I and II), which provide a 
platform for the selective interaction with downstream effectors such as formins 
(Dvorsky and Ahmadian, 2004). Over the last years, binding of the Rho-GTPases RhoA 
and Cdc42 to the N-terminus of the Drf mDia1 has been extensively studied (Lammers 
et al, 2008; Otomo et al., 2005; Lammers et al., 2005). RhoA binds mDia1 via 
interaction of the Switch I region to the GBD of mDia1, and interaction of Switch II with 
 
Figure 27: Endogenous FMNL2 localizes to the lamellipodium of B16F1 cells. 
B16-F1 melanoma cells were immunolabelled for FMNL2 and counterstained for the actin 
cytoskeleton by fluorescent phalloidin. Cells were treated with aluminium fluoride to induce 
lamellipodia. Note specific accumulation of FMNL2 at the leading edge (white arrows). Scale 
bar equals 10µm. 
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the GBD and the Armadillo repeat subdomain (Rose et al., 2005b), which is located 
within the Diaphanous inhibitory domain (DID, see Figure 23) of the formin. 
To further characterise the contribution of FMNL2 to cell migration and lamellipodia 
formation, it was essential to determine which Rho-GTPases signal to FMNL2. 
Assuming that the structural requirements of Rho-GTPase-binding to the N-terminus of 
FMNL2 would be similar to the ones previously described for RhoA and mDia1, I 
generated a construct harbouring the GBD and the Armadillo repeat subdomain of 
FMNL2 (AA 1-428), called FMNL2-Arr.  
To assess whether the N-terminus of FMNL2 can interact with certain Rho-GTPases, 
pull-down assays using EGFP-FMNL2-Arr or EGFP-FMNL2∆DAD and beads coupled 
to respective GTPases were performed.  
 
Interestingly, pull-downs indicate strong, perhaps direct interactions between FMNL2 
and active, mostly GTP loaded, Cdc42 (L61) and Rac1 (L61) (Figure 28A). FNML2-Arr 
 
Figure 28: FMNL2 interacts with constitutively active Cdc42 and Rac1. 
B16-F1 cells transfected with EGFP-tagged FMNL2-Arr or FMNL2∆DAD as indicated, were 
subjected to pull-downs using beads coupled to active and inactive variants of Rho-GTPases. 
Rho-GTPases were fused to GST (A) or MBP (B) and coupled to Gluthatione-sepharose and 
amylose beads, respectively. Note binding of FMNL2-Arr and FMNL2∆DAD to active Cdc42 
(L61) and active Rac1 (L61), but not to their dominant negative counterparts or any other 
GTPase tested. No binding of EGFP to active Cdc42 and active Rac could be detected (C). 
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was not able to pull down dominant negative, so mostly GDP-bound, Cdc42 (N17) and 
Rac1 (N17), suggesting a nucleotide-dependent binding of FMNL2 to Cdc42 and Rac1, 
as has been reported previously for other Drfs (Alberts, 2001, Watanbabe et al., 1997). 
FMNL2-Arr did not bind to active Rho A (L63), RhoG (V12), RhoD (V26), Rif (L77) and 
GST or MBP alone (Figure 28). To exclude non-specific binding of the EGFP-tag to 
active Cdc42 or active Rac1, pull-down assays using EGFP alone were performed as 
control (Figure 28C). Together, these data suggest that FMNL2 acts as novel bona fide 
effector of Cdc42 and Rac1. 
To directly test the in vivo relevance of the interaction between FMNL2 and Cdc42 or 
Rac1, EGFP-tagged, full length FMNL2A and FMNL2B constructs have been co-
expressed with the respective Rho-GTPase in B16-F1 cells. The FMNL2C variant was 
not explored in this assay, since it targeted to the cell periphery without co-expression 
of ectopic GTPase, and might thus be already sufficiently activated by endogenous 
Rho-GTPases. 
 
A direct confirmation of the physiological relevance of the interaction between FMNL2 
and Cdc42 is presented in Figure 29. In contrast to full length FMNL2A and B that 
 
Figure 29: Cdc42 (but not Rac) induced targeting of FMNL2 to the cell periphery  
B16-F1 cells transiently co-expressing EGFP-FMNL2A and myc-tagged Cdc42(L61) (A), EGFP-
FMNL2B and myc-tagged Cdc42 (B), EGFP-FMNL2A and myc tagged Rac(L61) (C) and EGFP-
FMNL2B and myc tagged Rac (L61) (D). Note prominent accumulation of FMNL2A and FMNL2B at 
the cell periphery upon co-expression of active Cdc42 (A and B) but not active Rac (C and D). Scale 
bars equal 10µm. 
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remained entirely cytosolic (see Figure 24), co-expression of L61-Cdc42 caused strong 
accumulation of FMNL2A and FMNL2B at the cell periphery (Figure 29A and B) at sites 
coincident with lamellipodia formation. Surprisingly co-expression of constitutively 
active Rac (L61) failed to drive FMNL2A and -B targeting to the cell periphery (Figure 
29C and D). Thus, the physiological relevance of Rac1 binding to FMNL2 observed in 
vitro remains elusive at this stage. 
As mentioned previously and in contrast to FMNL2A and FMNL2B, the splice variant 
FMNL2C accumulates at the cell periphery in B16-F1 cells. Considering all available 
data so far, this could be interpreted as this variant either to be constitutively active or 
to be sufficiently activated by endogenous levels of Cdc42 in B16-F1 cells. To 
distinguish between this possibilities, EGFP-FMNL2C was expressed in Cdc42 fl/- and 
Cdc42 -/- cells kindly provided by Prof. Cord Brakebusch (Copenhagen, Denmark). As 
expected, EGFP-FMNL2C localised to the leading edge in Cdc42 fl/- cells (white 
arrows in Figure 30A) but failed to do so in Cdc42-deficient cells (arrowhead in Figure 
30B), although these cells were still able to form lamellipodia. To test directly if the lack 
of EGFP-FMNL2C localisation in Cdc42-deficient cells was indeed due to the lack of 
Cdc42 expression, I re-expressed ectopic constitutively active Cdc42 in cdc42-/- cells. 
 
Figure 30: Expression of FMNL2C splice variant in cdc42 fl/- and cdc42 -/- cells 
EGFP-FMNL2C full length accumulates at the cell periphery in cdc42 fl/- (white arrow in A). 
Note lack of accumulation of FMNL2C full length in cdc42-/- cells (arrowheads in B). Bars 
equal 10µm. 
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As can be seen in Figure 31A, re-expression of active Cdc42 was sufficient to drive 
targeting of EGFP-FMNL2C to the cell periphery. This was not the case upon co-
expression of active Rac (L61) with FMNL2C in these cells (Figure 31B) consistent with 
the inability of Rac to drive FMNL2A and –B recruitment to the cell periphery in B16-F1 
cells (Figure 29). These data suggest that basal Cdc42 levels in B16-F1 and Cdc42 
WT cells are sufficient to cause activation and subsequent localisation of FMNL2C but 
not FMNL2A and B to the lamellipodium. Note that the only sequence difference 
between splice variants lies within the extreme C-terminus encoding the DAD-domain. 
Thus. The different behaviour of FMNL2C must be due to inefficient autoinhibition or, in 
other words, efficient release from autoinhibition affected by Cdc42, since this splice 
variant harbours the shortest C-terminus. 
 
 
Figure 31: Co-expression of FMNL2C and Cdc42 (but not Rac) 
drives targeting in Cdc42-/- cells 
Cdc42-/- fibroblast cells transiently transfected with EGFP-FMNL2C 
and myc-tagged Cdc42 (L61) and myc-tagged Rac (L61), respectively. 
(A) Note prominent localisation of FMNL2C at the cell periphery at 
sides coincident with lamellipodia formation. (B) Cotransfection of 
EGFP-FMNL2C with myc-tagged Rac (L61) was not sufficient to target 
FMNL2C to cytoskeletal structures such as lamellipodia (arrowheads). 
Bars equal 10µm. 
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3.11 Potential N-terminal myristoylation of FMNL2 influences 
subcellular localisation, but is not required for Cdc42-induced 
accumulation at the cell periphery 
 
Co- and posttranslational modifications occur on a wide variety of cellular proteins, one 
important modification being the covalent attachment of fatty acids. The two most 
common forms of protein fatty acylation are modifications with myristate, a 14-carbon 
saturated fatty acid, and palmitate, a 16-carbon saturated fatty acid (Resh MD, 1999). 
Using an online tool to search for sequences prone to posttranslational modifications 
(Maurer-Stroh et al., 2002), FMNL2 was established to belong to roughly 0.5% of all 
eukaryotic proteins harbouring the consensus sequence MGXXXS/T, which identifies 
FMNL2 as a N-terminal myristoylated protein (collaboration with Dr. Matthias Geyer, 
Max-Planck-Institute for Molecular Physiology, Dortmund). Although not following this 
consensus, FMNL1 was also reported recently to be N-myristoylated (Han et al., 2009). 
The function of protein myristoylation has been linked to membrane binding and protein 
stabilisation. The myristate moiety can adopt an exposed conformation able to promote 
membrane binding or lie hidden inside a hydrophobic binding pocket within the 
myristoylated protein. The transition between these two conformations is regulated by a 
myristoyl switch that can be induced by ligand binding or phosphorylation (Resh, 2006).  
The predicted myristoylation of FMNL2 could have relevant implications for 
autoregulation and membrane targeting of this protein, and was therefore examined 
more closely. Myristoylation is a cotranslational lipid modification, where the N-
myristoyltransferase (NMT) covalently attaches a C14-fatty acid to the C-terminus of 
the protein. Since the NMT requires the myristoylation consensus sequence (MGxxxS) 
to be the first aminoacids of the protein, an N-terminal tag could disrupt the signal for 
the incorporation of the lipid anchor. (Keller et al., 2005; Tang and Teng, 2004; 
Neumann-Gießen et al., 2004). Thus, to preserve the lipid modification of the N-
terminus, it is important to use constructs that will produce C-terminally EGFP-tagged 
formin variants. These constructs have been expressed in B16-F1 cells and analysed 
concerning their subcellular dynamics. 
Fusing the EGFP-moiety to the C-terminus of the respective splice variants had a 
drastic effect on the subcellular localisation of the formin. As shown in Figure 32, 
FMNL2A and -B constructs which are presumed to become myristoylated, accumulates 
at the cell periphery, in contrast to constructs harbouring the EGFP-moiety at the N-
terminus of the formin, remaining entirely cytosolic (compare with Figure 24B and C).  
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To further characterise how the myristate modification influences the subcellular 
behaviour of FMNL2, non-myristoylatable FMNL2 variants were generated by mutating 
the N-terminal Glycin, which is essential for covalent linking of the fatty acid, to Alanin 
(G2A) (Perez et al., 2004). Biochemical experiments have recently demonstrated that 
this mutation does indeed abolish myristoylation of FMNL2 (Mathias Geyer, MPI 
Dortmund, Germany, unpublished observations). In order to exclude any influence of 
endogenous Cdc42 on the cellular localisation pattern or the autoinhibition of FMNL2, 
experiments were performed in Cdc42-deficient cells.  
 
 
 
 
 
Figure 32: C-terminally tagged FMNL2A and –B accumulate at the 
leading edge of B16 cells. 
B16-F1 cells transiently expressing FMNL2A-EGFP and FMNL2-EGFP, 
respectively. To preserve potential lipid modification, the EGFP moiety was  
fused to the C-terminus of FMNL2A and B. Note prominent accumulation at 
the cell periphery in contrast to C-terminal fusions that remained largely 
cytosolic. Bar equals 10µm. 
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Figure 33: Myristoylation can contribute to, but is not essential for 
subcellular positioning of FMNL2. 
A) Cdc42 deficient cells transiently transfected with presumably myristoylated 
FMNL2B-EGFP. Note weak association of wildtype FMNL2B to the leading edge. 
(B) Mutation of Glycin at position 2 to Alanin (G2A) abrogates membrane 
accumulation of FMNL2B in Cdc42-/- cells. (C)The non-myristoylatable FMNL2B 
mutant is capable of targeting to the cell periphery upon co-transfection of active 
Cdc42. Images are shown for FMNL2B, but are representative for the two other 
splice variants as well (data not shown). Bars equal 10µm. 
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A weak association to the leading edge of the cells could be observed for all three 
splice variants (Figure 33A). To ascertain that this Cdc42-independent accumulation at 
the cell periphery was not caused by interfering with the autoinhibition of the formin by 
fusing the EGFP-tag in close proximity to the regulatory DAD-domain, the subcellular 
localisation of the myristoylation-deficient mutant was analysed. This mutant showed no 
specific accumulation to cytoskeletal structures such as lamellipodia but remained 
cytosolic (Figure 33B). The same localisation pattern was previously observed for N-
terminally-tagged FMNL2A and –B full length and interpreted to be indicative of 
autoinhibition. Even more importantly the behaviour of the myristoylatable FMNL2-
constructs compared to the myristoylation-deficient mutants indicates that N-terminal 
myristoylation of FMNL2 contributes to FMNL2 accumulation at the cell periphery in the 
absence of Cdc42. This could be explained either by interference of the myristate 
moiety with autoinhibiton of the formin splice variants or targeting activity to the cell 
periphery by the lipid modification itself.  
In any case, myristoylation would also have additional effects, e.g. it could be a 
prerequisite of proper interaction with Cdc42. To test this the myristoylation-deficient 
mutant was co-expressed with constitutively active Cdc42 in Cdc42-/- cells. As shown 
in Figure 33C, this treatment caused strong accumulation of non myristoylatable 
FMNL2 at the cell periphery. Thus, the N-terminal myristoylation is dispensable for 
binding and activation of the formin by Cdc42. 
 
3.12 Cdc42 is not essential for FMNL2 targeting to the leading edge 
Considering published results in context of other diaphanous-related formins, we 
assume that co-expression of active Cdc42 is able to release the autoinhibited state of 
FMNL2 resulting in an accumulation of the formin at the cell periphery. However, it was 
still unclear whether Cdc42 can directly mediate targeting of FMNL2 to the leading 
edge. Previous data concerning the influence of Rho-GTPases on formin localisation 
have led to conflicting statements. The membrane localisation activity of mDia1 and 
FRLα was concluded to derive, in part, from the interactions with Rho-GTPases, 
however, an additional membrane associated factor seems to be involved in 
membrane binding at least for these Drfs (Seth et al., 2006). Other studies utilised 
mDia1 and mDia2 variants lacking their GTPase binding domains. Over-expression of 
these constructs showed that the interaction with the respective GTPase does not 
determine intracellular localisation (Tominaga et al., 2000, Gazman et al., 2003, Yang 
et al., 2007). To evaluate whether FMNL2 requires Cdc42 for proper targeting to the 
leading edge, I expressed constitutively active FMNL2 variants lacking the DAD-
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domain in Cdc42-/- cells. Taking into account the possible influence of myristoylation 
on membrane targeting, constructs harbouring the EGFP moiety at the C-terminus of 
FMNL2 and thereby preserving the lipid modification and a myristoylation-deficient 
mutant were used. 
 
As expected, FMNL2∆DAD-EGFP and the myristoylation-deficient mutant 
(FMNL2∆DAD-G2A-EGFP) accumulated at the cell periphery of Cdc42 control cells 
without affecting the cell morphology of fibroblast cells (Figure 34A). 
However, Figure 34B shows that FMNL2-∆DAD-EGFP was also strongly enriched in 
the leading edge of Cdc42-deficient cells, indicating that Cdc42 is not required for 
subcellular targeting of FMNL2, and suggesting that Cdc42 operates solely in relieving 
autoinhibition of FMNL2. This is consistent with the view that myc-tagged Cdc42 does 
not specifically accumulate at the tips of protrusions, but the entire plasma membrane 
(data not shown). To examine whether the N-terminal myristoylation could at least 
contribute to the accumulation to protrusive structures in the absence of Cdc42, a 
myristoylation-deficient construct (FMNL2∆DAD-G2A-EGFP) was analysed in the 
absence of Cdc42. However, the non-myristoylatable ∆DAD-FMNL2 accumulated at 
 
Figure 34: Cdc42 is not required for targeting of FMNL2∆DAD to the cell periphery 
(A) FMNL2∆DAD-EGFP and FMNL2-G2A-EGFP expressed in Cdc42fl/- cells. Note localisation 
of both FMNL2 constructs to the cell periphery. (B) FMNL2∆DAD-EGFP and FMNL2-G2A-
∆DAD-EGFP expressed in Cdc42 deficient cells. Active FMNL2 is capable of accumulating at 
the leading edge in the absence of both Cdc42 and the N-terminal lipid modification. Bars equal 
10µm. 
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the cell periphery equally well as the myristoylatable construct (Figure 34B), thus 
subcellular targeting does not require either signal, Cdc42 and myristoylation. We 
conclude that in FMNL2 full length, all splice variants of which are autoinhibited in the 
absence of the myristate moiety and Cdc42, these signals can both contribute to 
activation, but both are dispensable for localisation, which must be mediated by other 
means. 
3.13 FMNL2 elongates but does not nucleate actin filaments in vitro 
Recent studies by Vaillant et al. (2008) explored the induction of actin assembly of 
isolated FH2-domains of FMNL2 and -3 and proposed that FMNL2 and -3 can nucleate 
and bundle actin filaments in vitro. However, the actin nucleation activity reported in 
this study was comparably modest (e.g. relative to mDia1) (Seth et al., 2001). Since it 
is well established today that actin nucleation mediated by formins is significantly 
enhanced by the profilin-binding activity of the FH1-domain (Kovar et al., 2003; Kovar 
and Pollard, 2004; Romero et al., 2004; Kovar et al., 2006), we aimed at studying the 
effects of FMNL2-FH1-FH2-mediated actin assembly in vitro. The FH1-domain in 
FMNL2 contains a stretch of 8 prolines and a second stretch of 21 consecutive proline 
residues with the potential to bind profilactin (complex of profilin and actin). 
Spectroscopic and calorimetric studies (Petrella et al., 1996) and crystal structures 
(Mahoney et al., 1997; 1999) show that eight prolines span the full binding site of 
profilin. To aid expression and purification in bacteria, we engineered expression 
constructs with 8 out of 21 proline residues [FMNL2-FH1(8P)-FH2] and a second one 
with the complete second stretch of 21 proline residues [FMNL2-FH1(21P)-FH2]. Both 
constructs lacked the first stretch of 8 proline residues. The biochemical 
characterisation of FMNL2 including protein purification and construct design has been 
carried out in collaboration by Dr. Jan Faix and Dennis Breitsprecher (Hannover 
Medical School), who kindly provided the data presented in this chapter.  
First, pyrene-actin polymerisation (Cooper et al., 1983) were performed. In this assay, 
unlabelled actin and 10% pyrene-labelled actin were mixed in the presence of FMNL2-
FH1(8P)-FH2. Subsequently, the fluorescence intensity, which is much higher after 
polymerisation of pyrene-actin, was measured. In Figure 35A, the polymerisation time 
course for actin alone (black line) or with increasing concentrations of FMNL2-FH1(8P)-
FH2 is displayed. Apparently, the FMNL2 variant inhibited spontaneous actin 
assembly, which was confirmed by plotting the polymerisation rate against the molar 
ratio of FMNL2/actin (Figure 35B).  
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A disadvantage of pyrene-actin-polymerisation assays is the inability to distinguish 
between filament nucleation and elongation. To directly visualise individual actin 
filaments in real time, total internal reflection microscopy (TIRF) was employed, which 
allows elongation rates of individual actin filaments to be measured directly, in a 
manner uncoupled from nucleation (Amman and Pollard, 2001; Harris and Higgs, 
2006).  
A direct confirmation of FMNL2-mediated actin assembly is presented in Figure 36A. 
FMNL2 (21P) incubated with actin alone did not significantly promote processive actin 
assembly. Just in the presence of profilin and actin filament barbed ends captured by 
FMNL2(8P) or FMNL2 (21P) grew substantially faster and appeared dimmer than free 
barbed ends (Figure 36A). This behaviour can be explained by the notion that FH1-
bound profilin-actin is highly favoured for addition to barbed ends over bulk-phase 
actin, and that profilin has a higher affinity to unlabelled actin. It is well established that 
profilin bound to actin does not elongate actin filaments (Pollard and Cooper, 1984; 
Kaiser et al., 1999) but promotes actin elongation in the presence of formins (Kovar et 
al., 2003; Romero et al., 2004). In addition, filament buckling, which occurs when both 
ends of the filament are attached to the glass slide and the formin continuously 
elongates the filament, can be observed for both constructs, and can be taken as 
evidence for actin filament assembly mediated by the formin fragment.  
 
 
Figure 35: Biochemical analysis of FMNL2-mediated actin assembly 
(A) FMNL2 inhibits actin polymerization. 3 µM G-actin (10% pyrene-labelled) were polymerised 
in 1x pyrene buffer in the presence of FMNL2 8P at concentrations as indicated. (B) Plot of the 
dependence of the polymerization rate (slope) on the concentration of FMNL2 8P. 
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Actin subunits on-rates of individual filaments (Figure 36B and C) with or without 
profilin were significantly enhanced in the presence of FMNL2 and profilin. For single 
filaments 25.8 subunits per second were added by FMNL2 in the presence of profilin 
 
Figure 36: TIRF analyses of FMNL2 mediated actin assembly. 
(A) FMNL2 processively assembles actin filaments. Spontaneous assembly of 1.5 µM 
actin (30% Alexa-488 labelled) in the presence of 20 nM of FMNL2 8P (top) or FMNL2 
21P (bottom) and 5 µM profilin monitored by TIRF microscopy. Formin-captured barbed 
ends are encircled; arrows indicate dim, buckling filaments. Time is indicated in seconds. 
Scale bar 10 µm. (B) Single filament analysis of FMNL2-FH1(21P)-FH2 elongated actin 
filaments. Blue lines represent actin subunits added on filaments in the presence of 
FMNL2 alone, red lines correspond to actin filaments elongated in the presence of 
FMNL2 and 5µM profilin (C) FMNL2 enhances filament elongation in the presence of 
profilin. Barbed end on-rates are determined by TIRF microscopy. For actin alone and 
FMNL2-FH1(8P)-FH2 45 and 21 actin filaments were measured, respectively. For 
FMNL2-FH1(8P)-FH2 and FMNL2 FH1(21P)-FH2 13 and 8 actin filaments were 
analysed, respectively.  Error bars represent standard deviation (STD). (D) FMNL2 does 
not nucleate actin filaments. Barbed ends in an area of 100 x 140 µm in the presence 
and absence of FMNL2 8P and 21P over a time period of 15min were quantified. Error 
bars represent STD. All data derive from three independent measurements. 
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whereas only 0.19 subunits per second were added without profilin. These data 
demonstrate that FMNL2 elongates actin filaments in a processive fashion. 
The prevailing view that formins per se nucleate actin filaments has been challenged 
again in Figure 36D. Counting filament numbers in the absence and presence of 
FMNL2(8P) or FMNL2(21P) revealed that FMNL2 does not alter the number of 
filaments. These data taken together with results obtained from pyrene polymerisation 
assays performed in the absence of profilin implicate that FMNL2 does not nucleate but 
elongate actin filaments in vitro. 
 
3.14 FMNL3 interacts with Cdc42 and accumulates at the cell 
periphery upon co-expression with active Cdc42 
 
The FMNL or FRL subfamily of diaphanous related formins consists of 3 members, 
FMNL1 (FRL1), FMNL2 (FRL3) and FMNL3 (FRL2). FMNL2- and -3 are not identical in 
sequence (roughly 70% identity), but slightly more homologous to each other than each 
one of them to FMNL1 (Katoh and Katoh, 2003). As shown in the gene array analysis, 
FMNL3 is mainly expressed in the tested murine cell lines (Table 7), where it might be 
interesting to look for potential redundant functions of FMNL2 and -3. Interestingly, the 
FMNL3 gene harbours sequence deletions as compared to FMNL2 slightly N-terminal 
to and within the FH1-domain. This might have interesting consequences for effects on 
actin assembly. 
To determine possible FMNL3 interactions with Rho-GTPases, I cloned the FMNL3 N-
terminus according to FMNL2-Arr and performed pull-down assays. I transfected B16-
F1 cells with EGFP-FMNL3-Arr and pulled this construct by using constitutively-active 
and dominant negative Rho-GTPases coupled to sepharose-beads.  
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The N-terminus of FMNL3 showed strong, 
presumably direct interactions with active, so 
mostly GTP-bound Cdc42 (L61) and Rac1 (L61) 
(Figure 37), comparable to the results obtained 
in FMNL2 pull-down experiments. FMNL3-Arr 
was not able to pull-down dominant negative, 
mostly GDP bound Cdc42 (N17 (Figure 37), 
supporting a nucleotide dependent binding to 
Cdc42. No interactions could be observed 
between FMNL3 and active RhoA (L63) and 
GST (Figure 37).  
To further characterise potential redundant 
functions of FMNL2 and -3, it was essential to 
have a closer look at the subcellular localisation 
of FMNL3. At first, I generated an EGFP-FMNL3 
full length construct and expressed this in B16-
F1 cells. 
 
 
 
 
 
Figure 37: FMNL3 
interacts with 
constitutively active 
Cdc42 and Rac1. 
B16-F1 cells transfected 
with EGFP-tagged FMNL3-
Arr were subjected to pull-
downs using beads coupled 
to active and inactive 
variants of Rho-GTPases. 
Rho-GTPase were fused to 
GST and coupled to 
glutathione-sepharose. 
Note binding of FMNL3-Arr 
to active Cdc42 (L61) and 
active Rac1 (L61), but not 
dominant negative Cdc42 
(N17) or active RhoA (L63) 
or GST. 
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Although the cells exhibit an actively protruding lamellipodium no specific accumulation 
at peripheral regions could be observed (Figure 38). Instead, FMNL3 accumulated in 
the perinuclear region, which can be explained simply by high thickness in this region. 
To explore a potential physiological relevance of the interactions of FMNL3 with Cdc42 
and Rac1 in vitro, EGFP-FMNL3 was co-expressed with either Rho-GTPases. 
 
Figure 38: EGFP-FMNL3 full length is cytosolic in B16 cells 
B16-F1 mouse melanoma cells transfected with EGFP-FMNL3 and subjected to live microscopy. 
Cells show an actively protruding lamellipodium but lack an accumulation of FMNL3 to the cell 
periphery. Bar equals 10µm. 
 
Figure 39: Co-expression of active Cdc42 but not active Rac leads to an accumulation of 
FMNL3 at the leading edge 
(A) B16-F1 cells transiently co-expressing EGFP-FMNL3 and myc-tagged Cdc42 (L61). The 
actin cytoskeleton has been visualised by Phalloidin staining. Note prominent localisation of 
EGFP-FMNL3 at the cell periphery. (B) Counterstaining of FMNL3 and Cdc42 expressing cells 
for Arp2/3-complex revealed prominent co-accumulation of Arp-complex at the leading edge. 
(C) and (D) Co-expression of myc-tagged active Rac (L61) is not sufficient to target FMNL3 to 
the cell periphery. Bar in B is valid for (A) and (B). Bars equal 10 µm. 
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Interestingly Cdc42 co-expression resulted in a prominent localisation of FMNL3 at the 
cell periphery at sites coincident with lamellipodia formation (Figure 39A and B). 
Fluorescence microscopy of FMNL3- and Cdc42- co-expressing cells stained with 
Phalloidin indicated FMNL3 targeting to coincide with formation of lamellipodia. This 
was confirmed by counterstaining of FMNL3-containing structures with Arp2/3-complex. 
FMNL3 and Arp2/3-complex showed virtually identical localisation at the cell periphery 
(Figure 39B). 
As opposed to Cdc42, co-expression of active Rac was not sufficient to target FMNL3 
to the leading edge which has been shown both by live-cell microscopy (Figure 39C) 
and counterstaining with phalloidin (Figure 39D). Similar results were obtained 
previously for co-expression of active Rac with FMNL2. Thus, both FMNL2 and FMNL3 
can be induced to target to the leading edge by active Cdc42 but not Rac1. 
 
3.15 FMNL2 and FMNL3 regulate the migration speed of B16 cells 
So far the data showed that both FMNL2 and FMNL3 can localise to the cell periphery, 
implicating functional importance of the endogenous protein for the formation and/or 
maintenance of these protrusions. Although Rac is best established to drive the 
formation of lamellipodia (Ridley et al., 1992), I failed to establish a physiological 
connection between Rac/FMNL interactions in pull-down experiments and 
accumulation of FMNL2 and -3 at the cell periphery. Cdc42 was initially shown to be 
capable of inducing lamellipodia and filopodia although activation of the former was 
concluded to be driven indirectly through Cdc42-mediated activation of Rac (Nobes et 
al., 1995). The direct Cdc42-interactor and promising effector N-WASP, linking Cdc42 
activity and actin assembly, lacks an accumulation in the lamellipodium and was 
additionally shown to be dispensable for lamellipodia and filopodia formation (Lommel 
et al., 2001; Snapper et al., 2001). Another prominent Cdc42 effector, mDia2, was 
occasionally observed to accumulate at the leading edge (Block et al., 2008; Yang et 
al., 2007), but this has been interpreted as an artefact derived from mDia2 over-
activation (see chapter 3.5).  
As a first step to shedding more light on the function of FMNL2 and -3 in the formation 
of cellular protrusions, and thereby potentially gaining additional information about the 
contribution of Cdc42 to lamellipodia formation, I examined the effect of FMNL2 and 
FMNL3 knockdown by RNA interference in B16-F1 cells. A prerequisite for this 
technique however is the availability of antibodies, which are sensitive enough to 
reliably assess protein rundown -at least in Western Blotting- in response to RNAi. 
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Therefore, a commercially available monoclonal antibody raised against FMNL2 was 
characterised in detail. Surprisingly, this antibody detected two different bands with 
molecular weights at ~ 120kDa and ~150kDa when used on cell lysates of different 
murine and human cell lines (Figure 40B). Taking into consideration a sequence 
identity of roughly 70% between FMNL2 and -3 I hypothesized that the antibody may 
be able to detect both FMNL subfamily formins. Expecting that FMNL3 would run at a 
lower molecular weight due to the absence of sequence stretches N-terminal of the 
FH2 and within the FH1-domain, I figured that the 120kDa band might correspond to 
FMNL3 and the 150 kDa band represents FMNL2. Comparison of the gene array data 
(Figure 18) and the Western Blot results supported this theory. In line with the 
expression profile obtained from gene array analyses, the upper band was present in 
all cell lines tested. According to the microarray analyses, FMNL3 is restricted mainly to 
murine cell lines. Western blot analyses revealed that the 120 kDa band can be 
detected in the murine cell lines B16-F1, Swiss 3T3 and NIH 3T3 but not in the human 
lines Hela S3 and A431. The only discrepancy arises in VA-13 cells, where no FMNL3 
message could be detected but a strong signal occurs in western blot analyses. The 
reason for this inconsistency is presently not clear. In any case, additional experiments 
revealed reactivity of the FMNL2 antibody with ectopically-expressed EGFP-FMNL2 
and EGFP-FMNL3 in western blot analysis (Figure 40A). To precisely determine the 
specificity of the antibodies, FMNL2- and FMNL3-specific RNAi experiments were 
performed, and reduced expression levels of respective bands were evaluated (Figure 
40B and C). Importantly, FMNL2- and FMNL3-specific knockdown reduced the top and 
bottom band recognised by the FMNL2 antibody, respectively. Thus, all these data 
clearly indicate that the 150kDa band corresponds to FMNL2 and the 120 kDa band 
represents FMNL3 migrating at a lower molecular weight due to the absence of 
sequences N-terminal of the FH2-domain.  
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To analyse the precise function of FMNL2 and -3 in the formation of cellular 
protrusions, I downregulated their expression by RNA interference. First, I studied the 
involvement of FMNL2 and -3 in lamellipodia formation by knocking down either 
FMNL2 alone or in combination with FMNL3. To examine morphological changes upon 
reduced protein expression, transient FMNL2, FMNL2/FMNL3 knockdown and mock-
treated cells were seeded on laminin-coated coverslips and treated with aluminium 
fluoride, which was demonstrated earlier to strongly induce lamellipodia formation in 
these cells (Hahne et al., 2001). 
 
 
 
Figure 40: Expression analyses of FMNL2 and -3 and FMNL2 antibody characterisation 
(A) Western Blotting of cell extracts as indicated using a commercial anti-FMNL2 antibody, 
which detects a protein with a molecular weight of roughly 150kDa (as expected) and another 
protein with a molecular weight of 120kDa in various cell lines, and EGFP-tagged FMNL2 as 
well as EGFP-tagged FMNL3 ectopically expressed in B16-F1 mouse melanoma cells. Note 
that EGFP-FMNL3 migrates at the same molecular weight as endogenous FMNL2; the correct 
size of EGFP-FMNL3 was additionally confirmed by detection with α-GFP antibody. (B and B) 
Determination of band specificity by using FMNL2- and FMNL3-specific RNAi constructs in 
B16-F1 cells. Note reduced expression level of the protein with a molecular weight of 150 kDa 
in the FMNL2-specific RNAi approach (B, asterisk) and reduced expression level of the protein 
with a molecular weight of 120 kDa in the FMNL3-specific RNAi approach (C, asterisk). 
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Examining the morphology of both mock treated and FMNL2 or FMNL2 and -3 
knockdown cell populations revealed that all cell populations formed prominent 
lamellipodia after ALF4-stimulation (Figure 41). Lamellipodia formation triggered by this 
treatment was reported to be strongly abrogated for instance in cells interfered for 
WAVE-complex components (Steffen et al., 2004) and Arp2/3-complex (Steffen et al., 
2006). These data suggest that lamellipodia formation does not require the Cd42 
effectors FMNL2 and -3 as essential components of the core actin nucleation 
machinery. 
Assuming that FMNL2 and -3 affect actin reorganisation events downstream of Cdc42, 
I explored potential functions of these formins in cell migration. For this purpose, cells 
were seeded subconfluently and tracks of individually migrating cells were followed 
using low magnification phase contrast and epifluorescence optics. Knockdown 
efficiency was analysed by Western Blotting using FMNL2- and FMNL3-reactive 
 
Figure 41: Lamellipodia formation in B16 cells is largely unaffected by FMNL2 or FMNL2 
and -3 knockdown 
Architecture of the actin cytoskeleton in Mock, FMNL2 and FMNL2/3 RNAi-treated B16-F1 cells 
after ALF4-stimulation. Transfection with RNAi vectors is documented by expression of a EGFP 
variant encoded by the pSIRNA vectors. Bar equals 10µm. Efficient knockdown is verified by 
Western blotting using FMNL2- and -3-reactive antibody and tubulin as a loading control. 
Asterisk marks crossreaction of the antibody in these cells. 
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antibody (Figure 42B). Interestingly, the speed of randomly migrating cells was reduced 
in the absence of FMNL2. Average velocity (arithmetic mean as calculated from the 
average distance over time) was 0,45µm/min (±0,02, n= 92) and 0,38µm/min (±0,01; 
n= 107) for mock-treated and FMNL2 knockdown cell populations, respectively (p 
=0,001) (Figure 42A). However, reduction in migration speed was more severe if cells 
were simultaneously  reduced for expression of both FMNL2 and -3. In this case, the 
velocity averages 0,3µm/min (±0,02, n= 98) for FMNL2 and -3 double knockdown cells 
in comparison to 0,45µm/min in mock treated cells (p < 0,001) (Figure 42A). Tracks of 
individually migrating cells are displayed in a so called polar plot, the FMNL2/FMNL3 
double knockdown population appears much more concentrated around the centre 
than the FMNL2 knockdown or control population (Figure 42C).  
The data obtained so far documented that FMNL2 and -3 are new bona fide effectors 
of Cdc42. In contrast to the prevailing view that formins are per se actin nucleators, 
FMNL2 exhibits no nucleation activity but processively elongates actin filaments in the 
presence of profilin. To finally understand the function of FMNL2 and -3 in cell 
migration, which is impaired upon knockdown of both formins, additional data are 
required to analyse whether FMNL2 and -3 directly influence protrusion of the 
lamellipodium or if the reduced migration speed is connected to other processes 
accompanying cell motility. 
 
 
 
                                                                                                     Results 
 
 91 
 
Figure 42: FMNL2 and FMNL2 and -3 knockdown reduces migration speed in B16 cells 
(A) Box plot diagrams showing migration speed in FMNL2, FMNL2 and -3 and mock-treated RNAi 
cells in subconfluent cultures. The line within the box indicates median, the box boundaries contain 
50% (25–75%) and the whiskers 80% (10–90%) of all measurements, whereas outlying points are 
shown as dots. The reduced migration speed in FMNL2 knockdown and FMNL2 and -3 double 
knockdown cells was statistically significant at p=0,001 and p<0,001 (Mann-Whitney rank sum test). 
(B) Efficient knockdown proved by western blotting. Tubulin was used as loading control. (C) Polar 
plots of mock treated, FMNL2 and FMNL2 and -3 knockdown cells in random migration assay. The 
position of each cell at time zero was centered at the origin of the grid and the tracks correspond to 
the movement of individual cells over time. The total duration of the movies was 24h. Tracks of 
FMNL2 and -3 double knockdown cells do not spread far away from the center compared to mock 
treated cells. All data derive from three independent experiments. 
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4 Discussion/Outlook 
Diaphanous related formins emerged as key regulators of many actin-based processes 
including endocytosis, mitosis and cell motility. Although the knowledge about cellular 
functions of diaphanous related formins drastically increased over the last years, their 
contribution to lamellipodia and filopodia formation remains poorly defined. So the aims 
of this thesis were to investigate how the Drfs Drf3 and FMNL2 influence the formation 
of these protrusive structures. 
4.1 Drf3-induced filopodia formation 
To characterise diaphanous related formins such as Drf3 and FMNL2 in more detail it 
was essential to determine the subcellular positioning of these proteins. A widely used 
tool to study the localisation of proteins of interest in mammalian and other systems is 
the fusion to a fluorescent tag such as EGFP. Although it could be argued that fusing 
an EGFP-tag to a Drf could interfere with proper autoinhibiton or subcellular positioning, 
it has been shown that many EGFP-tagged proteins retain their biological activity and 
display the same trafficking pattern as the native proteins (Bialkowska et al., 2005; 
Jarvik et al., 2002; Tarasova et al. 1997; Carter and Sorkin, 1998). Using fluorescent 
tags allows to directly visualise not only the protein distribution within the cell but also 
provides information about the dynamic behaviour of the targeted protein which can not 
be obtained by immunofluorescence staining of endogenous proteins. In addition, 
visualisation of EGFP-tagged proteins eliminates the risk of introducing artefacts into 
protein distribution due to fixation procedures (Brock, Hamelers et al. 1999). 
Many full length Drfs labelled with EGFP or other tags were reported to be mainly 
cytoplasmic, which was explained by an inactive conformation of the formin preventing 
specific subcellular localisation (Homem and Pfeifer, 2009; Pellegrin and Mellor, 2005; 
Wallar et al., 2006; Han et al., 2009; Vaillant et al., 2008). This seems to apply as well 
to full length EGFP-tagged Drf3, which was enriched in the cytoplasm and did not 
target to any cytoskeletal structures (Figure 7). To gain insight into the subcellular 
localisation and dynamics of the formin, it was essential therefore to maintain Drf3 in an 
active conformation enabling specific targeting to cytoskeletal structures. Thus, I used a 
Drf3 construct rendered active through removal of the C-terminal DAD-domain 
permitting accumulation at sites of activity. Expression of active Drf3 in B16-F1 and 
other cell lines induced the formation of dozens of filopodia tipped by the active formin 
(Figure 7 and Figure 14). These findings confirmed other studies reporting the 
recruitment of Drf3 or its homologs to filopodia tips and its ability to induce these 
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structures in various cell types (Homen and Pfeifer, 2009; Beli et al., 2007; Yang et al., 
2007; Schirenbeck et al., 2006).  
4.1.1 Convergent elongation or de novo nucleation of filopodia 
To unravel the precise machinery generating these finger-like protrusions major efforts 
have been made over the last years leading to two contradictory models, the 
convergent elongation and the de novo nucleation model (reviewed in Faix et al., 2009 
and see 1.2.2). A recent study observing similar club shaped filopodia upon expression 
of an N-terminally deleted mDia2/Drf3 proposed that mDia2/Drf3-induced filopodia are 
formed by convergent elongation of lamellipodial filaments (Yang et al., 2007). 
However, the club shaped nature of mDia2/Drf3-induced filopodia is apparently difficult 
to reconcile with filopodia originating from a limited number of filaments within the 
lamellipodium as proposed in the convergent elongation model. The authors explained 
the club-like shape of mDia2/Drf3-induced filopodia by fast depolymerisation of 
mDia2/Drf3-nucleated filaments from unprotected pointed ends and proposed that 
these aberrant filopodia are caused by an imbalance between mDia2/Drf3 and Arp2/3-
complex activities. Consistent with the latter hypothesis, the data presented here 
demonstrate that the formation of club shaped filopodia strongly depends on the 
expression level of the formin (Figure 7). Since cells expressing low levels of Drf3 
formed normally tapered filopodia, it is not very likely (although it can not be excluded) 
that over-expression of the active formin interferes with the machinery in general. 
However, I agree with Yang and colleagues in so far as the club like phenotype 
suggests that the protrusion of these filopodia results from imbalanced activities 
between the active formin at the tip and other factors required for filopodia formation. 
Furthermore it has to be considered that the deleted DAD-domain might fulfil additional 
functions besides the interaction with the DID domain. Recent publications claimed e.g. 
that some DAD-domains might comprise an additional actin binding WH2-domain 
(Vaillant et al., 2008; Chhabra and Higgs, 2006).  
Nevertheless, the active Drf3 construct was used as a tool to determine whether 
filopodia are exclusively formed by convergent elongation or whether formin-mediated 
nucleation at the filopodium tip generates these structures. Convergent elongation of 
lamellipodial filaments postulates that only a limited number of filaments are available 
for filopodia formation. As a consequence, the clubbed shape of Drf3-induced filopodia 
would have to arise either from splaying of a constant number of filaments at the tip or 
increased depolymerisation in the shaft. The results obtained in this work argue against 
both possibilities. The observed thickening of filopodia after protruding beyond the 
cellular network in coincidence with an increase in fluorescence intensity of formin at 
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the filopodium tip (Figure 10) could admittedly be explained by splaying apart of a 
constant number of filaments in the tip or increased depolymerisation in the shaft. 
However, the direct correlation between active Drf3 and filament mass (Figure 11) 
demonstrates that the active formin causes the formation of new actin filaments. In 
addition, Drf3-induced filopodia display a constant packing density and a linear 
correlation between filopodium width (e.g. tip versus shaft) and filament number (Figure 
13), proving that filaments within the club-shaped filopodium tip do not splay apart 
during growth as proposed by Yang et al. (2007). Furthermore filopodia were even 
found to emanate from the sides of existing filopodia, without any apparent involvement 
of lamellipodial filaments (Figure 12). Finally, active Drf3 induced filopodia in the 
absence of functional WAVE-complex (Figure 15), which is essential for Arp2/3-
complex mediated nucleation of lamellipodial filaments. Due to the fact that these cells 
lack lamellipodia (Steffen et al., 2006), Drf3-induced filopodia can not employ 
lamellipodial filaments for their generation, indicating that the filaments formed within 
the filopodium are newly nucleated. Taken together, these data can only be explained 
by de novo nucleation of actin filaments in the filopodium tip presumably mediated by 
the active formin in these conditions, although I can not exclude that convergent 
elongation of lamellipodial filaments might be at play to allow the generation of specific 
types or subsets of filopodia. In any case unlike previous dogma my data unequivocally 
demonstrate that convergent elongation is certainly not an essential, and presumably 
not even the predominant mechanism of filopodia initiation. 
4.1.2 Drf3 targeting to filopodia tips 
A critical role for Abi1 in recruiting mDia2 to the leading edge has been proposed by 
Yang et al., who could detect direct binding of mDia2 to Abi but not to any other 
member of the WAVE-complex. These data suggest that mDia2 and Abi1 form a 
distinct macromolar signalling unit with respect to the WAVE-complex (Yang et al., 
2007). A later study reported conflicting data proposing that WAVE (and indirectly the 
Arp2/3-complex) but not Abi1 interact with mDia2 (Beli et al., 2008). The authors 
suggested that mDia2 forms a complex with Wave and Arp2/3-complex jointly inhibiting 
the formation of filopodia. The reasons for this discrepancy are unclear and since no 
interaction studies with Drf3 have been performed in this work, I can not shed light on 
this issue. However, since Drf3 is concentrated at the tips of filopodia elicited in Nap1 
knockdown VA-13 cells (Figure 15), which have been shown to express reduced 
amounts of all other WAVE-complex components including Abi1 (Steffen et al., 2006), a 
crucial role for Abi1 in Drf3 targeting could not be confirmed. It is worth noting however, 
that protein knockdown efficiency by RNAi is never complete, especially in this case 
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where downregulation of Abi1 is an indirect effect of Nap1 RNAi, and remaining levels 
of Abi1 might be sufficient to target Drf3 to the tips of filopodia. Future experiments 
should aim at verifying the dispensability of Abi proteins in mDia2/Drf3 targeting and at 
identifying missing candidates of interaction mediating mDia2/Drf3 recruitment. 
4.1.3 Drf3 is involved but not essential for filopodia formation in Hela S3 
cells 
Since my data excluded the convergent elongation model as the exclusive mechanism 
of filopodia formation, but instead argued for de novo nucleation of filopodial filaments 
by a formin, I aimed at defining the contribution of mDia2 to filopodia formation. Even 
though active mDia2 strongly induced filopodia and accumulated at their tips, cell lines 
like Swiss 3T3 and NIH 3T3 expressing only minute amounts of Drf3 (Figure 18; 
Tominaga et al., 2000) are well established to form these finger-like structures. This 
points towards significant redundancy with other formins in the system. In Dictyostelium 
the mDia2 homolog dDia2 is critical for the formation of these finger-like projections 
(Schirenbeck et al., 2006), and knockdown of mDia2 in mammalian cells has been 
reported to abrogate filopodia (Beli et al., 2007; Yang et al., 2007). However, data 
presented in this work could not corroborate a crucial role of mDia2 in filopodia 
formation in Hela S3 cells (Figure 20). The reason for this discrepancy remains 
unclear, especially as Beli et al. (2007) observed loss of filopodia upon mDia2 
knockdown in exactly the same cell type. However, it has to be mentioned that Beli et 
al. counted filopodia in Hela S3 cells after fixation and phalloidin stainings. Filopodia 
are highly dynamic structures and in particular Hela S3 cells display many kinds of 
membrane projections and retractions, which, especially in fixed samples, can easily 
be mistaken for filopodia. Filopodia are characterised by their protrusive nature, thus 
the only way to reliably count them is by live-video microscopy, as has been done here. 
It is worth mentioning that Yang et al. employed B16-F1, cells which only express 
minute amounts of Drf3 (Figure 18). It is difficult to envisage how knockdown of a 
marginally expressed protein can cause such strong phenotypical effects. I refrained 
from knockdowns in this cell type, since it would have been impossible to document the 
knockdown in Western Blotting. 
In my experimental setup, Hela S3 cells expressing reduced levels of Drf3 were even 
slightly enhanced in their ability to generate filopodia. This is in contrast to published 
studies and might at first glance appear inconsistent with my afore mentioned results 
that were suggestive of Drf3 nucleation activity in filopodia. However, it is difficult to 
exclude that Drf3 performs additional yet unknown functions explaining the enhanced 
filopodia phenotype upon Drf3 knockdown. In addition, the knockdown of Drf3 could 
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affect expression levels of other formins which might enhance the generation of 
filopodia. This hypothesis is supported by the fact that mDia1 (Copeland et al., 2007; 
Higashida et al., 2004; Sarmiento et al., 2008) and FMNL2 (Figure 25) concentrate at 
the tips of filopodia in various cell lines, potentially sharing similar functions with mDia2. 
Redundancy between formins is a frequently observed phenomenon, found e.g. in 
yeast where neither one of the two yeast formins Bni1p and Bnr1p is essential, but both 
are required for viability (Vallen et al., 2000; Ozaki-Kuroda et al., 2001; Sagot et al., 
2002b; Pruyne et al., 2004). Partial redundancy has also been observed in mammalian 
cells, in which invadopodia formation and invasion of breast cancer cells depends not 
on one specific but on all three Dia isoforms (Lizárraga et al., 2009), indicating that at 
least mDia1, 2 and 3 can fulfil overlapping functions in certain cellular processes. In 
order to clarify which formins contribute to the formation of filopodia, it will be essential 
to determine the precise signalling pathways leading to the generation of these 
structures. It becomes evident that the signalling pathways driving filopodia formation 
are divergent, as these structures can be formed downstream of several different Rho-
GTPases e.g. Cdc42 and Rif. Due to the fact that structural constraints exclude an 
interaction of mDia1 with the well-established filopodia effector Cdc42 (Lammers et al., 
2008), future experiments will have to aim at identifying Rho-GTPase(s) activating 
mDia1 and resulting in subsequent filopodia targeting. Potential candidates are Rho 
GTPases influencing filopodia such as Rif, TC10 and Wrch1 (Aspenström et al., 2009; 
Burridge and Wennerberg, 2004; Ellis and Mellor, 2000), but whether they are capable 
of interacting with and activating mDia1 and how that might affect filopodia formation is 
currently unknown.  
4.1.4 Drf3 and lamellipodia formation 
In addition to its function in filopodia formation, contradictory results have recently been 
published concerning the impact of mDia2/Drf3 on the generation of lamellipodia. 
Interestingly, Yang et al. observed the loss of filopodia and lamellipodia upon mDia2 
knockdown, whereas in a conflicting work, mDia2 was instead suppressed by the 
Arp2/3/WAVE-complex pathway driving lamellipodia formation (Beli et al., 2008). In an 
attempt to shed light on this controversy, I explored the impact of Drf3 on lamellipodia 
formation in more detail. First of all, the atypical accumulation of fascin in Drf3∆DAD-
stained lamellipodia (Figure 17), which is consistent with published data by Yang et al. 
(2007) strongly indicate that Drf3∆DAD stained lamellipodia differ from canonical 
lamellipodia lacking fascin at their tips. In addition knockdown of Drf3 in Hela S3 cells 
did not alter the formation of Rac-induced lamellipodia (Figure 21). Although I can not 
fully exclude that Drf3 contributes to filament formation or elongation within the 
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lamellipodium, these data suggest that lamellipodia-like structures containing active 
Drf3 might reflect unnatural protrusive entities. The accumulation of constitutively active 
Drf3 at the cell periphery apparently drives the formation of hybrids of filopodia and 
lamellipodia marked by the filopodial marker protein fascin. The development of 
functional antibodies to confirm the absence of endogenous Drf3 within the 
lamellipodium will be crucial to verify this hypothesis. 
4.2 Functional characterisation of FMNL2 
The data presented here demonstrate so far that mDia2/Drf3 is involved but not 
essential for filopodia formation. Other formins might be able to substitute mDia2/Drf3 
function in its absence. To narrow down other formins capable of effecting or 
modulating lamellipodia and filopodia formation in mammals, I explored the expression 
of different formins in various tissue culture cell lines. FMNL2, also referred to as FRL3, 
is widely expressed and abundant in all cell lines tested (Figure 18; Katoh et al., 2003). 
Therefore, it was a promising candidate to be analysed concerning its contribution to 
the formation of actin dependent protrusive structures. The expression profile of two 
FMNL2 splice variants, A and B, have been analysed previously in detail by a 
bioinformatic approach (Katoh et al., 2003). Surprisingly, amplification of FMNL2 from 
Hela S3 cDNA revealed a third splice variant FMNL2C, the existence of which had 
already been proposed previously (NCBI reference sequence: NM_001004422.1), but 
experimental data confirming its expression were so far not available. Data presented 
in this work suggests FMNL2C to be expressed in Hela S3 cells, but additional 
experiments should explore the expression profiles of different FMNL2 splice variants 
in various cell types, which will allow more insights into the physiological functions of all 
these variants. 
4.2.1 FMNL2 localises to the lamellipodium and filopodium tip 
Similar to many other full length formins FMNL2A and B are entirely cytosolic (Figure 
24), at least when expressed by itself and when fused to EGFP on its N-terminus. For 
reasons having become clear at later stages of my work, FMNL2 A and B variants 
fused to EGFP at their C-terminus did show distinct subcellular localisation (see below) 
In contrast to EGFP-FMNL2A and B, EGFP-FMNL2C was not cytoplasmic but 
accumulated at the leading edge and at tips of filopodia in B16 cells (Figure 24) similar 
to an active FMNL2 construct lacking the DAD-domain (Figure 25), suggesting that 
autoinhibition in this splice variant is less efficient. Similar observations have already 
been made for other full length Drfs such as FRL2 (also referred to as FMNL3) and 
FMNL1γ, which were observed not to be cytosolic but to accumulate at membranes 
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(Vaillant et al., 2008; Han et al., 2009). The authors of both studies concluded that 
these specific Drf family members are constitutively active, thus do not comprise 
functional DAD-domains. Due to the fact that EGFP-FMNL2C localisation was 
abrogated in Cdc42-deficient cells (Figure 30) the absence of autoinhibition seems 
unlikely. FMNL2A and B are dramatically translocated to the leading edge upon co-
expression of active Cdc42 (see below), indicating that the localisation of FMNL2C, 
which only differs in its sequence to –A and –B at its extreme C-terminus, is also 
mediated by Cdc42. If endogenous Cdc42 activity in B16-F1 cells was indeed sufficient 
to release the autoinhibiton of FMNL2C, this could be explained by weaker interactions 
between the DAD and the DID domain, resulting in more efficient release of the 
autoinhibition upon Cdc42 binding compared to the FMNL2A and B splice variants. 
However, this hypothesis needs to be experimentally verified e.g. by structural data 
and in vitro assays analysing DID-DAD binding in these variants. It would be interesting 
to investigate the expression profiles of these specific formin splice variants in 
appropriate cell lines and tissues, and combine this with the knowledge of expression 
levels of interacting Rho-GTPases. One possibility would be that Drf splice variants that 
feature weaker DID-DAD interactions are restricted to tissues and cell lines expressing 
reduced amounts of the relevant Rho-GTPase, thereby facilitating activation of the Drf. 
Interestingly EGFP-FMNL2 is the first formin variant convincingly localising to the 
lamellipodium front without inducing atypical lamellipodial behaviour or unusual 
accumulation of fascin (Figure 26), as has previously been observed for active Drf3. In 
addition, such a localisation to the leading edge could also be confirmed by 
immunofluorescence stainings using an antibody raised against FMNL2 (Figure 27). 
However, since the antibody used for immunofluorescence stainings detected FMNL3 
in addition to FMNL2 on western blots, stainings might reflect localisation of both 
endogenous FMNL2 and -3. This is not entirely unlikely, since EGFP-tagged FMNL3 
was also found to target to the leading edge in a fashion indistinguishable to FMNL2 
(see below). Whatever the case, the data strongly indicate that FMNL proteins can 
accumulate in principle to the tips of lamellipodia, pointing at potential functions for 
these proteins in the protrusion of these structures, so far considered to exclusively 
depend on Arp2/3-complex function. 
4.2.2 Regulation and targeting of FMNL2 to the leading edge 
Although pull-down assays revealed strong, perhaps direct, interactions with Cdc42 
and the well established lamellipodia effector Rac (Figure 28), I failed to link Rac 
binding to the accumulation of FMNL2 at the lamellipodium tip (Figure 29). Surprisingly, 
targeting of FMNL2 to the lamellipodium occurs downstream of Cdc42 (Figure 29). This 
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small Rho-GTPase is thought to be involved in filopodia formation rather than in the 
generation of lamellipodia, although numerous studies reported that active Cdc42 is 
capable of triggering the formation of lamellipodia (Aspenström et al., 2004; Hall, 1998; 
Nobes and Hall, 1995). Since Cdc42-induced lamellipodia formation could be blocked 
by dominant negative Rac (Nobes and Hall, 1995), this phenotype was interpreted to 
derive from Cdc42-mediated Rac activation. In spite of this view, a recent study 
indicated Cdc42 functions in migration on top of, and not just upstream of Rac-
GTPases (Monypenny et al., 2009). However, it remains to be demonstrated that 
Cdc42 can indeed induce the formation of lamellipodia or lamellipodia-like structures in 
the absence of Rac-GTPases. Irrespective of the question whether Cdc42 can trigger 
the protrusion of a lamellipodium in the absence of Rac, I was able to identify a new 
Cdc42 effector convincingly accumulating at the leading edge and presumably playing 
a role in the formation of these protrusive structures. 
I was surprised to find that the interaction between FMNL2 and Rac1 in vitro is not 
sufficient to cause membrane targeting of the formin in vivo. The reasons for this are 
currently unclear. While characterising FMNL2 in this thesis, an N-terminal 
myristoylation site was identified (see below). Since the interaction studies were 
performed with non-myristoylatable constructs (due to an N-terminal EGFP-tag), I can 
not exclude at present that myristoylation contributes to the specificity of interaction of 
the FMNL2 N-terminus with different Rho-GTPases. Besides its well established ability 
to mediate membrane targeting, the myristate moiety has in the past been implicated in 
influencing protein-protein interactions (Resh, 2006; 1999). To clarify whether the 
myristate moiety could have an impact on the specificity of interactions with different 
Rho-GTPases, additional pull-down assays utilising potentially myristoylatable 
constructs compared with the myristoylation-deficient mutants are required 
(collaboration with Dr. Mathias Geyer, MPI Dortmund). Another explanation for the 
observed binding of FMNL2 to Rac1 could be that Rac1 is not upstream but 
downstream of FMNL2 implicating that the formin is affecting Rac1 activity. This has 
already been proposed for other Drfs such as mDia1 and DAAM1, both of which seem 
to be capable of activating RhoA by interacting with a Rho GEF (Habas et al., 2001; 
Kitzing et al., 2007). It can not be excluded at this stage that FMNL2 interacted 
indirectly with Rac in pull-down experiments through a Rac interacting protein such as 
a GEF or GAP. It would be interesting to compare activation levels of Rac in FMNL2-
expressing and FMNL2-knockdown cells, e.g. by pull-downs with PAK-CRIB beads that 
bind exclusively to activated Rac and Cdc42. 
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4.2.3 Regulation by myristoylation 
A recent publication discovered a myristoylation consensus in the hematopoietic family 
member FMNL1. The authors described that the membrane localisation of FMNL1 and 
the induction of blebbing critically depends on the myristate moiety, since a 
myristoylation deficient mutant failed to induce membrane blebs and did not target to 
the cell membrane (Han et al., 2009). Importantly, the myristoylation characterised here 
was discovered based on a sequence consensus lacking in FMNL1 (Maurer-Stroh et 
al., 2002; collaboration with Mathias Geyer, MPI Dortmund). To gain further insight into 
the function of this cotranslational modification, I generated constructs preserving the 
lipid modification by fusing the EGFP-tag to the C-terminus of the protein and a 
myristoylation-deficient mutant by changing the second Glycin of FMNL2, which is 
essential for addition of the myristate moiety, to Alanin. Surprisingly, presumably 
myristoylatable full length constructs accumulated at the leading edge in B16-F1 cells 
in a fashion comparable to active FMNL2∆DAD or full length FMNL2 co-expressed with 
active Cdc42 (Figure 32). To explore whether this targeting in B16-F1 cells is achieved 
by release of autoinhibition of FMNL2 by endogenous Cdc42, I analysed the 
localisation of the myristoylatable FMNL2 variants in a Cdc42-deficient cell line. Since 
the myristoylatable FMNL2 constructs also concentrated weakly at the leading edge in 
the absence of Cdc42, whereas the non-myristoylatable mutant did not (Figure 33), the 
myristate moiety in theory could either mediate targeting to the leading edge on its own 
or interfere with proper autoinhibition. However, as opposed to published results (Han 
et al., 2009), I found the myristoylation to be required neither for release of 
autoinhibition nor for targeting, since the myristoylation-deficient FMNL2 mutant is 
enriched at the cell periphery upon co-expression of active Cdc42 in Cdc42 -/- cells 
(Figure 33) and a comparable mutant rendered active through removal of its DAD-
domain was capable of accumulating at the leading edge even in the absence of 
Cdc42 (Figure 34). In conclusion, these data not only demonstrate that both 
myristoylation and Cdc42 can aid intracellular targeting presumably by counteracting 
autoinhibition, but also that neither signal constitutes an essential localisation 
determinant once the formin is activated. 
4.2.4 Potential regulation by formin binding proteins 
The data described above suggest that other yet unknown factors mediate subcellular 
positioning of the formin. Although the myristate moiety has been implicated in 
membrane targeting (Han et al., 2009) many studies indicated that this modification 
alone is not sufficient to mediate localisation to cell membranes (Swierczynski et al., 
1996; Zhou et al., 1994). Usually membrane targeting by such lipid modifications is 
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achieved by myristate plus additional basic aminoacid residues, an additional 
palmitoylation of the protein or a domain that interacts with other membrane-bound 
components (Resh et al., 2006; 1999), indicating that there has to be an additional yet 
unidentified signal causing membrane targeting of FMNL2. Although Rho-GTPases 
have been implicated in recruiting formins to specific sites (Martin et al., 2007; Seth et 
al., 2006), my data suggest that at least Cdc42 is not required for determination of 
membrane localisation, since constitutively active FMNL2 is enriched at the leading 
edge even in Cdc42-deficient cells in a fashion comparable to Cdc42-expressing 
control cells (Figure 34). I would like to argue that Cdc42 is only responsible for 
releasing autoinhibition as a prerequisite for membrane targeting, the latter of which is 
mediated by other FMNL2-interacting proteins, lipid modification or both. Furthermore, 
the fact that co-expression of active Cdc42 with full length Drf3 and full length FMNL2 
does not cause similar subcellular localisation patterns implies that Cdc42 is indeed not 
capable of mediating subcellular positioning. More specifically, co-expression of Drf3 
with active Cdc42 resulted in the concentration of Drf3 at the entire plasma membrane 
(Figure 8) whereas the same treatment caused FMNL2 targeting to the lamellipodium 
(Figure 29). Thus, this data suggest that subcellular targeting can not solely be 
achieved by interactions with Cdc42 or any other GTPases such as Rac, since none of 
the GTPases have been found to convincingly accumulate at the tips of lamellipodia 
(data not shown). 
In addition to Rho-GTPases many other formin binding proteins have been identified, 
some of them influencing the subcellular localisation of formins (Aspenström, 2009). 
For instance Src family kinases are prominent modulators of formin function. These 
non receptor tyrosine kinases can bind formins directly and Src has been reported to 
relocate Formin-1 from the nucleus to the plasma membrane (Uetz et al., 1996). 
Interestingly the FH3-domain, which comprises the DID and the dimerisation domain, 
has been shown to determine subcellular localisation (Petersen et al., 1998; Katoh et 
al., 2001; Ozaki-Kuroda et al., 2001; Sharpless and Harris, 2002). This is supported by 
a recent study showing that IQGAP1 interacts with the FH3-domain of mDia1 and is 
required for the localisation of mDia1 without activating or inhibiting the formin (Brandt 
el al., 2007). It will be instrumental in future experiments to determine how localisation 
of FMNL2 at the leading edge is achieved.  
4.3 FMNL2 does not nucleate actin filaments in vitro 
The majority of previously analysed formins have been demonstrated to nucleate actin 
filaments. FMNL1, the hematopoietic homolog of FMNL2, bundles actin filaments, 
competes with capping protein for barbed end binding, severs actin filaments and 
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accelerates polymerisation from actin monomers (Harris et al., 2004; 2006). Previous 
work utilising the FH2-domains of FMNL2 and -3 demonstrated that these formins are 
also capable of filament bundling in vitro (Vaillant et al., 2008). In addition, the FH2-
domains of both FMNL2 and -3 appeared to induce actin polymerisation, even though 
the effect observed in pyrene–actin polymerisation assays was comparably modest. 
Although the FH2-domain in formins is necessary and sufficient to induce actin 
polymerisation, it is well established that the profilin-binding activity of the FH1-domain 
critically contributes to formin-mediated actin assembly (Kovar et al., 2003; Kovar and 
Pollard, 2004; Romero et al., 2004; Kovar et al., 2006). Since the biochemical 
properties of FMNL2 and -3 were previously analysed by using isolated FH2-domains, 
it seemed important to extend this analysis to the FH1-FH2-domains of FMNL2. 
Surprisingly, using this experimental setup FMNL2 was not capable of nucleating actin 
filaments from actin monomers neither in pyrene-actin polymerisation nor TIRF assays 
(Figure 35 and Figure 36). This discrepancy to published results could arise from using 
a construct comprised of the FH1- and FH2-domains instead of isolated FH2-domains 
used in previous in vitro assays. So far the only other described formin not capable of 
nucleating actin filaments in vitro is FHOD3 (Taniguchi et al., 2009). Together with the 
data presented in this thesis, one could assume that actin nucleation is not a 
necessarily feature applying to all formins. However, I can not exclude that additional 
factors not present in the in vitro system influence FMNL2 activity and facilitate FMNL2 
mediated actin nucleation in vivo.  
Due to the prominent accumulation of FMNL2 in the lamellipodium, it can be assumed 
that it fulfils certain functions such as regulating elongation or nucleation in this cellular 
compartment. Although the Arp2/3-complex is well established to be responsible for 
filament nucleation within the lamellipodium, formins such as FMNL2 and -3 might 
contribute to filament formation in these protrusive structures. However, functions 
mediated by FMNL2 and -3 must be different from Arp2/3-complex, since B16-F1 cells 
expressing reduced levels of FMNL2 and -3 did form lamellipodia (Figure 41), which is 
in contrast to Arp2/3-knockdown cells largely lacking these structures (Steffen et al., 
2006; Gomez et al., 2007; Nicholson-Dykstra and Higgs, 2007). Whatever the case, the 
precise role of FMNL2 accumulation in the lamellipodium remains uncertain at present. 
 
4.3.1 FMNL2 elongates actin filaments in vitro and regulates cell motility 
in vivo 
Although FMNL2-FH1-FH2 does not nucleate actin filaments, it binds to barbed ends of 
actin filaments and promotes processive barbed end elongation in the presence of 
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profilin in vitro (Figure 36). Since profilinactin is the predominant species of actin 
monomers available for polymerisation within the cell (Pollard et al., 2000; Kaiser et al., 
1999), this biochemical behaviour might be quite close to the situation within living 
organisms. In conjunction with its localisation at the leading edge and reduced 
migration speed in B16-F1 melanoma cells upon FMNL2 knockdown (Figure 42), this 
suggests that FMNL2 positively regulates motility in B16 F1 cells. This is consistent 
with upregulation of FMNL2 in colorectal cancer cells, which could be directly 
correlated with higher invasiveness and enhanced metastasis (Zhu et al., 2008). 
FMNL2 might regulate elongation of actin filaments nucleated by the Arp2/3-complex 
within the lamellipodium, thereby enhancing cell motility, although this remains to be 
directly demonstrated. As the double knockdown of FMNL2 and -3 causes an even 
more severe reduction in migration speed, these two formins might work closely 
together and fulfil similar functions. This could be consistent with the observations that 
FMNL3 also interacts with active Cdc42 and active Rac1 in pull-down experiments 
(Figure 37), and is enriched at the leading edge upon co-expression of active Cdc42, 
supporting potential redundant functions of the two formins. In addition, FMNL2 and -3 
were reported to be capable of forming heterodimers via their DID-, DAD-, their 
dimerisation- and FH2-domains, possibly regulating the activity of both proteins 
(Vaillant et al., 2008). Whether the sequence stretches lacking N-terminal to and within 
the FH1-domain of FMNL3 compared to FMNL2 are relevant for its ability to interact 
with actin filaments remains to be investigated in the future, but this might have 
interesting consequences for FMNL3 functions within the lamellipodium and in cell 
motility.  
FMNL2, and maybe also FMNL3, might act as a filament elongation factors within the 
lamellipodium similar to VASP, another actin binding protein promoting filament 
assembly at the tip of the lamellipodium. However, in contrast to the reduced migration 
speed in FMNL2 and -3 knockdown cells, genetic removal of the Ena/VASP family 
members Mena and VASP in fibroblast cells results in increased other than decreased 
cell motility (Bear et al., 2000). This seems paradoxical given that lamellipodial 
protrusion rate positively correlates with the intensity of GFP-VASP at the leading 
edge, and Ena/VASP proteins were shown to enhance actin-based motility of Listeria 
monocytogenes (Rottner et al., 1999a; Laurent et al., 1999; Loisel et al., 1999). 
However, the protrusion rates of lamellipodia do not necessarily correlate with global 
migration rate observed in these cells. Mena/VASP-deficient lamellipodia appeared to 
protrude slower but more persistently, resulting in increased cell translocation rates, 
indicating that an optimal balance between lamellipodia extension, adhesion, 
translocation and cell polarisation controls productive locomotion (Bear et al., 2002; 
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Krause et al., 2003). It will be a very interesting task to explore how lamellipodial 
protrusion rates correlate with EGFP-FMNL2 intensity at the leading edge, or with 
RNAi-mediated knockdown of FMNL2 and -3. It also might be attractive to compare 
FMNL2 and -3 with VASP functions in the lamellipodium. Of note, immunofluorescence 
stainings showed normal accumulation of VASP in the lamellipodia of cells over-
expressing active FMNL2 (Figure 26), indicating that both proteins can localise 
simultaneously in these protrusive structures.  
4.3.2 FMNL2 and FMNL3 have potentially redundant functions 
In this work, I additionally characterised FMNL3, another member of the diaphanous 
related formins sharing roughly 70% sequence identity with FMNL2. As previously 
observed for FMNL2, the N-terminus of FMNL3 is capable of binding active Cdc42 and 
Rac1 (Figure 37). Co-expression of active Cdc42 but not active Rac is sufficient to 
cause accumulation of FMNL3 full length in the leading edge in B16 cells. As 
mentioned for FMNL2 earlier, the physiological relevance of Rac binding to FMNL3 
remains elusive at this stage. In addition, FMNL3 also contains a myristoylation 
consensus sequence (Han et al., 2009) making it reasonable to assume that this lipid 
modification will regulate the protein´s activity in a fashion comparable to FMNL2. 
Remarkably, FMNL3 has been proposed to be constitutively active, although its DID is 
able to bind its DAD both in vivo and in vitro (Vaillant et al., 2008). Vaillant et al. 
employed a reporter gene assay, which records activation of the actin/MAL/SRF 
pathway in response to depletion of the cellular G-actin pool, as observed e.g. in case 
of formin-mediated actin polymerisation. Since all experiments in this study concerning 
the autoregulation of FMNL3 were performed in NIH3T3 cells, so in the presence of 
endogenous Cdc42, it is possible that the endogenous GTPase interfered with proper 
autoinhibition in vivo as observed in our case for EGFP-FMNL2C (see above). In my 
experimental setup, I could not obtain any indication that FMNL3 is constitutively 
active, as the full length protein did not accumulate to any protrusive cytoskeletal 
structures. Future experiments employing SRF reporter assays should benefit from 
carefully choosing cell lines, devoid perhaps of high activity of the respective interacting 
Rho-GTPase. 
4.4 Concluding remarks  
This work has provided new insights into the formation of filopodia mediated by 
formins. A constitutively active variant of Drf3 lacking the C-terminal DAD-domain 
strongly induced filopodia and localised to the tips of these protrusive structures. The 
data presented here strongly suggest that filopodia are generated by de novo filament 
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nucleation and not by convergent elongation of lamellipodial actin filaments. In contrast 
to the prevailing view that mDia2/Drf3 is required for the formation of filopodia, my 
experiments also showed that Drf3 is dispensable for filopodia formation in Hela S3 
cells. Future experiments will have to evaluate how other diaphanous related formins 
such as mDia1 influence the formation of filopodia and whether they share redundant 
functions. We still have to wait for an individual factor the removal of which will abolish 
filopodia formation.  
In a second project, I examined the molecular regulation and cellular function of the yet 
poorly characterised formin FMNL2, and the related protein FMNL3. Both formins are 
activated by the small Rho-GTPase Cdc42 to localise to the leading edge of the cell. 
An N-terminal myristoylation of FMNL2 contribute to the regulation of autoinhibition, but 
is not essential for subcellular positioning per se, as proposed previously (Han et al., 
2009). Biochemical evidence suggests that FMNL2 does not nucleate but instead 
elongates actin filaments, promising exciting effects on the modulation of the actin 
filament network in the lamellipodium. Finally, FMNL2 and -3 are involved in regulating 
cell migration, although it remains unknown how exactly this relates to their 
biochemical activity within the lamellipodium. Future work will thus aim at clarifying this 
issue, and at shedding light on the functions of formins or related factors such as 
Ena/VASP proteins relative to the proposed dominating role of Arp2/3-complex in actin 
filament nucleation in the lamellipodium. 
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5 Summary 
In the present work, the contribution of the diaphanous related formins mDia2/Drf3 and 
FMNL2/3 to the actin-based formation of lamellipodia and filopodia was analysed. 
Since filopodia formation can occur upon suppression of Arp2/3-complex, filopodial 
actin filaments may assemble by means of other actin nucleators such as formins. To 
characterize the role of mDia2/Drf3 in mammalian cells, an EGFP-tagged active Drf3 
variant, lacking the C-terminal DAD-domain (Drf3∆DAD), was generated. Expression of 
EGFP-Drf3∆DAD in B16-F1 mouse melanoma cells strongly induced the formation of 
filopodia tipped by the formin. Interestingly, Drf3∆DAD–containing filopodia frequently 
thickened at their tips after protruding beyond the cell periphery. Yet, actin filament 
spacing in these filopodia was largely independent of filopodial width, as determined by 
electron microscopy. In addition to that, Drf3∆DAD levels and F-actin amounts showed 
a linear correlation in these filopodia tips. Thus, these data demonstrated that 
thickening of Drf3∆DAD-induced filopodia tips occurs through de novo actin filament 
nucleation. My results indicate nucleation of actin filaments to be the predominant 
mechanism of actin filament generation in filopodia, rather than simple elongation of 
pre-existing lamellipodial filaments. Although clearly involved in this process, Drf3 can 
be functionally replaced by other formins, as I found its removal to abolish filopodia 
formation. 
For instance, both Drfs FMNL2 and FMNL3 emerged as potential additional regulators 
of filopodia, but also lamellipodia formation. Active EGFP-tagged FMNL2 was strongly 
enriched at the tips of protruding lamellipodia and filopodia in B16-F1 cells. FMNL2 and 
-3 interacted with active Cdc42 and Rac1 in vitro. Interestingly, co-expression of Cdc42 
but not Rac was sufficient to mediate accumulation of EGFP-tagged FMNL2 and -3 at 
the tips of lamellipodia and filopodia. In addition, FMNL2 appeared to be regulated by 
N-terminal myristoylation. Although myristoylation was not essential for interaction of 
the formin with Cdc42 and proper subcellular targeting, both the lipid modification and 
active Cdc42 contribute to localisation and activation by counteracting autoinhibition. In 
vitro polymerisation assays indicated that FMNL2 does not promote actin filament 
nucleation, but instead elongation powered by profilin. In vivo the presence of both 
FMNL2 and -3 was relevant for efficient cell motility, significantly expanding the 
repertoire of Cdc42 effectors directly promoting actin filament assembly and turnover in 
migration. 
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6 Abbreviations 
A   Ampere 
aa   amino acid 
Abi1  Abl interactor1 
ADF   actin-depolymerising factor 
ATCC   American Type Culture Collection 
ATP   Adenosine triphosphate 
bp   base pairs 
BSA   bovine serum albumin 
CC  coiled-coil domain 
Cc   critical concentration 
cAMP   cyclic adenosin monophosphate 
cGMP   cyclic guanosin monophosphate 
Cdc42  cell division cycle 42 
cDNA   copy DNA 
C-terminal  carboxy-terminal 
kDa  Kilodalton 
DAD  diaphanous autoinhibitory domain 
DD  dimerisation domain 
DID  diaphanous inhibitory domain 
DMSO   dimethylsulfoxide 
DNA   desoxyribonucleic acid 
Drf3  diaphanous related formin 3 
E. coli   Escherichia coli 
EDTA   Ethylene diamine tetraacetic acid 
EGTA  Ethylene glycol-bis(2-aminoethylether)-tetraacetic acid 
EGFP   enhanced green fluorescent protein 
ELISA  enzyme-linked immunosorbent assay 
et al.   et alia 
f-actin  filamentous actin 
FCS  fetal calf serum 
FRAP   Fluorescence recovery after photobleaching 
FH1  formin homology 1 
FH2   formin homology 2 
fw   forward 
G-actin   globular actin 
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GAP  GTPase activating protein 
GBD   GTPase-binding domain 
GDI   GDP dissociation inhibitor 
GDP   Guanosine diphosphate 
GEF   guanine nucleotide exchange factor 
GTP   Guanosine triphosphate 
GFP   green fluorescent protein 
HEPES   N-2-Hydroxyethylpiperazine-N’-2-ethane sulfonic acid 
IF  immunofluorescence 
Ig   immunoglobulin 
IP  immunoprecipitation 
µ   micro 
M   molar 
mc  monoclonal 
l    liter 
mRFP   monomeric red fluorescent protein 
mRNA   messenger RNA 
Nap1   Nck associated protein1 
NMT  N-myristoyltransferase 
NPF   nucleation promoting factor 
N-terminal amino terminal 
PAGE   polyacrylamide-gel electrophoresis 
PBS   phosphate buffered saline 
pc   polyclonal 
PCR   polymerase chain reaction 
PEG   Polyethylene glycol 
PI3-K   phosphatidylinositol-3-kinase 
PO  peroxidase 
Rac1   Ras-related C3 botulinum toxin substrate 1 
rev  reverse 
RNA   ribonucleic acid 
Rho   Ras homolog gene family 
RhoA/B/C/G  Ras homolog gene family, member A/B/C/G 
RZPD   Deutsches Ressourcenzentrum für Genomforschung GmbH 
SDS   sodium dodecyl sulphate 
SH2   Src-Homologie-Region2 
SH3  Src-Homologie-Region3 
Sra-1   specifically Rac associated protein 1 
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TAE   Tris-Acetate-EDTA-buffer 
Toca-1   transducer of Cdc42 dependent actin assembly 1 
Tris   Tris-(hydroxymethyl) aminomethane 
TIRF   Total Internal Reflection Fluorescense 
UK  United Kingdom 
USA   United States of America 
V  Volt 
v/v   volume per volume 
x g   times gravity 
VASP   Vasodilator stimulated phosphoprotein 
WASH  Wiskott-Aldrich Syndrome protein and Scar omolog 
WASP   Wiskott-Aldrich Syndrome protein 
WAVE  Wiskott-Aldrich Syndrome verprolin homologue protein 
WB   Western blot 
WHAMM  WASP homolog associated with actin, membranes and microtubules 
w/v   weight per volume 
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9 Appendix 
9.1 Video Legends (Supplementary material available on CD) 
 
Movie1. B16-F1 cell moving on laminin and expressing EGFP-tagged full-length 
human Drf3. Display rate is 330-fold. Bar is 10 µm. 
Movie 2. B16-F1 cell over-expressing EGFP-tagged, active Drf3. Display rate is 330-
fold. Bar is 10 µm. 
Movie 3. Control siRNA-treated (Control RNAi) VA-13 fibroblast cell (Steffen et al., 
2006) transiently transfected with Drf3∆DAD. Display rate is 330-fold. Bar is 10 µm. 
Movie 4. Nap1 knockdown VA-13 fibroblast (Nap1 RNAi) transiently expressing 
Drf3∆DAD. Note prominent formation of filopodia tipped by EGFP-tagged Drf3∆DAD in 
spite of WAVE-complex loss of function and coincident lack of lamellipodia (Steffen et 
al., 2004). Display rate is 330-fold. Bar is 10 µm. 
Movie 5. B16-F1 cell moving on laminin and expressing EGFP-tagged, active Drf3. 
Note the accumulation of Drf3 at the tips of both filopodia and lamellipodia-like 
structures. Display rate is 330-fold. Bar is 10µm. 
Movie 6: B16-F1 cell moving on laminin and expression EGFP-tagged full length 
human FMNL2A. Time as indicated. Bar is 10µm. 
Movie 7: B16-F1 cell over-expressing EGFP-tagged full length human FMNL2B. Time 
as indicated. Bar is 10µm. 
Movie 8: Migrating B16-F1 cell expressing EGFP-tagged full length human FMNL2C. 
Note weak localisation of this splice variant to the lamellipodium in contrast to EGFP-
tagged full length human FMNL2A and FMNL2B. Display rate is 330-fold. Bar equals 
10µm. 
Movie 9: B16-F1 cells moving on laminin and expressing EGFP-tagged, active FMNL2. 
Note prominent accumulation at the lamellipodium and tips of filopodia. Time as 
indicated. Bar equals 10µm. 
                                                                                                                      Appendix 
   
9.2 List of Figures 
Figure 1: Actin treadmilling at steady state ................................................................... 3 
Figure 2: Migrating fibroblast showing different types of membrane protrusions........... 4 
Figure 3: Domain organisation and molecular regulation of diaphanous related formins
...............................................................................................................................10 
Figure 4: Schematic of a formin in action.....................................................................12 
Figure 5: The Rho- family of proteins...........................................................................21 
Figure 6: The GTPase cycle........................................................................................22 
Figure 7: Expression of active Drf3∆DAD induces the formation of filopodia ...............47 
Figure 8: Cdc42-induced targeting of Drf3 to the plasma membrane and the tips of 
filopodia upon Rac inhibition. ..................................................................................48 
Figure 9: Co-transfection of Drf3 full length with constitutively active Rif induces 
filopodia. .................................................................................................................49 
Figure 10: Spontaneous thickening of Drf3∆DAD-induced filopodia. ...........................50 
Figure 11: B16-F1 cell over-expressing EGFP-tagged Drf3∆DAD and counterstained 
for phalloidin. ..........................................................................................................51 
Figure 12: Filopodia ultra-structure in control and Drf3∆DAD over-expressing cells. ...52 
Figure 13: Analysis of filament numbers in Drf3∆DAD-induced filopodia .....................53 
Figure 14: Control siRNA-treated (Control RNAi) VA-13 fibroblast cell (Steffen et al., 
2006) transiently transfected with Drf3∆DAD. .........................................................55 
Figure 15: Nap1 knockdown VA-13 fibroblast (Nap1 RNAi) transiently expressing 
Drf3∆DAD...............................................................................................................55 
Figure 16: Drf3∆DAD can target to the tip of a lamellipodium like structure. ................56 
Figure 17: Drf3∆DAD induced lamellipodia-like- structures contain Arp2/3 complex and 
fascin. .....................................................................................................................58 
Figure 18: Microarray analyses of cell lines as indicated. ............................................59 
Figure 19: Expression of Drf3 in different murine and human cell lines........................60 
Figure 20: Filopodia formation does not require Drf3 in Hela cells...............................61 
Figure 21: Drf3 is not required for Rac-induced lamellipodia formation........................62 
Figure 22: Expression profile of formins in different murine and human cell lines. .......63 
Figure 23: Domain organisation of FMNL2 and splice variants ....................................66 
Figure 24: FMNL2A and FMNL2B are entirely cytosolic whereas FMNL2C localises to 
the leading edge of B16 mouse melanoma cells. ....................................................67 
Figure 25: FMNL2∆DAD at the tips of protruding filopodia and lamellipodia. ...............68 
Figure 26: FMNL2∆DAD-stained lamellipodia contain Arp2/3-complex and Arp2/3-
complex activators but no fascin. ............................................................................69 
Figure 27: Endogenous FMNL2 localizes to the lamellipodium of B16F1 cells. ...........70 
Figure 28: FMNL2 interacts with constitutively active Cdc42 and Rac1. ......................71 
Figure 29: Cdc42 (but not Rac) induced targeting of FMNL2 to the cell periphery .......72 
Figure 30: Expression of FMNL2C splice variant in cdc42 fl/- and cdc42 -/- cells ........73 
                                                                                                                      Appendix 
 130 
 
Figure 31: Co-expression of FMNL2C and Cdc42 (but not Rac) drives targeting in 
Cdc42-/- cells..........................................................................................................74 
Figure 32: C-terminally tagged FMNL2A and –B accumulate at the leading edge of B16 
cells. .......................................................................................................................76 
Figure 33: Myristoylation can contribute to, but is not essential for subcellular 
positioning of FMNL2..............................................................................................77 
Figure 34: Cdc42 is not required for targeting of FMNL2∆DAD to the cell periphery....79 
Figure 35: Biochemical analysis of FMNL2-mediated actin assembly..........................81 
Figure 36: TIRF analyses of FMNL2 mediated actin assembly. ...................................82 
Figure 37: FMNL3 interacts with constitutively active Cdc42 and Rac1. ......................84 
Figure 38: EGFP-FMNL3 full length is cytosolic in B16 cells .......................................85 
Figure 39: Co-expression of active Cdc42 but not active Rac leads to an accumulation 
of FMNL3 at the leading edge.................................................................................85 
Figure 40: Expression analyses of FMNL2 and -3 and FMNL2 antibody characterisation
...............................................................................................................................88 
Figure 41: Lamellipodia formation in B16 cells is largely unaffected by FMNL2 or 
FMNL2 and -3 knockdown ......................................................................................89 
Figure 42: FMNL2 and FMNL2 and -3 knockdown reduces migration speed in B16 cells
...............................................................................................................................91 
 
9.3 List of Tables 
Table 1: List of constructs used in this work. ...............................................................29 
Table 2: List of primers for amplifying, sequencing and site directed mutagenesis used 
in this thesis............................................................................................................31 
Table 3: Generation of EGFP-FMNL2 fusion protein. ..................................................32 
Table 4: Primers used for cDNA synthesis...................................................................35 
Table 5: Primary antibodies.........................................................................................37 
Table 6: Secondary reagents ......................................................................................38 
Table 7: Cell lines employed in this work.....................................................................40 
Table 8: Knockdown vectors employed in this work.....................................................42 
 
 
 
 
 
 
                                                                                                                                                                                                                                                             
 131 
 
10 Lebenslauf 
 
Name: Jennifer Block 
email: Jennifer.Block@helmholtz-hzi.de 
Geburtsdatum: 04.01.1982 
Geburtsort: Friesoythe 
Staatsangehörigkeit: Deutsch 
 
Ausbildung: 
 
November 2006 bis heute: Doktorarbeit in der Arbeitsgruppe für 
Zytoskelettdynamik am Helmholtz-Zentrum für 
Infektionsforschung in Braunschweig, 
Deutschland 
Januar 2006- Oktober 2006: Diplomarbeit „Dynamik und `Turnover´ von 
Aktinmonomeren in migrierenden Zellen“ in der 
Arbeitsgruppe für Zytoskelettdynamik am 
Helmholtz-Zentrum für Infektionsforschung in 
Braunschweig, Deutschland 
Oktober 2001- Oktober 2006:    Diplomstudiengang Biologie an der Technischen 
Universität Carolo-Wilhelmina zu Braunschweig 
Schullaufbahn: 
 
1994-2001: Albertus-Magnus Gymnasium in Friesoythe, 
Schulabschluss mit dem Abitur 
1992-1994: Orientierungsstufe Friesoythe  
1988-1992: St. Ludgeri Grundschule Friesoythe 
 
 
 
